FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Hans-Jürgen Möller

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Co-author Network

Publications

TOP 3
Alexander Soutschek; Wolfgang Schwarzkopf; Christian Sorg; Kathrin Finke; Kristina Hennig-Fast; Hans-Jürgen Möller; Hermann J Müller; Michael Riedel; Torsten Schubert
Interference control in adult ADHD: No evidence for interference control deficits if response speed is controlled by delta plots.
Borwin Bandelow; Reinhard Boerner J; Siegfried Kasper; Michael Linden; Hans-Ulrich Wittchen; Hans-Jürgen Möller
The diagnosis and treatment of generalized anxiety disorder.
Felix M Segmiller; Thomas Volkamer; Igor Hermisson; Gerd Laux; Hans-Jürgen Möller; Michael Riedel; Florian Seemüller; Alexander Brunnauer
Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Hans-Jürgen Möller (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alexander Soutschek; Wolfgang Schwarzkopf; Christian Sorg; Kathrin Finke; Kristina Hennig-Fast; Hans-Jürgen Möller; Hermann J Müller; Michael Riedel; Torsten Schubert
Interference control in adult ADHD: No evidence for interference control deficits if response speed is controlled by delta plots.
Acta psychologica 2013;143(1):71-8.
2013: Borwin Bandelow; Reinhard Boerner J; Siegfried Kasper; Michael Linden; Hans-Ulrich Wittchen; Hans-Jürgen Möller
The diagnosis and treatment of generalized anxiety disorder.
Deutsches Ärzteblatt international 2013;110(17):300-10.
2013: Felix M Segmiller; Thomas Volkamer; Igor Hermisson; Gerd Laux; Hans-Jürgen Möller; Michael Riedel; Florian Seemüller; Alexander Brunnauer
Driving ability according to German guidelines in stabilized bipolar I and II outpatients receiving lithium or lamotrigine.
Journal of clinical pharmacology 2013;53(4):459-62.
2013: Jens Benninghoff; Victor Brantl; Rainald Moessner; Hans-Jürgen Möller; Werner Rauh; Robert Schloesser; Dan Rujescu
Cholinergic impact on neuroplasticity drives muscarinic M1 receptor mediated differentiation into neurons.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2013;14(3):241-6.
2013: Anna Costa; Christian la Fougère; Hans-Jürgen Möller; Oliver Pogarell; Michael Riedel; Ulrich Ettinger
Impulsivity is related to striatal dopamine transporter availability in healthy males.
Psychiatry research 2013;211(3):251-6.
2013: Angela Carballedo; Ciara Fahey; Brigitta Bondy; Michael Gill; Eva M Meisenzahl; Hans-Jürgen Möller; Derek Morris; Elena Reinhold; Peter Zill; Thomas Frodl
Brain-derived neurotrophic factor Val66Met polymorphism and early life adversity affect hippocampal volume.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2013;162B(2):183-90.
2013: Gary Donohoe; C Fahey; I Giegling; M Gill; A Hargreaves; A M Hartmann; Hans-Jürgen Möller; D W Morris; P Muglia; M C O'Donovan; Michael J Owen; E J Rose; D Rujescu; D Tropea; J Walters; S Bellini; E Cummins; A Corvin
Neuropsychological effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
Genes, brain, and behavior 2013;12(2):203-9.
2013: Alkomiet Hasan; Jeffrey Lieberman; Hans-Jürgen Möller; Florence Thibaut; Thomas Wobrock; Peter Falkai; Wagner F Gattaz; Birte Y Glenthoj
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2013;14(1):2-44.
2013: Nicola M Wöstmann; Désirée S Aichert; Anna Costa; Hans-Jürgen Möller; Katya Rubia; Ulrich Ettinger
Reliability and plasticity of response inhibition and interference control.
Brain and cognition 2013;81(1):82-94.
2013: Ina Giegling; Annette M Hartmann; Bettina Konte; Philipp Krämer; Hans-Jürgen Möller; Stefano Porcelli; Beatrice Balzarro; Diana De Ronchi; Marion Friedl; Martin Schäfer; Alessandro Serretti; Hans H Stassen; Dan Rujescu
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.
European archives of psychiatry and clinical neuroscience 2013;263(1):65-74.
2013: Cosima Rhein; Peter Zill; Mazda Adli; Ulrich Hegerl; Christoph Hiemke; Roland Mergl; Hans-Jürgen Möller; Christiane Mühle; Julia Naumann; Martin Reichel; Johannes Kornhuber
The Acid Sphingomyelinase Sequence Variant p.A487V Is Not Associated With Decreased Levels of Enzymatic Activity.
JIMD reports 2013;8():1-6.
2013: Jens Benninghoff; Sandra Dehning; Just Genius; Heinz Grunze; Hans-Jürgen Möller; C Schindler; Robert Schloesser; A van der Ven; J Wiltfang; Dan Rujescu
Ziprasidone--not haloperidol--induces more de-novo neurogenesis of adult neural stem cells derived from murine hippocampus.
Pharmacopsychiatry 2013;46(1):10-5.
2012: Verena Henkel; Jürg Hüsler; Stephan Krähenbühl; Michael Obermeier; Florian Seemüller; Flurina Casaulta; Hans-Jürgen Möller
Study design features affecting outcome in antidepressant trials.
Journal of affective disorders 2012;141(2-3):160-7.
2012: Désirée S Aichert; Anna Costa; Christine Macare; Hans-Jürgen Möller; Katya Rubia; Johanna R Wenig; Nicola M Wöstmann; Ulrich Ettinger
Associations between trait impulsivity and prepotent response inhibition.
Journal of clinical and experimental neuropsychology 2012;34(10):1016-32.
2012: Florian Seemüller; R Musil; Michael Riedel; R Schennach; M Bauer; S Doucette; Ute Lewitzka; S Meyer; Hans-Jürgen Möller
The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
Pharmacopsychiatry 2012;45(7):292-6.
2012: R Schennach; M Schmauss; Lutz G Schmidt; Florian Seemüller; E Rüther; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; S Klingberg; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; S Meyer; Hans-Jürgen Möller; D Naber; H Pfeiffer; Michael Riedel
Insight in schizophrenia-course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(8):625-33.
2012: Christoph Völter; Nicola Wöstmann; Désirée S Aichert; David A Collier; Anna Costa; Ina Giegling; Annette M Hartmann; Veena Kumari; Sarah Lobo; Hans-Jürgen Möller; Boris B Quednow; Michael Riedel; Dan Rujescu; Anne Schmechtig; Ulrich Ettinger
Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2012;15(10):1427-40.
2012: Florian Seemüller; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingenberg; Joachim Klosterkötter; Ute Lewitzka; Wolfgang Maier; Andreas Mayr; Hans-Jürgen Möller; Richard Musil; Christian Ohmann; Michael Riedel; Rebecca Schennach; Ralf Schlösser; Andrea Schmitt; Frank Schneider
Akathisia and suicidal ideation in first-episode schizophrenia.
Journal of clinical psychopharmacology 2012;32(5):694-8.
2012: Ulrich Ettinger; Veena Kumari; Eva M Meisenzahl; Hans-Jürgen Möller; Steven C R Williams; Nikolaos Koutsouleris
Association between brain structure and psychometric schizotypy in healthy individuals.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2012;13(7):544-9.
2012: Florian Seemüller; Ilja Spellmann; Joachim Zeiler; M Obermeier; Michael Riedel; R Schennach-Wolff; Mazda Adli; M Bauer; W Bender; Peter Brieger; Wolfgang Gaebel; I Heuser; M Ising; Klaus-Thomas Kronmüller; Gerd Laux; S Meyer; Hans-Jürgen Möller
The validity of self-rated psychotic symptoms in depressed inpatients.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(7):547-52.
2012: Nikolaos Koutsouleris; Ronald Bottlender; Petra Decker; Christian Gaser; Hans-Jürgen Möller; Katja Patschurek-Kliche; Maximilian Reiser; J Scheuerecker; Gisela Schmitt; Eva M Meisenzahl
Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis.
Human brain mapping 2012;33(9):2104-24.
2012: Rebecca Schennach; Richard Musil; Michael Riedel; Hans-Jürgen Möller
Treatment Response in First-episode Schizophrenia.
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 2012;10(2):78-87.
2012: Peter Falkai; Hans-Jürgen Möller
Biomarkers and neurobiology of schizophrenia.
European archives of psychiatry and clinical neuroscience 2012;262(5):363-4.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Richard Musil; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Response trajectories in "real-world" naturalistically treated schizophrenia patients.
Schizophrenia research 2012;139(1-3):218-24.
2012: Alkomiet Hasan; Jeffrey Lieberman; Hans-Jürgen Möller; Florence Thibaut; Thomas Wobrock; Peter Falkai; Wagner F Gattaz; Birte Glenthoj
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2012;13(5):318-78.
2012: U Palm; O Pogarell; E Reisinger; C Schiller; Z Fintescu; D Keeser; Hans-Jürgen Möller; M A Nitsche; M Obermeier; Frank Padberg
Transcranial direct current stimulation in treatment resistant depression: a randomized double-blind, placebo-controlled study.
Brain stimulation 2012;5(3):242-51.
2012: J Soldner; Arun Bokde; K Bürger; Harald Hampel; W Koch; Thomas Meindl; Hans-Jürgen Möller; M F Reiser; Stefan J Teipel
[Structural and functional neuronal connectivity in Alzheimer's disease: a combined DTI and fMRI study].
Der Nervenarzt 2012;83(7):878-87.
2012: Florian Seemüller; Felix Segmiller; Michael Obermeier; Hans-Jürgen Möller
[Sleep disorders in major psychiatric diseases].
MMW Fortschritte der Medizin 2012;154(12):53-6.
2012: Peter Falkai; Hans-Jürgen Möller
From pathophysiological aspects towards unravelling the neurobiological background of cognitive deficits.
European archives of psychiatry and clinical neuroscience 2012;262(4):275-6.
2012: Borwin Bandelow; Robertas Bunevicius; Eric Hollander; Siegfried Kasper; Hans-Jürgen Möller; Leo Sher; Joseph Zohar
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care.
International journal of psychiatry in clinical practice 2012;16(2):77-84.
2012: Rebecca Schennach; Hans-Jürgen Möller; Richard Musil; Michael Riedel
Functional outcomes in schizophrenia: employment status as a metric of treatment outcome.
Current psychiatry reports 2012;14(3):229-36.
2012: Hans-Jürgen Möller
How close is evidence to truth in evidence-based treatment of mental disorders?
European archives of psychiatry and clinical neuroscience 2012;262(4):277-89.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.
The Psychiatric quarterly 2012;83(2):187-207.
2012: Oliver Pogarell; Klaus Tatsch; N Müller; Gabriele Poepperl; Sandra Dehning; S Karch; Walter Koch; Hans-Jürgen Möller
Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.
Pharmacopsychiatry 2012;45 Suppl 1():S36-41.
2012: Georg Juckel; Susanne Karch; Wolfram Kawohl; V Kirsch; Gregor Leicht; J Lutz; Hans-Jürgen Möller; M Ertl; Victor Perez; Lorenz Jäger; Oliver Pogarell; M Reiser; A Stammel; Christoph Mulert
Age effects on the P300 potential and the corresponding fMRI BOLD-signal.
NeuroImage 2012;60(4):2027-34.
2012: Just Genius; Ina Giegling; Annette Hartmann; Hans-Jürgen Möller; Nadine Reuter; Jens Benninghoff; Isabella Braun; Dan Rujescu
Dysequilibrium of neuronal proliferation and apoptosis in a pharmacological animal model of psychosis.
Methods (San Diego, Calif.) 2012;56(4):519-27.
2012: Peter Falkai; Hans-Jürgen Möller
Psychopathology: genetics and the stress-vulnerability hypothesis.
European archives of psychiatry and clinical neuroscience 2012;262(3):181-2.
2012: G J E Schmitt; Hans-Jürgen Möller; Reinhard J Boerner; Stefan Dresel; Thomas Frodl; K Hahn; Christian la Fougère; Eva M Meisenzahl
Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients.
European archives of psychiatry and clinical neuroscience 2012;262(3):183-91.
2012: Rebecca Schennach; Florian Seemüller; Ilja Spellmann; Peter Zill; Brigitta Bondy; Anja Cerovecki; Sandra Dehning; Daniela Hauer; Daniela Krause; Judith Matz; Hans-Jürgen Möller; Norbert Müller; Richard Musil; Michael Obermeier; Markus Opgen-Rhein; Michael Riedel
The CNR1 gene in depression and schizophrenia - is there an association with early improvement and response?
Psychiatry research 2012;196(1):160.
2012: Peter Falkai; Hans-Jürgen Möller
Neurobiology of schizophrenia: from outcome to pathophysiological insights.
European archives of psychiatry and clinical neuroscience 2012;262(2):93-4.
2012: Désirée S Aichert; Veena Kumari; Hans-Jürgen Möller; Steven C R Williams; Ulrich Ettinger
Functional neural correlates of psychometric schizotypy: an fMRI study of antisaccades.
Psychophysiology 2012;49(3):345-56.
2012: Emanuel Severus; Nadine Schaaff; Hans-Jürgen Möller
State of the art: treatment of bipolar disorders.
CNS neuroscience & therapeutics 2012;18(3):214-8.
2012: Michael Riedel; Eckart Rüther; Max Schmauß; Stefan Leucht; Hans-Jürgen Möller
Critical trial-related criteria in acute schizophrenia studies.
European archives of psychiatry and clinical neuroscience 2012;262(2):151-5.
2012: Peter Falkai; Hans-Jürgen Möller
Emotional status: diagnosis and treatment for severe psychiatric disorders.
European archives of psychiatry and clinical neuroscience 2012;262(1):1-2.
2012: Wolfgang Gaebel; Hans-Jürgen Möller
European guidance: a project of the European Psychiatric Association.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(2):65-7.
2012: Hans-Jürgen Möller; I Bitter; J Bobes; K Fountoulakis; C Höschl; Siegfried Kasper
Position statement of the European Psychiatric Association (EPA) on the value of antidepressants in the treatment of unipolar depression.
European psychiatry : the journal of the Association of European Psychiatrists 2012;27(2):114-28.
2012: Thomas C Baghai; David S Baldwin; Michael Bauer; Pierre Blier; Kostas N Fountoulakis; Guy M Goodwin; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.
European archives of psychiatry and clinical neuroscience 2012;262(1):13-22.
2012: Evelina Haralanova; Svetlozar Haralanov; Anna Beraldi; Hans-Jürgen Möller; Kristina Hennig-Fast
Subjective emotional over-arousal to neutral social scenes in paranoid schizophrenia.
European archives of psychiatry and clinical neuroscience 2012;262(1):59-68.
2012: Ina Giegling; Hans-Jürgen Möller; Stefano Porcelli; Dan Rujescu; Martin Schäfer; Costanza Andrisano; Beatrice Balzarro; Alessandro Serretti
Antipsychotic response in the first week predicts later efficacy.
Neuropsychobiology 2012;66(2):100-5.
2012: Peter Zill; Thomas C Baghai; Christoph Born; Andreas Büttner; Wolfgang Eisenmenger; Clemens Früstück; Hans-Jürgen Möller; Rainer Rupprecht; Cornelius Schüle; Gabriella Varallo-Bedarida; Brigitta Bondy
DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression.
PloS one 2012;7(7):e40479.
2012: Rebecca Schennach; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Dieter Naber; Michael Obermeier; Herbert Pfeiffer; Michael Riedel; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Hans-Jürgen Möller
Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
Psychopathology 2012;45(5):276-85.
2012: Oliver Peters; E Rüther; Klaus Schmidtke; J Schröder; Stefan J Teipel; S Wellek; A Fesche; Lutz Frölich; Hermann-Josef Gertz; Michael Hüll; H Jahn; Frank Jessen; J Kornhuber; D Lorenz; Christian Luckhaus; W Maier; Hans-Jürgen Möller; J Pantel; R Perneczky; Isabella Heuser
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.
The journal of nutrition, health & aging 2012;16(6):544-8.
2012: Christoph Völter; Nicola Wöstmann; Désirée S Aichert; Anna Costa; Hans-Jürgen Möller; Torsten Schubert; Tilo Strobach; Ulrich Ettinger
Schizotypy and behavioural adjustment and the role of neuroticism.
PloS one 2012;7(2):e30078.
2012: Just Genius; Thomas Klopstock; Hans-Jürgen Möller; Andreas Bender; Johanna Geiger; Dan Rujescu
Creatine protects against excitoxicity in an in vitro model of neurodegeneration.
PloS one 2012;7(2):e30554.
2012: Florian Seemüller; Sandra Dittmann; Hans-Jürgen Möller; Richard Musil
Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?
BMC medicine 2012;10():17.
2012: Michael Riedel; Heinrich Sauer; Andrea Schmitt; Frank Schneider; Florian Seemüller; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Wolfgang Maier; Andreas Mayr; Hans-Jürgen Möller; Rebecca Schennach-Wolff
Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: comparing treatment with risperidone and haloperidol.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2012;13(1):30-8.
2011: Peter Falkai; Hans-Jürgen Möller
Mood disorders in the light of genes, comorbidity and contemporary treatment.
European archives of psychiatry and clinical neuroscience 2011;261(8):531-2.
2011: Rebecca Schennach-Wolff; Max Schmauss; Lutz G Schmidt; Florian Seemüller; Eckart Rüther; Wolfgang Gaebel; Markus Gastpar; Isabella Heuser; Markus Jäger; Stefan Klingberg; Joachim Klosterkötter; Gerd Laux; Matthias R Lemke; Wolfgang Maier; Sebastian Meyer; Hans-Jürgen Möller; Dieter Naber; Herbert Pfeiffer; Michael Riedel
Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
Journal of psychiatric research 2011;45(12):1639-47.
2011: Angela Carballedo; Myles Doyle; Arun Bokde; Eva M Meisenzahl; Hans-Jürgen Möller; J Scheuerecker; Veronika Schoepf; Martin Wiesmann; Thomas Frodl
Functional connectivity of emotional processing in depression.
Journal of affective disorders 2011;134(1-3):272-9.
2011: Peter Falkai; Hans-Jürgen Möller
From generation of biomarkers to treatment and psychosocial aspects of psychosis.
European archives of psychiatry and clinical neuroscience 2011;261(7):457-8.
2011: Peter Falkai; Hans-Jürgen Möller
Achievement and maintenance of the new impact factor 2010.
European archives of psychiatry and clinical neuroscience 2011;261(6):387-9.
2011: Michael Riedel; Rebecca Schennach-Wolff; Joachim Zeiler; Mazda Adli; Michael Bauer; Wolfram Bender; Peter Brieger; Wolfgang Gaebel; Verena Henkel; Isabella Heuser; Klaus-Thomas Kronmüller; Gerd Laux; Hans-Jürgen Möller; Michael Obermeier; Florian Seemüller
Clinical predictors of response and remission in inpatients with depressive syndromes.
Journal of affective disorders 2011;133(1-2):137-49.
2011: Stefan J Teipel; Jose L Cantero; Lea Grinberg; Michel Grothe; Helmut Heinsen; Thomas Meindl; Hans-Jürgen Möller; Maximilian F Reiser; Harald Hampel
The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.
Human brain mapping 2011;32(9):1349-62.
2011: Ulrich Ettinger; Dominic Fannon; Elizabeth Kuipers; Hans-Jürgen Möller; Preethi Premkumar; Steven C R Williams; Veena Kumari
Functional magnetic resonance imaging of a parametric working memory task in schizophrenia: relationship with performance and effects of antipsychotic treatment.
Psychopharmacology 2011;216(1):17-27.
2011: R Schennach-Wolff; Lutz G Schmidt; Florian Seemüller; E Rüther; Gerhard Buchkremer; Wolfgang Gaebel; Markus Gastpar; I Heuser; Markus Jäger; Joachim Klosterkötter; Gerd Laux; M R Lemke; Wolfgang Maier; T Messer; Hans-Jürgen Möller; D Naber; M Obermeier; H Pfeiffer; Michael Riedel
Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
European psychiatry : the journal of the Association of European Psychiatrists 2011;26(5):284-92.
2011: Ingo Frommann; Wolfgang Gaebel; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Ralf Pukrop; Michael Riedel; Stephan Ruhrmann; Andreas Bechdolf; Julia Berning; Jürgen Brinkmeyer; Petra Decker; Wolfgang Wölwer; Michael Wagner
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.
Schizophrenia bulletin 2011;37(4):861-73.
2011: Ulrich Palm; Hans-Jürgen Möller
Reception of Kraepelin's ideas 1900-1960.
Psychiatry and clinical neurosciences 2011;65(4):318-25.
2011: Hans-Jürgen Möller; P Falkai
Pain, affect and psychotic illness.
European archives of psychiatry and clinical neuroscience 2011;261(4):311-2.
2011: Rebecca Schennach-Wolff; Markus Jäger; Andreas Mayr; Sebastian Meyer; Kai-Uwe Kühn; Stefan Klingberg; Isabella Heuser; Joachim Klosterkötter; Markus Gastpar; Andrea Schmitt; Ralf Schlösser; Frank Schneider; Wolfgang Gaebel; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Predictors of response and remission in the acute treatment of first-episode schizophrenia patients--is it all about early response?
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2011;21(5):370-8.
2011: Gregor Leicht; Susanne Karch; Evangelos Karamatskos; Ina Giegling; Hans-Jürgen Möller; Ulrich Hegerl; Oliver Pogarell; Dan Rujescu; Christoph Mulert
Alterations of the early auditory evoked gamma-band response in first-degree relatives of patients with schizophrenia: hints to a new intermediate phenotype.
Journal of psychiatric research 2011;45(5):699-705.
2011: Hans-Jürgen Möller; Markus Jäger; Michael Riedel; M Obermeier; Anton Strauss; Ronald Bottlender
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification.
European psychiatry : the journal of the Association of European Psychiatrists 2011;26(4):231-43.
2011: Georg Juckel; Roland Mergl; Martin Brüne; Isabelle Villeneuve; Thomas Frodl; Gisela Schmitt; Thomas Zetzsche; Christine Born; Klaus Hahn; Maximilian Reiser; Hans-Jürgen Möller; Karl-Jürgen Bär; Ulrich Hegerl; Eva Maria Meisenzahl
Is evaluation of humorous stimuli associated with frontal cortex morphology? A pilot study using facial micro-movement analysis and MRI.
Cortex; a journal devoted to the study of the nervous system and behavior 2011;47(5):569-74.
2011: Michael Soyka; Henry R Kranzler; Wim van den Brink; John Krystal; Hans-Jürgen Möller; Siegfried Kasper
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2011;12(3):160-87.
2011: Ina Giegling; Antonio Drago; Martin Schäfer; Annette M Hartmann; Thomas Sander; Mohammad Reza Toliat; Hans-Jürgen Möller; Diana De Ronchi; Hans H Stassen; Dan Rujescu; Alessandro Serretti
Lack of association between 71 variations located in candidate genes and response to acute haloperidol treatment.
Psychopharmacology 2011;214(3):719-28.
2011: Thomas Frodl; Johanna Scheuerecker; Veronika Schoepf; Jennifer Linn; Nikolaos Koutsouleris; Arun L W Bokde; Harald Hampel; Hans-Jürgen Möller; Hartmut Brückmann; Martin Wiesmann; Eva M Meisenzahl
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study.
The Journal of clinical psychiatry 2011;72(4):448-57.
2011: D Keeser; Frank Padberg; E Reisinger; Oliver Pogarell; V Kirsch; U Palm; Susanne Karch; Hans-Jürgen Möller; M A Nitsche; Christoph Mulert
Prefrontal direct current stimulation modulates resting EEG and event-related potentials in healthy subjects: a standardized low resolution tomography (sLORETA) study.
NeuroImage 2011;55(2):644-57.
2011: Peter Falkai; Hans-Jürgen Möller
The functional sequelae of schizophrenia: consequences of long-term pharmacotherapy and the neurobiology of addiction.
European archives of psychiatry and clinical neuroscience 2011;261(2):83-4.
2011: R Schennach-Wolff; M Obermeier; Florian Seemüller; Markus Jäger; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale.
Acta psychiatrica Scandinavica 2011;123(3):228-38.
2011: Peter Zill; V Vielsmeier; Andreas Büttner; Wolfgang Eisenmenger; Frank Siedler; Bea Scheffer; Hans-Jürgen Möller; Brigitta Bondy
Postmortem proteomic analysis in human amygdala of drug addicts: possible impact of tubulin on drug-abusing behavior.
European archives of psychiatry and clinical neuroscience 2011;261(2):121-31.
2011: Verena Mittermeier; Gregor Leicht; Susanne Karch; Ulrich Hegerl; Hans-Jürgen Möller; Oliver Pogarell; Christoph Mulert
Attention to emotion: auditory-evoked potentials in an emotional choice reaction task and personality traits as assessed by the NEO FFI.
European archives of psychiatry and clinical neuroscience 2011;261(2):111-20.
2011: Hans-Jürgen Möller; P Falkai
The psychosis continuum: diagnosis and other phenotypes.
European archives of psychiatry and clinical neuroscience 2011;261(1):1-2.
2011: Michael Riedel; W. Emanuel Severus; Rebecca Schennach-Wolff; Richard Musil; Ilja Spellmann; Birgit Oppolzer; Hans-Jürgen Möller; Jürgen Köhler; Florian Seemüller
Effectiveness of quetiapine in outpatients with schizophrenia assessed under "real-life" conditions: a German clinical-practice evaluation programme.
Journal of clinical psychopharmacology 2011;31(1):120-2.
2011: Gary Donohoe; James Walters; Derek W Morris; Andreia Da Costa; Emma Rose; April Hargreaves; Katie Maher; Eimear Hayes; Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Pierandrea Muglia; Valentina Moskvina; Michael J Owen; Michael C O'Donovan; Michael Gill; Aiden Corvin; Dan Rujescu
A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.
Schizophrenia research 2011;125(2-3):304-6.
2011: Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Wölwer; Ansgar Klimke; Matthias Eickhoff; Martina Von Wilmsdorff; Matthias Lemke; Isabella Heuser; Wolfgang Maier; Wolfgang Huff; Andrea Schmitt; Heinrich Sauer; Michael Riedel; Stefan Klingberg; Wolfgang Köpcke; Christian Ohmann; Hans-Jürgen Möller
Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
The Journal of clinical psychiatry 2011;72(2):205-18.
2011: Ilja Spellmann; Dan Rujescu; Richard Musil; Andreas Mayr; Ina Giegling; Just Genius; Peter Zill; Sandra Dehning; Markus Opgen-Rhein; Anja Cerovecki; Annette M Hartmann; Martin Schäfer; Brigitta Bondy; Norbert Müller; Hans-Jürgen Möller; Michael Riedel
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients.
Journal of psychiatric research 2011;45(2):234-41.
2011: Ina Giegling; Antonio Drago; Martin Schäfer; Hans-Jürgen Möller; Dan Rujescu; Alessandro Serretti
Sociodemographic and treatment related variables are poor predictors of haloperidol induced motor side effects.
Progress in neuro-psychopharmacology & biological psychiatry 2011;35(1):74-7.
2011: Hans-Jürgen Möller
Effectiveness studies: advantages and disadvantages.
Dialogues in clinical neuroscience 2011;13(2):199-207.
2011: Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Stefano Porcelli; Dan Rujescu; Raffaella Calati; Diana De Ronchi; Alessandro Serretti
NCAM1, TACR1 and NOS genes and temperament: a study on suicide attempters and controls.
Neuropsychobiology 2011;64(1):32-7.
2011: Verena C Buschert; Uwe Friese; Harald Hampel; Wibke Merensky; Hans-Jürgen Möller; Dan Rujescu; Philine Schneider; Stefan J Teipel; Katharina Buerger
Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study.
Journal of Alzheimer's disease : JAD 2011;25(4):679-94.
2011: Leonhard Lennertz; Dan Rujescu; Michael Wagner; Ingo Frommann; Svenja Schulze-Rauschenbach; Anna Schuhmacher; Martin W Landsberg; Petra Franke; Hans-Jürgen Möller; Wolfgang Wölwer; Wolfgang Gaebel; Heinz Häfner; Wolfgang Maier; Rainald Mössner
Novel schizophrenia risk gene TCF4 influences verbal learning and memory functioning in schizophrenia patients.
Neuropsychobiology 2011;63(3):131-6.
2011: Verena Henkel; Florian Seemüller; M Obermeier; Mazda Adli; M Bauer; K Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; W Bender; I Heuser; Joachim Zeiler; Wolfgang Gaebel; A Mayr; Michael Riedel; Hans-Jürgen Möller
Relationship between baseline severity of depression and antidepressant treatment outcome.
Pharmacopsychiatry 2011;44(1):27-32.
2010: Siegfried Kasper; Markus Gastpar; Walter E Müller; Hans-Peter Volz; Hans-Jürgen Möller; Angelika Dienel; Sandra Schläfke
Efficacy and safety of silexan, a new, orally administered lavender oil preparation, in subthreshold anxiety disorder - evidence from clinical trials.
Wiener medizinische Wochenschrift (1946) 2010;160(21-22):547-56.
2010: Peter Falkai; Hans-Jürgen Möller
Sleep, hypothalamus, and stigma.
European archives of psychiatry and clinical neuroscience 2010;260(8):563-4.
2010: Rebecca Schennach-Wolff; Michael Obermeier; Florian Seemüller; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Rolf R Engel; Hans-Jürgen Möller; Michael Riedel
Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.
Journal of clinical psychopharmacology 2010;30(6):726-31.
2010: Verena Henkel; Roland Mergl; Antje-Kathrin Allgaier; Martin Hautzinger; Ralf Kohnen; James C Coyne; Hans-Jürgen Möller; Victor Perez
Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients.
European psychiatry : the journal of the Association of European Psychiatrists 2010;25(8):491-8.
2010: T C Baghai; Hans-Jürgen Möller; S Nitschmann
[Efficiency of antidepressant therapy for patients with less severe depression].
Der Internist 2010;51(11):1456-8.
2010: R Schennach-Wolff; Hans-Jürgen Möller; Markus Jäger; Florian Seemüller; M Obermeier; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Michael Riedel
A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Pharmacopsychiatry 2010;43(7):245-51.
2010: Nikolaos Koutsouleris; Christian Gaser; Ronald Bottlender; Christos Davatzikos; Petra Decker; Markus Jäger; Gisela Schmitt; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Use of neuroanatomical pattern regression to predict the structural brain dynamics of vulnerability and transition to psychosis.
Schizophrenia research 2010;123(2-3):175-87.
2010: Nikolaos Koutsouleris; Katja Patschurek-Kliche; J Scheuerecker; Petra Decker; Ronald Bottlender; Gisela Schmitt; Dan Rujescu; Ina Giegling; Christian Gaser; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Neuroanatomical correlates of executive dysfunction in the at-risk mental state for psychosis.
Schizophrenia research 2010;123(2-3):160-74.
2010: Florian Seemüller; Hans-Jürgen Möller; Michael Obermeier; Mazda Adli; Michael Bauer; Klaus Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Rebecca Schennach-Wolff; Verena Henkel; Michael Riedel
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials.
The Journal of clinical psychiatry 2010;71(11):1425-33.
2010: Michael Riedel; Hans-Jürgen Möller; Michael Obermeier; Rebecca Schennach-Wolff; Michael Bauer; Mazda Adli; Klaus Kronmüller; Thomas Nickel; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Florian Seemüller
Response and remission criteria in major depression--a validation of current practice.
Journal of psychiatric research 2010;44(15):1063-8.
2010: Peter Falkai; Hans-Jürgen Möller
Biomarkers, population-based studies and a proof of principle investigation in pharmacotherapy.
European archives of psychiatry and clinical neuroscience 2010;260(7):507-8.
2010: Susanne Stübner; Renate Grohmann; Irmela von Stralendorff; Eckart Rüther; Hans-Jürgen Möller; Bruno Müller-Oerlinghausen; Rolf R Engel; Andreas Horvath; Waldemar Greil
Suicidality as rare adverse event of antidepressant medication: report from the AMSP multicenter drug safety surveillance project.
The Journal of clinical psychiatry 2010;71(10):1293-307.
2010: Ina Giegling; Alberto Chiesa; Laura Mandelli; Sara Gibiino; Annette M Hartmann; Hans-Jürgen Möller; Barbara Schneider; Axel Schnabel; Konrad Maurer; Diana De Ronchi; Dan Rujescu; Alessandro Serretti
Influence of neuronal cell adhesion molecule (NCAM1) variants on suicidal behaviour and correlated traits.
Psychiatry research 2010;179(2):222-5.
2010: Peter Falkai; Hans-Jürgen Möller
Understanding mental disorders from neuronal networks to glial cells and proteomics.
European archives of psychiatry and clinical neuroscience 2010;260(6):441-2.
2010: J Scheuerecker; Eva M Meisenzahl; Nikolaos Koutsouleris; Martin Roesner; Veronika Schöpf; Jennifer Linn; Martin Wiesmann; Hartmut Brückmann; Hans-Jürgen Möller; Thomas Frodl
Orbitofrontal volume reductions during emotion recognition in patients with major depression.
Journal of psychiatry & neuroscience : JPN 2010;35(5):311-20.
2010: Ulrich W Preuss; Thomas Zetzsche; Oliver Pogarell; Christoph Mulert; Thomas Frodl; Dirk Müller; Gisela Schmidt; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Ulrich Hegerl; Eva M Meisenzahl
Anterior cingulum volumetry, auditory P300 in schizophrenia with negative symptoms.
Psychiatry research 2010;183(2):133-9.
2010: Katja Wiethoff; Michael Bauer; Thomas C Baghai; Hans-Jürgen Möller; Robert Fisher; Dorothea Hollinde; Julia Kiermeir; Iris Hauth; Gerd Laux; Joachim Cordes; Peter Brieger; Klaus-Thomas Kronmüller; Joachim Zeiler; Mazda Adli
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project.
The Journal of clinical psychiatry 2010;71(8):1047-54.
2010: Peter Falkai; Hans-Jürgen Möller
Affective disorders: the role of the duration of untreated illness, suicidality and pharmacogenetics.
European archives of psychiatry and clinical neuroscience 2010;260(5):365-6.
2010: Hans-Jürgen Möller; Jörg Schnitker; W Flürenbrock
Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany.
Pharmacopsychiatry 2010;43(6):210-5.
2010: Norbert Müller; Daniela Krause; Sandra Dehning; Richard Musil; Rebecca Schennach-Wolff; Michael Obermeier; Hans-Jürgen Möller; Volker Klauss; Markus Schwarz; Michael Riedel
Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.
Schizophrenia research 2010;121(1-3):118-24.
2010: Hans-Jürgen Möller; Markus Jäger; Michael Riedel; Michael Obermeier; Anton Strauss; Ronald Bottlender
The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.
European archives of psychiatry and clinical neuroscience 2010;260(5):367-84.
2010: Rebecca Schennach-Wolff; Markus Jäger; Michael Obermeier; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(5):729-38.
2010: Michael Riedel; Richard Musil; Florian Seemüller; Ilja Spellmann; Hans-Jürgen Möller; Rebecca Schennach-Wolff
Safety evaluation of zotepine for the treatment of schizophrenia.
Expert opinion on drug safety 2010;9(4):659-66.
2010: Rebecca Schennach-Wolff; Florian Hannes Seemüller; Andreas Mayr; Wolfgang Maier; Stefan Klingberg; Isabella Heuser; Joachim Klosterkötter; Markus Gastpar; Heinz Häfner; H Sauer; Frank Schneider; Wolfgang Gaebel; Markus Jäger; Hans-Jürgen Möller; Michael Riedel
An early improvement threshold to predict response and remission in first-episode schizophrenia.
The British journal of psychiatry : the journal of mental science 2010;196(6):460-6.
2010: Hans-Jürgen Möller; Dan Rujescu
Pharmacogenetics--genomics and personalized psychiatry.
European psychiatry : the journal of the Association of European Psychiatrists 2010;25(5):291-3.
2010: Ina Giegling; Antonio Drago; Martin Schäfer; Hans-Jürgen Möller; Dan Rujescu; Alessandro Serretti
Interaction of haloperidol plasma level and antipsychotic effect in early phases of acute psychosis treatment.
Journal of psychiatric research 2010;44(8):487-92.
2010: Florian Seemüller; Rebecca Schennach-Wolff; Hans-Jürgen Möller; Michael Obermeier; Michael Riedel
Review: antidepressants associated with increased risk of suicidality in adults aged less than 25 years.
Evidence-based mental health 2010;13(2):52.
2010: Hans-Jürgen Möller
[Bipolar affective disorder].
Der Nervenarzt 2010;81(5):523-4.
2010: Florian Seemüller; Michael Riedel; S Dargel; N Djaja; R Schennach-Wolff; Sandra Dittmann; Hans-Jürgen Möller; W. Emanuel Severus
[Bipolar depression. Spectrum of clinical pictures and differentiation from unipolar depression].
Der Nervenarzt 2010;81(5):531-8.
2010: Markus Jäger; Michael Riedel; M Obermeier; R Schennach-Wolff; Florian Seemüller; T Messer; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; K-U Kühn; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Ronald Bottlender; Hans-Jürgen Möller
Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients.
Schizophrenia research 2010;118(1-3):183-8.
2010: Florian Seemüller; Michael Riedel; Michael Obermeier; Michael Bauer; Mazda Adli; Klaus Kronmüller; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Eva Dichgans; Roland Bottländer; Richard Musil; Hans-Jürgen Möller
Outcomes of 1014 naturalistically treated inpatients with major depressive episode.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2010;20(5):346-55.
2010: R Schennach-Wolff; Markus Jäger; Florian Seemüller; M Obermeier; M Schmauss; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; S Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
Acta psychiatrica Scandinavica 2010;121(5):359-70.
2010: Arian Mobascher; D Rujescu; K Mittelstrass; I Giegling; Claudia Lamina; B Nitz; H Brenner; C Fehr; L P Breitling; J Gallinat; D Rothenbacher; E Raum; H Müller; A Ruppert; A M Hartmann; Hans-Jürgen Möller; A Gal; Ch Gieger; H E Wichmann; T Illig; N Dahmen; Georg Winterer
Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010;153B(2):684-90.
2010: Dino Santangelo de Souza; Michael Riedel; Hans-Jürgen Möller; Emanuel Severus
[Bipolar disorders: update on current treatment options].
MMW Fortschritte der Medizin 2010;152(9):50-2.
2010: Michael Riedel; Ilja Spellmann; R Schennach-Wolff; R Musil; Sandra Dehning; A Cerovecki; M Opgen-Rhein; J Matz; Florian Seemüller; M Obermeier; W. Emanuel Severus; Rolf R Engel; N Müller; Hans-Jürgen Möller
Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.
Pharmacopsychiatry 2010;43(2):50-7.
2010: Michael Riedel; R Schennach-Wolff; R Musil; Sandra Dehning; A Cerovecki; M Opgen-Rhein; J Matz; Florian Seemüller; M Obermeier; Rolf R Engel; Norbert Müller; Hans-Jürgen Möller; Ilja Spellmann
Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone.
Human psychopharmacology 2010;25(2):116-25.
2010: Eva M Meisenzahl; Doerthe Seifert; Ronald Bottlender; Stefan J Teipel; Thomas Zetzsche; Markus Jäger; Nikolaos Koutsouleris; Gisela Schmitt; J Scheuerecker; Bernhard Burgermeister; Harald Hampel; Tobias Rupprecht; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Thomas Frodl
Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study.
European archives of psychiatry and clinical neuroscience 2010;260(2):127-37.
2010: Daniela Eser; Caroline Nothdurfter; Cornelius Schüle; Julia Damm; Yvonne Steng; Hans-Jürgen Möller; Rainer Rupprecht; Thomas C Baghai
The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(2 Pt 2):447-56.
2010: Siegfried Kasper; Stuart A Montgomery; Hans-Jürgen Möller; Helga J J van Oers; Albert Jan Schutte; Peter Vrijland; Egbert A van der Meulen
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2010;11(1):36-44.
2010: Wolfgang Maier; Hans-Jürgen Möller
Meta-analyses: a method to maximise the evidence from clinical studies?
European archives of psychiatry and clinical neuroscience 2010;260(1):17-23.
2010: Hans-Jürgen Möller; Karl Broich
Principle standards and problems regarding proof of efficacy in clinical psychopharmacology.
European archives of psychiatry and clinical neuroscience 2010;260(1):3-16.
2010: Stefan J Teipel; Arun Bokde; Thomas Meindl; Edson amaro; Jasmin Soldner; Maximilian F Reiser; Sabine C Herpertz; Hans-Jürgen Möller; Harald Hampel
White matter microstructure underlying default mode network connectivity in the human brain.
NeuroImage 2010;49(3):2021-32.
2010: Thomas Frodl; J Stauber; N Schaaff; N Koutsouleris; J Scheuerecker; Michael Ewers; M Omerovic; M Opgen-Rhein; Harald Hampel; M Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Amygdala reduction in patients with ADHD compared with major depression and healthy volunteers.
Acta psychiatrica Scandinavica 2010;121(2):111-8.
2010: Hans-Jürgen Möller; Wolfgang Maier
Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.
European archives of psychiatry and clinical neuroscience 2010;260(1):25-39.
2010: Gregor Leicht; Valerie Kirsch; Ina Giegling; Susanne Karch; Irmgard Hantschk; Hans-Jürgen Möller; Oliver Pogarell; Victor Perez; Dan Rujescu; Christoph Mulert
Reduced early auditory evoked gamma-band response in patients with schizophrenia.
Biological psychiatry 2010;67(3):224-31.
2010: Siegfried Kasper; Hans-Jürgen Möller; Anthony Hale
The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
European archives of psychiatry and clinical neuroscience 2010;260(1):59-68.
2010: Thomas Frodl; Arun Bokde; J Scheuerecker; Danuta Lisiecka; Veronika Schoepf; Harald Hampel; Hans-Jürgen Möller; Hartmut Brückmann; Martin Wiesmann; Eva M Meisenzahl
Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression.
Biological psychiatry 2010;67(2):161-7.
2010: Daniela Eser; Thomas C Baghai; Hans-Jürgen Möller
Agomelatine: The evidence for its place in the treatment of depression.
Core evidence 2010;4():171-9.
2010: Arun Bokde; Michaela Karmann; Christine Born; Stefan J Teipel; Muamer Omerovic; Michael Ewers; Thomas Frodl; Eva M Meisenzahl; Maximilian Reiser; Hans-Jürgen Möller; Harald Hampel
Altered brain activation during a verbal working memory task in subjects with amnestic mild cognitive impairment.
Journal of Alzheimer's disease : JAD 2010;21(1):103-18.
2009: Markus Jäger; M Schmauss; Gerd Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; D Degner; Gerhard Buchkremer; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(8):501-6.
2009: Rebecca Schennach-Wolff; Markus Jäger; Florian Seemüller; Michael Obermeier; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Attitude towards adherence in patients with schizophrenia at discharge.
Journal of psychiatric research 2009;43(16):1294-301.
2009: Ina Giegling; Paolo Olgiati; Annette M Hartmann; Raffaella Calati; Hans-Jürgen Möller; Dan Rujescu; Alessandro Serretti
Personality and attempted suicide. Analysis of anger, aggression and impulsivity.
Journal of psychiatric research 2009;43(16):1262-71.
2009: Peter Zwanzger; Daniela Eser; C Nothdurfter; Thomas C Baghai; Hans-Jürgen Möller; Frank Padberg; Rainer Rupprecht
Effects of the GABA-reuptake inhibitor tiagabine on panic and anxiety in patients with panic disorder.
Pharmacopsychiatry 2009;42(6):266-9.
2009: Michael Linden; W Maier; Hans-Jürgen Möller; H Sass
[Science is invigorated by discussion].
Der Nervenarzt 2009;80(11):1341-2.
2009: Hans-Jürgen Möller
Is evidence sufficient for evidence-based medicine?
European archives of psychiatry and clinical neuroscience 2009;259 Suppl 2():S167-72.
2009: Anna Schuhmacher; Rainald Mössner; Boris B Quednow; Kai-Uwe Kühn; Michael Wagner; Gabriela Cvetanovska; Dan Rujescu; Peter Zill; Hans-Jürgen Möller; Marcella Rietschel; Petra Franke; Wolfgang Wölwer; Wolfgang Gaebel; Wolfgang Maier
Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia.
Pharmacogenetics and genomics 2009;19(11):843-51.
2009: Hans-Jürgen Möller
Development of DSM-V and ICD-11: tendencies and potential of new classifications in psychiatry at the current state of knowledge.
Psychiatry and clinical neurosciences 2009;63(5):595-612.
2009: Susanne Karch; Gregor Leicht; Ina Giegling; Jürgen Lutz; Jörg Kunz; Moritz Buselmeier; Patric Hey; Alexander Spörl; Lorenz Jäger; Thomas Meindl; Oliver Pogarell; Hans-Jürgen Möller; Victor Perez; Dan Rujescu; Christoph Mulert
Inefficient neural activity in patients with schizophrenia and nonpsychotic relatives of schizophrenic patients: evidence from a working memory task.
Journal of psychiatric research 2009;43(15):1185-94.
2009: Gisela Johanna Elisabeth Schmitt; Eva M Meisenzahl; Thomas Frodl; Christian la Fougère; Klaus Hahn; Hans-Jürgen Möller; Stefan Dresel
Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [(123)I]IBZM SPECT.
Psychiatry research 2009;173(3):183-9.
2009: Nikolaos Koutsouleris; Gisela J E Schmitt; Christian Gaser; Ronald Bottlender; J Scheuerecker; Philip McGuire; Bernhard Burgermeister; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes.
The British journal of psychiatry : the journal of mental science 2009;195(3):218-26.
2009: Rebecca Schennach-Wolff; Markus Jäger; Florian Seemüller; Michael Obermeier; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Wolfgang Huff; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Hans-Jürgen Möller; Michael Riedel
Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
Schizophrenia research 2009;113(2-3):210-7.
2009: Susanne Karch; Christoph Mulert; Tobias Thalmeier; Jürgen Lutz; Gregor Leicht; Thomas Meindl; Hans-Jürgen Möller; Lorenz Jäger; Oliver Pogarell
The free choice whether or not to respond after stimulus presentation.
Human brain mapping 2009;30(9):2971-85.
2009: Thomas Wobrock; Oliver Gruber; Thomas Schneider-Axmann; Wolfgang Wölwer; Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Maier; Joachim Klosterkötter; Frank Schneider; Gerhard Buchkremer; Hans-Jürgen Möller; Andrea Schmitt; Stefan Bender; Ralf Schlösser; Peter Falkai
Internal capsule size associated with outcome in first-episode schizophrenia.
European archives of psychiatry and clinical neuroscience 2009;259(5):278-83.
2009: Nikolaos Koutsouleris; Eva M Meisenzahl; Christos Davatzikos; Ronald Bottlender; Thomas Frodl; Johanna Scheuerecker; Gisela Schmitt; Thomas Zetzsche; Petra Decker; Maximilian Reiser; Hans-Jürgen Möller; Christian Gaser
Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.
Archives of general psychiatry 2009;66(7):700-12.
2009: Stefan J Teipel; Oliver Pogarell; Thomas Meindl; Olaf Dietrich; Djyldyz Sydykova; Ulrike Hunklinger; Bea Georgii; Christoph Mulert; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Regional networks underlying interhemispheric connectivity: an EEG and DTI study in healthy ageing and amnestic mild cognitive impairment.
Human brain mapping 2009;30(7):2098-119.
2009: Verena Henkel; Florian Seemüller; Michael Obermeier; Mazda Adli; Michael Bauer; Christoph Mundt; Peter Brieger; Gerhard Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Andreas Mayr; Hans-Jürgen Möller; Michael Riedel
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Journal of affective disorders 2009;115(3):439-49.
2009: W. Emanuel Severus; Nikolaus Kleindienst; G Evoniuk; Charles L Bowden; Hans-Jürgen Möller; M Bohus; Sophia Frangou; Waldemar Greil; Joseph Calabrese
Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Journal of affective disorders 2009;115(3):466-70.
2009: J Damm; Daniela Eser; Cornelius Schüle; Hans-Jürgen Möller; Rainer Rupprecht; Thomas C Baghai
[Core symptoms of depression. Effectiveness of antidepressant therapy].
Der Nervenarzt 2009;80(5):515-6, 518, 520 passim.
2009: Stuart A Montgomery; Hans-Jürgen Möller
Is the significant superiority of escitalopram compared with other antidepressants clinically relevant?
International clinical psychopharmacology 2009;24(3):111-8.
2009: Peter Zill; Andreas Büttner; Wolfgang Eisenmenger; Josef Müller; Hans-Jürgen Möller; Brigitta Bondy
Predominant expression of tryptophan hydroxylase 1 mRNA in the pituitary: a postmortem study in human brain.
Neuroscience 2009;159(4):1274-82.
2009: Ina Giegling; Alberto Chiesa; Raffaella Calati; Annette M Hartmann; Hans-Jürgen Möller; Diana De Ronchi; Dan Rujescu; Alessandro Serretti
Do the estrogen receptors 1 gene variants influence the temperament and character inventory scores in suicidal attempters and healthy subjects?
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2009;150B(3):434-8.
2009: Arun Bokde; Michaela Karmann; Stefan J Teipel; Christine Born; Martin Lieb; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
Journal of clinical psychopharmacology 2009;29(2):147-56.
2009: Michael Riedel; F X Eich; Hans-Jürgen Möller
A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
European psychiatry : the journal of the Association of European Psychiatrists 2009;24(3):149-53.
2009: Hans-Jürgen Möller
[Relativising the significance of the results of metaanalyses: comments on the metaanalysis by Kirsch et al. 2008 regarding the effectiveness of modern antidepressants].
MMW Fortschritte der Medizin 2009;151(13):80-3.
2009: J Scheuerecker; S Ufer; M Käpernick; Martin Wiesmann; Hartmut Brückmann; E Kraft; D Seifert; Nikolaos Koutsouleris; Hans-Jürgen Möller; Eva M Meisenzahl
Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI.
Journal of psychiatric research 2009;43(6):607-14.
2009: Florian Seemüller; Michael Riedel; Michael Obermeier; Michael Bauer; Mazda Adli; Christoph Mundt; Florian Holsboer; Peter Brieger; Gerd Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Markus Jäger; Verena Henkel; Hans-Jürgen Möller
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2009;12(2):181-9.
2009: Hans-Jürgen Möller
Do "real world" studies on antipsychotics tell us the real truth?
World psychiatry : official journal of the World Psychiatric Association (WPA) 2009;8(1):32.
2009: T C Baghai; H P Volz; Hans-Jürgen Möller
[Antidepressive pharmacotherapy. In slight and severe disease, young and old].
Der Internist 2009;50(2):235-43.
2009: Hans-Jürgen Möller
Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(3):180-95.
2009: Robert Paul; Nadine Schaaff; Frank Padberg; Hans-Jürgen Möller; Thomas Frodl
Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: report of two cases.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(3):241-4.
2009: Ina Giegling; Daniel Moreno-De-Luca; Raffaella Calati; Annette M Hartmann; Hans-Jürgen Möller; Diana De Ronchi; Dan Rujescu; Alessandro Serretti
Tyrosine hydroxylase and DOPA decarboxylase gene variants in personality traits.
Neuropsychobiology 2009;59(1):23-7.
2009: T Möller; C Born; M F Reiser; Hans-Jürgen Möller; Harald Hampel; Stefan J Teipel
[Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex].
Der Nervenarzt 2009;80(1):54-61.
2009: Thomas Frodl; Johanna Scheuerecker; Jessica Albrecht; Anna Maria Kleemann; Steffanie Müller-Schunk; Nikolaos Koutsouleris; Hans-Jürgen Möller; Hartmut Brückmann; Martin Wiesmann; Eva Meisenzahl
Neuronal correlates of emotional processing in patients with major depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(3):202-8.
2009: Markus Jäger; Michael Riedel; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Gerd Buchkremer; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Prediction of symptom remission in schizophrenia during inpatient treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2009;10(4 Pt 2):426-34.
2008: Sandra Dittmann; Kristina Hennig-Fast; Sonja Gerber; Florian Seemüller; Michael Riedel; W Emanuel Severus; Jens Langosch; Rolf R Engel; Hans-Jürgen Möller; Heinz Grunze
Cognitive functioning in euthymic bipolar I and bipolar II patients.
Bipolar disorders 2008;10(8):877-87.
2008: Alexander Brunnauer; Gerd Laux; Irmgard David; Mirijam Fric; Igor Hermisson; Hans-Jürgen Möller
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients.
The Journal of clinical psychiatry 2008;69(12):1880-6.
2008: Thomas Frodl; Nikolaos Koutsouleris; Ronald Bottlender; Christine Born; Markus Jäger; M Mörgenthaler; J Scheuerecker; Peter Zill; Thomas C Baghai; Cornelius Schüle; Rainer Rupprecht; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Reduced gray matter brain volumes are associated with variants of the serotonin transporter gene in major depression.
Molecular psychiatry 2008;13(12):1093-101.
2008: Hans-Jürgen Möller
[25 years of progress in psychiatry: we are heading in the right direction].
MMW Fortschritte der Medizin 2008;150(48):160-1.
2008: Wolfgang Wölwer; Jürgen Brinkmeyer; Mathias Riesbeck; Lena Freimüller; Ansgar Klimke; Michael Wagner; Hans-Jürgen Möller; Stefan Klingberg; Wolfgang Gaebel
Neuropsychological impairments predict the clinical course in schizophrenia.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 5():28-34.
2008: Hans-Jürgen Möller
The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 5():7-17.
2008: Harald Scherk; Martin Backens; Peter Zill; Thomas Schneider-Axmann; Thomas Wobrock; Juliana Usher; Wolfgang Reith; Peter Falkai; Hans-Jürgen Möller; Brigitta Bondy; Oliver Gruber
SNAP-25 genotype influences NAA/Cho in left hippocampus.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(11):1513-8.
2008: Thomas Frodl; Hans-Jürgen Möller; Eva M Meisenzahl
Neuroimaging genetics: new perspectives in research on major depression?
Acta psychiatrica Scandinavica 2008;118(5):363-72.
2008: Hans-Jürgen Möller; Michael Riedel; Markus Jäger; Florian Wickelmaier; Wolfgang Maier; Kai-Uwe Kühn; Gerhard Buchkremer; Isabella Heuser; Joachim Klosterkötter; Markus Gastpar; Dieter F Braus; Ralf Schlösser; Frank Schneider; Christian Ohmann; Mathias Riesbeck; Wolfgang Gaebel
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(7):985-97.
2008: Thomas Frodl; Peter Zill; Thomas C Baghai; Cornelius Schüle; Rainer Rupprecht; Thomas Zetzsche; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Reduced hippocampal volumes associated with the long variant of the tri- and diallelic serotonin transporter polymorphism in major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(7):1003-7.
2008: Thomas S Frodl; Nikolaos Koutsouleris; Ronald Bottlender; Christine Born; Markus Jäger; Isabel Scupin; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Depression-related variation in brain morphology over 3 years: effects of stress?
Archives of general psychiatry 2008;65(10):1156-65.
2008: Kristina Hennig-Fast; Franziska Meister; Thomas Frodl; Anna Beraldi; Frank Padberg; Rolf R Engel; Maximilian Reiser; Hans-Jürgen Möller; Thomas Meindl
A case of persistent retrograde amnesia following a dissociative fugue: neuropsychological and neurofunctional underpinnings of loss of autobiographical memory and self-awareness.
Neuropsychologia 2008;46(12):2993-3005.
2008: Richard Musil; Ilja Spellmann; Michael Riedel; Sandra Dehning; Anette Douhet; Katja Maino; Peter Zill; Norbert Müller; Hans-Jürgen Möller; Brigitta Bondy
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients.
Journal of psychiatric research 2008;42(12):963-70.
2008: Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Large recurrent microdeletions associated with schizophrenia.
Nature 2008;455(7210):232-6.
2008: Thomas Frodl; Markus Jäger; Ivana Smajstrlova; Christine Born; Ronald Bottlender; Tanja Palladino; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study.
Journal of psychiatry & neuroscience : JPN 2008;33(5):423-30.
2008: Hans-Jürgen Möller
[Conflict of interest declarations in scientific publications].
Der Nervenarzt 2008;79(9):1001-5.
2008: Markus Jäger; T Messer; G Laux; H Pfeiffer; D Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; I Heuser; Wolfgang Maier; M R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Michael Riedel; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
Pharmacopsychiatry 2008;41(5):190-5.
2008: E M Meisenzahl; Gisela Schmitt; G Gründer; S Dresel; Thomas Frodl; Christian la Fougère; J Scheuerecker; Markus Schwarz; Reinhard J Boerner; J Stauss; Klaus Hahn; Hans-Jürgen Möller
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
Pharmacopsychiatry 2008;41(5):169-75.
2008: Edwin J C G van den Oord; Po-Hsiu Kuo; Annette M Hartmann; B Todd Webb; Hans-Jürgen Möller; John M Hettema; Ina Giegling; József Bukszár; Dan Rujescu
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism.
Archives of general psychiatry 2008;65(9):1062-71.
2008: Ina Giegling; A M Hartmann; Just Genius; J Benninghoff; Hans-Jürgen Möller; Dan Rujescu
Systems biology and complex neurobehavioral traits.
Pharmacopsychiatry 2008;41 Suppl 1():S32-6.
2008: Eva M Meisenzahl; Nikolaos Koutsouleris; Ronald Bottlender; J Scheuerecker; Markus Jäger; Stefan J Teipel; S Holzinger; Thomas Frodl; Ulrich W Preuss; Gisela Schmitt; B Burgermeister; Maximilian Reiser; Christine Born; Hans-Jürgen Möller
Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study.
Schizophrenia research 2008;104(1-3):44-60.
2008: Ilja Spellmann; Norbert Müller; Richard Musil; Peter Zill; Anette Douhet; Sandra Dehning; Anja Cerovecki; Brigitta Bondy; Hans-Jürgen Möller; Michael Riedel
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics.
European archives of psychiatry and clinical neuroscience 2008;258(6):335-44.
2008: Arun Bokde; Patricia Lopez-Bayo; Christine Born; Wentian Dong; Thomas Meindl; Gerda Leinsinger; Stefan J Teipel; Frank Faltraco; Maximilian Reiser; Hans-Jürgen Möller; Harald Hampel
Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study.
Psychiatry research 2008;163(3):248-59.
2008: Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan Stein; Rajiv Tandon; Marcio Versiani
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 3():3-23.
2008: Hans-Jürgen Möller
Do effectiveness ("real world") studies on antipsychotics tell us the real truth?
European archives of psychiatry and clinical neuroscience 2008;258(5):257-70.
2008: Christoph Mulert; Christian Seifert; Gregor Leicht; Valerie Kirsch; Matthias Ertl; Susanne Karch; Matthias Moosmann; Jürgen Lutz; Hans-Jürgen Möller; Victor Perez; Oliver Pogarell; Lorenz Jäger
Single-trial coupling of EEG and fMRI reveals the involvement of early anterior cingulate cortex activation in effortful decision making.
NeuroImage 2008;42(1):158-68.
2008: Thomas Zetzsche; Ulrich W Preuss; Thomas Frodl; Gerda Leinsinger; Christine Born; Maximilian Reiser; Victor Perez; Hans-Jürgen Möller; Eva M Meisenzahl
White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia.
European archives of psychiatry and clinical neuroscience 2008;258(5):278-84.
2008: Ina Giegling; Dan Rujescu; Laura Mandelli; Barbara Schneider; Annette M Hartmann; Axel Schnabel; Konrad Maurer; Diana De Ronchi; Hans-Jürgen Möller; Alessandro Serretti
Estrogen receptor gene 1 variants are not associated with suicidal behavior.
Psychiatry research 2008;160(1):1-7.
2008: Anna C Need; Deborah K Attix; Jill M McEvoy; Elizabeth T Cirulli; Kristen N Linney; Ana Patricia Wagoner; Curtis E Gumbs; Ina Giegling; Hans-Jürgen Möller; Clyde Francks; Pierandrea Muglia; Allen D Roses; Greg Gibson; Mike E Weale; Dan Rujescu; David B Goldstein
Failure to replicate effect of Kibra on human memory in two large cohorts of European origin.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(5):667-8.
2008: Eva M Meisenzahl; Nikolaos Koutsouleris; Christian Gaser; Ronald Bottlender; Gisela Schmitt; P McGuire; P Decker; B Burgermeister; Christine Born; Maximilian Reiser; Hans-Jürgen Möller
Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study.
Schizophrenia research 2008;102(1-3):150-62.
2008: Susanne Karch; Lorenz Jäger; Evangelos Karamatskos; Christian Graz; Andreas Stammel; Wilhelm Flatz; Jürgen Lutz; Bettina Holtschmidt-Täschner; Just Genius; Gregor Leicht; Oliver Pogarell; Christine Born; Hans-Jürgen Möller; Victor Perez; Maximilian Reiser; Michael Soyka; Christoph Mulert
Influence of trait anxiety on inhibitory control in alcohol-dependent patients: simultaneous acquisition of ERPs and BOLD responses.
Journal of psychiatric research 2008;42(9):734-45.
2008: Hans-Jürgen Möller
Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 2():48-73.
2008: Marten W deVries; Norbert Müller; Hans-Jürgen Möller; Lettew F Saugstad
Emil Kraepelin's legacy: systematic clinical observation and the categorical classification of psychiatric diseases.
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 2():1-2.
2008: Sandra Dittmann; Florian Seemüller; Heinz Grunze; Markus Schwarz; Johanna Zach; Kristina Fast; Christine Born; Sascha Dargel; Rolf R Engel; Britta Bernhard; Hans-Jürgen Möller; Michael Riedel; W. Emanuel Severus
The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study.
The Journal of clinical psychiatry 2008;69(6):899-906.
2008: Wolfram Kawohl; Ina Giegling; Paraskevi Mavrogiorgou; Oliver Pogarell; Christoph Mulert; Hans-Jürgen Möller; Victor Perez; Dan Rujescu; Georg Juckel
Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(4):477-83.
2008: Florian Seemüller; Michael Riedel; Florian Wickelmaier; Mazda Adli; Christoph Mundt; Andreas Marneros; Gerhard Laux; Wolfram Bender; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Markus Jäger; Hans-Jürgen Möller; Verena Henkel
Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity.
Journal of affective disorders 2008;108(3):271-8.
2008: Thomas Frodl; Markus Jäger; Christine Born; Sabine Ritter; Eduard Kraft; Thomas Zetzsche; Ronald Bottlender; Gerda Leinsinger; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Anterior cingulate cortex does not differ between patients with major depression and healthy controls, but relatively large anterior cingulate cortex predicts a good clinical course.
Psychiatry research 2008;163(1):76-83.
2008: V A Curtis; K Katsafouros; Hans-Jürgen Möller; R Medori; E Sacchetti
Long-acting risperidone improves negative symptoms in stable psychotic patients.
Journal of psychopharmacology (Oxford, England) 2008;22(3):254-61.
2008: Stephan Ruhrmann; J Paruch; Andreas Bechdolf; Ralf Pukrop; Michael Wagner; J Berning; Frauke Schultze-Lutter; Birgit Janssen; Wolfgang Gaebel; Hans-Jürgen Möller; Wolfgang Maier; Joachim Klosterkötter
Reduced subjective quality of life in persons at risk for psychosis.
Acta psychiatrica Scandinavica 2008;117(5):357-68.
2008: J Scheuerecker; S Ufer; M Zipse; Thomas Frodl; Nikolaos Koutsouleris; Thomas Zetzsche; Martin Wiesmann; Jessica Albrecht; Hartmut Brückmann; Gisela Schmitt; Hans-Jürgen Möller; Eva M Meisenzahl
Cerebral changes and cognitive dysfunctions in medication-free schizophrenia - an fMRI study.
Journal of psychiatric research 2008;42(6):469-76.
2008: Markus Jäger; Michael Riedel; Max Schmauss; Herbert Pfeiffer; Gerd Laux; Dieter Naber; Wolfgang Gaebel; Wolfgang Huff; Lutz G Schmidt; Isabella Heuser; Gerhard Buchkremer; Kai-Uwe Kühn; Eckart Rüther; Paul Hoff; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Psychiatry research 2008;158(3):297-305.
2008: Ina Giegling; Daniel Moreno-De-Luca; Dan Rujescu; Barbara Schneider; Annette M Hartmann; Axel Schnabel; Konrad Maurer; Hans-Jürgen Möller; Alessandro Serretti
Dopa decarboxylase and tyrosine hydroxylase gene variants in suicidal behavior.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147(3):308-15.
2008: Norbert Müller; Rebecca Schennach; Michael Riedel; Hans-Jürgen Möller
Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Expert review of neurotherapeutics 2008;8(4):527-36.
2008: Thomas Zetzsche; Ulrich W Preuss; B Bondy; Thomas Frodl; Peter Zill; Gisela Schmitt; Nikolaos Koutsouleris; Dan Rujescu; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
5-HT1A receptor gene C -1019 G polymorphism and amygdala volume in borderline personality disorder.
Genes, brain, and behavior 2008;7(3):306-13.
2008: Gisela Schmitt; Christian la Fougère; Stefan Dresel; Thomas Frodl; Klaus Hahn; Hans-Jürgen Möller; Eva M Meisenzahl
Dual-isotope SPECT imaging of striatal dopamine: first episode, drug naïve schizophrenic patients.
Schizophrenia research 2008;101(1-3):133-41.
2008: Georg Juckel; R Mergl; A Prässl; Paraskevi Mavrogiorgou; H Witthaus; Hans-Jürgen Möller; Victor Perez
Kinematic analysis of facial behaviour in patients with schizophrenia under emotional stimulation by films with "Mr. Bean".
European archives of psychiatry and clinical neuroscience 2008;258(3):186-91.
2008: K Broich; Hans-Jürgen Möller
Pharmacogenetics, pharmacogenomics and personalized psychiatry: are we there yet?
European archives of psychiatry and clinical neuroscience 2008;258 Suppl 1():1-2.
2008: Hans-Jürgen Möller; Sunny Johnson; Temenuzhka Mateva; Martin Brecher; Ola Svensson; Frank Miller; Didier Meulien
Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
International clinical psychopharmacology 2008;23(2):95-105.
2008: W. Emanuel Severus; Nikolaus Kleindienst; Florian Seemüller; Sophia Frangou; Hans-Jürgen Möller; Waldemar Greil
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
Bipolar disorders 2008;10(2):231-7.
2008: Leonardo H Tonelli; John W Stiller; Dan Rujescu; Ina Giegling; B Schneider; K Maurer; A Schnabel; Hans-Jürgen Möller; Hegang Chen; Teodor T Postolache
Elevated cytokine expression in the orbitofrontal cortex of victims of suicide.
Acta psychiatrica Scandinavica 2008;117(3):198-206.
2008: Jürgen Fritze; Josef Aldenhoff; Frank Bergmann; Gabriel Eckermann; Wolfgang Maier; Hans-Jürgen Möller; Wolfgang Gaebel
[Priority for atypical antipsychotics--comments on the article by Dose M. Priority for Atypicals? Current studies clarify some aspects. Psychiat Prax 2007; 34:46-49].
Psychiatrische Praxis 2008;35(2):94-7; author reply 97-8.
2008: Andreas Thalmeier; Martin Dickmann; Ina Giegling; Barbara Schneider; Annette M Hartmann; Konrad Maurer; Axel Schnabel; Gerold Kauert; Hans-Jürgen Möller; Dan Rujescu
Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2008;11(2):217-28.
2008: Nikolaos Koutsouleris; Christian Gaser; Markus Jäger; Ronald Bottlender; Thomas Frodl; Silvia Holzinger; Gisela Schmitt; Thomas Zetzsche; Bernhard Burgermeister; J Scheuerecker; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study.
NeuroImage 2008;39(4):1600-12.
2008: Hans-Jürgen Möller
The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2008;7(1):35-6.
2008: Siegfried Kasper; M Gastpar; W E Müller; Hans-Peter Volz; Angelika Dienel; Meinhard Kieser; Hans-Jürgen Möller
Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials.
European archives of psychiatry and clinical neuroscience 2008;258(1):59-63.
2008: Oliver Pogarell; Walter Koch; Nadine Schaaff; Gabriele Pöpperl; Christoph Mulert; Georg Juckel; Hans-Jürgen Möller; Victor Perez; Klaus Tatsch
[123I] ADAM brainstem binding correlates with the loudness dependence of auditory evoked potentials.
European archives of psychiatry and clinical neuroscience 2008;258(1):40-7.
2008: George I Papakostas; J Craig Nelson; Siegfried Kasper; Hans-Jürgen Möller
A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2008;18(2):122-7.
2008: Dan Rujescu; Ina Giegling; Laura Mandelli; Barbara Schneider; Annette M Hartmann; Axel Schnabel; Konrad Maurer; Hans-Jürgen Möller; Alessandro Serretti
NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2008;147B(1):42-8.
2008: Thomas C Baghai; Daniela Eser; Hans-Jürgen Möller
Effects of different antidepressant treatments on the core of depression.
Dialogues in clinical neuroscience 2008;10(3):309-20.
2008: Hans-Jürgen Möller
Is there a need for a new psychiatric classification at the current state of knowledge?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(2):82-5.
2008: Thomas C Baghai; Hans-Jürgen Möller
Electroconvulsive therapy and its different indications.
Dialogues in clinical neuroscience 2008;10(1):105-17.
2008: Hans-Jürgen Möller
Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(2):102-14.
2008: Michael Soyka; Henry R Kranzler; Mats Berglund; David Gorelick; Victor Hesselbrock; Bankole A Johnson; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2008;9(1):6-23.
2008: Hans-Jürgen Möller
[Acute psychosis: in an emergency always still haloperidol?].
Deutsche medizinische Wochenschrift (1946) 2008;133(3):96.
2008: Wolfgang Gaebel; Harald Zäske; Anja E Baumann; Joachim Klosterkötter; Wolfgang Maier; Petra Decker; Hans-Jürgen Möller
Evaluation of the German WPA "program against stigma and discrimination because of schizophrenia--Open the Doors": results from representative telephone surveys before and after three years of antistigma interventions.
Schizophrenia research 2008;98(1-3):184-93.
2007: Oliver Pogarell; Walter Koch; Gabriele Pöpperl; Klaus Tatsch; Franziska Jakob; Christoph Mulert; Nicola Grossheinrich; Rainer Rupprecht; Hans-Jürgen Möller; Victor Perez; Frank Padberg
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine.
Psychiatry research 2007;156(3):251-5.
2007: Stephan Ruhrmann; Andreas Bechdolf; Kai-Uwe Kühn; M Wagner; Frauke Schultze-Lutter; Birgit Janssen; K Maurer; H Häfner; Wolfgang Gaebel; Hans-Jürgen Möller; Wolfgang Maier; Joachim Klosterkötter
Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis.
The British journal of psychiatry. Supplement 2007;51():s88-95.
2007: C Francks; S Maegawa; J Laurén; Brett S. Abrahams; A Velayos-Baeza; S E Medland; S Colella; M Groszer; E Z McAuley; T M Caffrey; T Timmusk; P Pruunsild; I Koppel; P A Lind; N Matsumoto-Itaba; J Nicod; L Xiong; R Joober; W Enard; B Krinsky; E Nanba; Alexandra Richardson; B P Riley; N G Martin; S M Strittmatter; Hans-Jürgen Möller; D Rujescu; D St Clair; P Muglia; J L Roos; Simon E Fisher; R Wade-Martins; G A Rouleau; John Stein; Maria Karayiorgou; Daniel Geschwind; Jiannis Ragoussis; K S Kendler; M S Airaksinen; M Oshimura; L E DeLisi; Anthony P Monaco
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia.
Molecular psychiatry 2007;12(12):1129-39, 1057.
2007: Isabella Braun; Just Genius; Heinz Grunze; Andreas Bender; Hans-Jürgen Möller; Dan Rujescu
Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism.
Schizophrenia research 2007;97(1-3):254-63.
2007: Wolfgang Gaebel; Mathias Riesbeck; Wolfgang Wölwer; Ansgar Klimke; Matthias Eickhoff; Martina Von Wilmsdorff; Maria C Jockers-Scherübl; Kai-Uwe Kühn; Matthias Lemke; Andreas Bechdolf; Stefan Bender; Detlef Degner; Ralf Schlösser; Lutz G Schmidt; Andrea Schmitt; Markus Jäger; Gerhard Buchkremer; Peter Falkai; Stefan Klingberg; Wolfgang Köpcke; Wolfgang Maier; Heinz Häfner; Christian Ohmann; Hans Joachim Salize; Frank Schneider; Hans-Jürgen Möller
Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia.
The Journal of clinical psychiatry 2007;68(11):1763-74.
2007: Stuart A Montgomery; David S Baldwin; Pierre Blier; Naomi A Fineberg; Siegfried Kasper; Malcolm Lader; Raymond Lam; Jean-Pierre Lépine; Hans-Jürgen Möller; David J Nutt; Frederic Rouillon; Alan F Schatzberg; Michael E Thase
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Thomas Zetzsche; Ulrich W Preuss; Thomas Frodl; Dorothee Watz; Gisela Schmitt; Nikolaos Koutsouleris; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
In-vivo topography of structural alterations of the anterior cingulate in patients with schizophrenia: new findings and comparison with the literature.
Schizophrenia research 2007;96(1-3):34-45.
2007: Stefan J Teipel; Christine Born; Michael Ewers; Arun Bokde; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
NeuroImage 2007;38(1):13-24.
2007: Daniela Eser; Thomas C Baghai; Hans-Jürgen Möller
Evidence of agomelatine's antidepressant efficacy: the key points.
International clinical psychopharmacology 2007;22 Suppl 2():S15-9.
2007: Michael Riedel; Norbert Müller; Ilja Spellmann; Rolf R Engel; Richard Musil; Rosamaria Valdevit; Sandra Dehning; Anette Douhet; Anja Cerovecki; Martin Thomas Strassnig; Hans-Jürgen Möller
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
European archives of psychiatry and clinical neuroscience 2007;257(7):402-12.
2007: Djyldyz Sydykova; Robert Stahl; Olaf Dietrich; Michael Ewers; Maximilian F Reiser; Stefan O Schoenberg; Hans-Jürgen Möller; Harald Hampel; Stefan J Teipel
Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease: a diffusion tensor imaging and voxel-based morphometry study.
Cerebral cortex (New York, N.Y. : 1991) 2007;17(10):2276-82.
2007: Ina Giegling; Dan Rujescu; Laura Mandelli; Barbara Schneider; Annette M Hartmann; Axel Schnabel; Konrad Maurer; Diana De Ronchi; Hans-Jürgen Möller; Alessandro Serretti
Tachykinin receptor 1 variants associated with aggression in suicidal behavior.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(6):757-61.
2007: Wolfgang Maier; Hans-Jürgen Möller
[Meta-analyses. A tool for maximizing therapy study evidence?].
Der Nervenarzt 2007;78(9):1028-36.
2007: Michael Riedel; Ilja Spellmann; Martin Thomas Strassnig; Anette Douhet; Sandra Dehning; Markus Opgen-Rhein; Rosamaria Valdevit; Rolf R Engel; Nikolaus Kleindienst; Norbert Müller; Hans-Jürgen Möller
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
European archives of psychiatry and clinical neuroscience 2007;257(6):360-70.
2007: Hans-Jürgen Möller; Wolfgang Maier
[Problems of evidence-based medicine in psychopharmacotherapy: problems of evidence grading and of the evidence basis for complex clinical decision making].
Der Nervenarzt 2007;78(9):1014-27.
2007: Hans-Jürgen Möller
Clinical evaluation of negative symptoms in schizophrenia.
European psychiatry : the journal of the Association of European Psychiatrists 2007;22(6):380-6.
2007: Eva M Meisenzahl; Gisela Schmitt; J Scheuerecker; Hans-Jürgen Möller
The role of dopamine for the pathophysiology of schizophrenia.
International review of psychiatry (Abingdon, England) 2007;19(4):337-45.
2007: Walter Koch; Nadine Schaaff; Gabriele Pöpperl; Christoph Mulert; Georg Juckel; Markus Reicherzer; Christoff Ehmer-von Geiso; Hans-Jürgen Möller; Victor Perez; Klaus Tatsch; Oliver Pogarell
[I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects.
Journal of psychiatry & neuroscience : JPN 2007;32(4):234-40.
2007: Stefan J Teipel; Arun Bokde; Christine Born; Thomas Meindl; Maximilian Reiser; Hans-Jürgen Möller; Harald Hampel
Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
Brain : a journal of neurology 2007;130(Pt 7):1745-58.
2007: Lakshmi N Yatham; Eduard Vieta; Allan H Young; Hans-Jürgen Möller; Björn Paulsson; Mårten Vågerö
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
International clinical psychopharmacology 2007;22(4):212-20.
2007: Anja Baumann; H Zäske; P Decker; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Wolfgang Gaebel
[Changes in the public's social distance toward individuals with schizophrenia in six German cities. Results of representative pre- and postinterventional telephone surveys from 2001 to 2004].
Der Nervenarzt 2007;78(7):787-8, 790-5.
2007: Markus Jäger; Michael Riedel; Hans-Jürgen Möller
[Acute and transient psychotic disorders (ICD-10: F23). Empirical data and implications for therapy].
Der Nervenarzt 2007;78(7):745-6, 749-52.
2007: Christoph Mulert; Gregor Leicht; Oliver Pogarell; Roland Mergl; Susanne Karch; Georg Juckel; Hans-Jürgen Möller; Victor Perez
Auditory cortex and anterior cingulate cortex sources of the early evoked gamma-band response: relationship to task difficulty and mental effort.
Neuropsychologia 2007;45(10):2294-306.
2007: Hans-Jürgen Möller; Jörg Schnitker
[Prospective study using a modified Montgomery-Asberg Depression Scale].
Der Nervenarzt 2007;78(6):685-90.
2007: Michael Riedel; Ilja Spellmann; Norbert Müller; Hans-Jürgen Möller
[Schizophrenic patients in the family practice].
MMW Fortschritte der Medizin 2007;149 Suppl 2():98-101.
2007: Anton Gietl; Ina Giegling; Annette M Hartmann; Barbara Schneider; Axel Schnabel; Konrad Maurer; Hans-Jürgen Möller; Dan Rujescu
ABCG1 gene variants in suicidal behavior and aggression-related traits.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2007;17(6-7):410-6.
2007: Alessandro Serretti; Laura Mandelli; Ina Giegling; Barbara Schneider; Annette M Hartmann; Axel Schnabel; Konrad Maurer; Hans-Jürgen Möller; Dan Rujescu
HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2007;144B(3):291-9.
2007: Michael Riedel; Norbert Müller; Martin Thomas Strassnig; Ilja Spellmann; Emanuel Severus; Hans-Jürgen Möller
Quetiapine in the treatment of schizophrenia and related disorders.
Neuropsychiatric disease and treatment 2007;3(2):219-35.
2007: Susanne Karch; Christian Graz; Lorenz Jager; Evangelos Karamatskos; Andreas Stammel Wilhelm Flatz; Jürgen Lutz; Bettina Holtschmidt-Taschner; Just Genius; Gregor Leicht Maximilian Reiser; Hans-Jürgen Möller; Victor Perez; Michael Soyka; Christoph Mulert
Influence of anxiety on electrophysiological correlates of response inhibition capacities in alcoholism.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2007;38(2):89-95.
2007: Christoph Mulert; Georg Juckel; Michael Brunnmeier; Susanne Karch; Gregor Leicht; Roland Mergl; Hans-Jürgen Möller; Victor Perez; Oliver Pogarell
Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication.
Clinical EEG and neuroscience : official journal of the EEG and Clinical Neuroscience Society (ENCS) 2007;38(2):78-81.
2007: Thomas Frodl; Cornelius Schüle; Gisela Schmitt; Christine Born; Thomas C Baghai; Peter Zill; Ronald Bottlender; Rainer Rupprecht; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
Archives of general psychiatry 2007;64(4):410-6.
2007: Peter Zwanzger; Daniela Eser; Nikolas Völkel; Thomas C Baghai; Hans-Jürgen Möller; Rainer Rupprecht; Frank Padberg
Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4).
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(2):285-9.
2007: Hans-Jürgen Möller; S Langer; M Schmauss
Escitalopram in clinical practice: results of an open-label trial in outpatients with depression in a naturalistic setting in Germany.
Pharmacopsychiatry 2007;40(2):53-7.
2007: Christoph Mulert; Georg Juckel; Michael Brunnmeier; Susanne Karch; Gregor Leicht; Roland Mergl; Hans-Jürgen Möller; Victor Perez; Oliver Pogarell
Prediction of treatment response in major depression: integration of concepts.
Journal of affective disorders 2007;98(3):215-25.
2007: Thomas Zetzsche; Ulrich W Preuss; Thomas Frodl; Gisela Schmitt; Doerthe Seifert; Elmar Münchhausen; Shahram Tabrizi; Gerda Leinsinger; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Hippocampal volume reduction and history of aggressive behaviour in patients with borderline personality disorder.
Psychiatry research 2007;154(2):157-70.
2007: Stefan J Teipel; Robert Stahl; Olaf Dietrich; Stefan O Schoenberg; Robert Perneczky; Arun Bokde; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Multivariate network analysis of fiber tract integrity in Alzheimer's disease.
NeuroImage 2007;34(3):985-95.
2007: Markus Jäger; Michael Riedel; Thomas Messer; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Wolfgang Huff; Isabella Heuser; Kai-Uwe Kühn; Matthias R Lemke; Eckart Rüther; Gerhard Buchkremer; Markus Gastpar; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders.
European archives of psychiatry and clinical neuroscience 2007;257(1):47-53.
2007: Dan Rujescu; Eva M Meisenzahl; S Krejcova; Ina Giegling; Thomas Zetzsche; M Reiser; Christine Born; Hans-Jürgen Möller; Andres Veske; Andreas Gal; Ulrich Finckh
Plexin B3 is genetically associated with verbal performance and white matter volume in human brain.
Molecular psychiatry 2007;12(2):190-4, 115.
2007: J Scheuerecker; Thomas Frodl; Nikolaos Koutsouleris; Thomas Zetzsche; Martin Wiesmann; A M Kleemann; Hartmut Brückmann; Gisela Schmitt; Hans-Jürgen Möller; Eva M Meisenzahl
Cerebral differences in explicit and implicit emotional processing--an fMRI study.
Neuropsychobiology 2007;56(1):32-9.
2007: Stefan J Teipel; A J Mitchell; Hans-Jürgen Möller; Harald Hampel
Improving linear modeling of cognitive decline in patients with mild cognitive impairment: comparison of two methods.
Journal of neural transmission. Supplementum 2007;(72):241-7.
2007: Stephan Herpertz; Mary Zanarini; Charles S Schulz; Larry J Siever; Klaus Lieb; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(4):212-44.
2007: Hans-Jürgen Möller
Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.
Drugs 2007;67(11):1541-66.
2007: Hans-Jürgen Möller
Do effectiveness studies tell us the real truth?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(3):138-40.
2007: Michael Bauer; Tom Bschor; Andrea Pfennig; Peter C Whybrow; Jules Angst; Marcio Versiani; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2007;8(2):67-104.
2007: Dan Rujescu; Andreas Thalmeier; Hans-Jürgen Möller; Thomas Bronisch; Ina Giegling
Molecular genetic findings in suicidal behavior: what is beyond the serotonergic system?
Archives of suicide research : official journal of the International Academy for Suicide Research 2007;11(1):17-40.
2007: Roland Mergl; Isabel Seidscheck; Antje-Kathrin Allgaier; Hans-Jürgen Möller; Victor Perez; Verena Henkel
Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.
Depression and anxiety 2007;24(3):185-95.
2007: Michael Riedel; Ilja Spellmann; Markus Schwarz; Martin Thomas Strassnig; Christopher Sikorski; Hans-Jürgen Möller; Norbert Müller
Decreased T cellular immune response in schizophrenic patients.
Journal of psychiatric research 2007;41(1-2):3-7.
2007: Peter Zill; Andreas Büttner; Wolfgang Eisenmenger; Hans-Jürgen Möller; Manfred Ackenheil; Brigitta Bondy
Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study.
Journal of psychiatric research 2007;41(1-2):168-73.
2006: Hans-Jürgen Möller
[Psychiatric emergencies: who has responsibility for patient admission?].
Deutsche medizinische Wochenschrift (1946) 2006;131(50):2864.
2006: Eva M Meisenzahl; J Scheuerecker; M Zipse; S Ufer; Martin Wiesmann; Thomas Frodl; Nikolaos Koutsouleris; Thomas Zetzsche; Gisela Schmitt; Michael Riedel; Ilja Spellmann; Sandra Dehning; Jennifer Linn; Hartmut Brückmann; Hans-Jürgen Möller
Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation.
European archives of psychiatry and clinical neuroscience 2006;256(8):522-31.
2006: Hans-Jürgen Möller
Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.
European archives of psychiatry and clinical neuroscience 2006;256(8):476-96.
2006: Alexander Brunnauer; Gerd Laux; Elisabeth Geiger; Michael Soyka; Hans-Jürgen Möller
Antidepressants and driving ability: results from a clinical study.
The Journal of clinical psychiatry 2006;67(11):1776-81.
2006: Thomas C Baghai; Elisabeth B Binder; Cornelius Schule; Daria Salyakina; Daniela Eser; Susanne Lucae; Peter Zwanzger; C Haberger; Peter Zill; Marcus Ising; Tobias Deiml; Manfred Uhr; T Illig; H-E Wichmann; Sieglinde Modell; Caroline Nothdurfter; Florian Holsboer; Bertram Müller-Myhsok; Hans-Jürgen Möller; Rainer Rupprecht; Brigitta Bondy
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism.
Molecular psychiatry 2006;11(11):1003-15.
2006: Ina Giegling; Annette M Hartmann; Hans-Jürgen Möller; Dan Rujescu
Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene.
Journal of affective disorders 2006;96(1-2):75-81.
2006: Oliver Pogarell; Georg Juckel; Paraskevi Mavrogiorgou; Christoph Mulert; Malte Folkerts; Walter Hauke; Michael Zaudig; Hans-Jürgen Möller; Victor Perez
Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2006;62(1):87-92.
2006: Thomas Frodl; Annette Schaub; Sandra Banac; Marketa Charypar; Markus Jäger; Petra Kümmler; Ronald Bottlender; Thomas Zetzsche; Christine Born; Gerda Leinsinger; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Reduced hippocampal volume correlates with executive dysfunctioning in major depression.
Journal of psychiatry & neuroscience : JPN 2006;31(5):316-23.
2006: Hans-Jürgen Möller
Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review.
European archives of psychiatry and clinical neuroscience 2006;256(6):329-43.
2006: Stefan J Teipel; Michael Ewers; Olaf Dietrich; Stefan O Schoenberg; Frank Jessen; Reinhard Heun; Nikolaus Freymann; Hans-Jürgen Möller; Harald Hampel
[Reliability of multicenter magnetic resonance imaging. Results of a phantom test and in vivo measurements by the German Dementia Competence Network].
Der Nervenarzt 2006;77(9):1086-92, 1094-5.
2006: Thomas Zetzsche; Thomas Frodl; Ulrich W Preuss; Gisela Schmitt; Doerthe Seifert; Gerda Leinsinger; Christine Born; Maximilian Reiser; Hans-Jürgen Möller; Eva M Meisenzahl
Amygdala volume and depressive symptoms in patients with borderline personality disorder.
Biological psychiatry 2006;60(3):302-10.
2006: Stefan J Teipel; Alexander Drzezga; Peter Bartenstein; Hans-Jürgen Möller; Markus Schwaiger; Harald Hampel
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.
Psychopharmacology 2006;187(1):86-94.
2006: Norbert Müller; Markus Schwarz; Sandra Dehning; A Douhe; A Cerovecki; Barbara Goldstein-Müller; Ilja Spellmann; G Hetzel; K Maino; Nikolaus Kleindienst; Hans-Jürgen Möller; Volker Arolt; Michael Riedel
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Molecular psychiatry 2006;11(7):680-4.
2006: Stefan J Teipel; Jens C Pruessner; Frank Faltraco; Christine Born; Manoela Rocha-Unold; Alan Evans; Hans-Jürgen Möller; Harald Hampel
Comprehensive dissection of the medial temporal lobe in AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and parahippocampal cortices using MRI.
Journal of neurology 2006;253(6):794-800.
2006: Christoph Mulert; Georg Juckel; Ina Giegling; Oliver Pogarell; Gregor Leicht; Susanne Karch; Paraskevi Mavrogiorgou; Hans-Jürgen Möller; Victor Perez; Dan Rujescu
A Ser9Gly polymorphism in the dopamine D3 receptor gene (DRD3) and event-related P300 potentials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(6):1335-44.
2006: Oliver Pogarell; Walter Koch; Gabriele Pöpperl; Klaus Tatsch; Franziska Jakob; Peter Zwanzger; Christoph Mulert; Rainer Rupprecht; Hans-Jürgen Möller; Victor Perez; Frank Padberg
Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study.
Journal of psychiatric research 2006;40(4):307-14.
2006: Markus Jäger; Michael Riedel; Hans-Jürgen Möller
[The role of the family physician in the treatment concept of schizophrenic disorders].
MMW Fortschritte der Medizin 2006;Spec no. 2():39-41.
2006: Hans-Jürgen Möller
Long-acting risperidone: focus on safety.
Clinical therapeutics 2006;28(5):633-51.
2006: Arun Bokde; P Lopez-Bayo; Thomas Meindl; S Pechler; Christine Born; Frank Faltraco; Stefan J Teipel; Hans-Jürgen Möller; Harald Hampel
Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Brain : a journal of neurology 2006;129(Pt 5):1113-24.
2006: Stefan J Teipel; Frode Willoch; K Ishii; Katharina Bürger; Alexander Drzezga; Rolf Engel; P Bartenstein; Hans-Jürgen Möller; M Schwaiger; Harald Hampel
Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
Neurobiology of aging 2006;27(5):681-90.
2006: Dan Rujescu; Andreas Bender; Martin E Keck; Annette M Hartmann; frauke ohl; Hanna Raeder; Ina Giegling; Just Genius; Robert W McCarley; Hans-Jürgen Möller; Heinz Grunze
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
Biological psychiatry 2006;59(8):721-9.
2006: Michael Bauer; Hans-Jürgen Möller; Edith Schneider
Duloxetine: a new selective and dual-acting antidepressant.
Expert opinion on pharmacotherapy 2006;7(4):421-7.
2006: Gisela Schmitt; Thomas Frodl; Stefan Dresel; Christian la Fougère; Ronald Bottlender; Nikolaos Koutsouleris; Klaus Hahn; Hans-Jürgen Möller; Eva M Meisenzahl
Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients.
European archives of psychiatry and clinical neuroscience 2006;256(2):115-21.
2006: Anna Forsthoff; Barbara Hummel; Hans-Jürgen Möller; Heinz Grunze
[Suicidality and the Internet. Danger from new media].
Der Nervenarzt 2006;77(3):343-5.
2006: Markus Schwarz; Holger Krönig; Michael Riedel; Sandra Dehning; Anette Douhet; Ilja Spellmann; Manfred Ackenheil; Hans-Jürgen Möller; Norbert Müller
IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia.
European archives of psychiatry and clinical neuroscience 2006;256(2):72-6.
2006: Edwin J C G van den Oord; Dan Rujescu; Jaime R Robles; Ina Giegling; Claire Birrell; József Bukszár; Lenn Murrelle; Hans-Jürgen Möller; Lefkos T Middleton; Pierandrea Muglia
Factor structure and external validity of the PANSS revisited.
Schizophrenia research 2006;82(2-3):213-23.
2006: W Bender; M Albus; Hans-Jürgen Möller; F Tretter
Towards systemic theories in biological psychiatry.
Pharmacopsychiatry 2006;39 Suppl 1():S4-9.
2006: Daniela C Glatz; Dan Rujescu; Yesheng Tang; Frank J Berendt; Annette M Hartmann; Frank Faltraco; Carlyn Rosenberg; Christine M Hulette; Kurt A Jellinger; Harald Hampel; Peter Riederer; Hans-Jürgen Möller; Athena Andreadis; Kerstin Henkel; Stefan Stamm
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
Journal of neurochemistry 2006;96(3):635-44.
2006: Hans-Jürgen Möller; Heinz Grunze; Karl Broich
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
European archives of psychiatry and clinical neuroscience 2006;256(1):1-16.
2006: Verena Henkel; Roland Mergl; Antje-Kathrin Allgaier; Ralf Kohnen; Hans-Jürgen Möller; Victor Perez
Treatment of depression with atypical features: a meta-analytic approach.
Psychiatry research 2006;141(1):89-101.
2006: Rainer Rupprecht; Daniela Eser; Peter Zwanzger; Hans-Jürgen Möller
GABAA receptors as targets for novel anxiolytic drugs.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(4):231-7.
2006: Thomas C Baghai; Hans-Peter Volz; Hans-Jürgen Möller
Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(4):198-222.
2006: Caroline Nothdurfter; Daniela Eser; Cornelius Schüle; Peter Zwanzger; Alain Marcuse; Ines Noack; Hans-Jürgen Möller; Rainer Rupprecht; Thomas C Baghai
The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(3):162-70.
2006: Thomas C Baghai; Alain Marcuse; Melanie Brosch; Cornelius Schüle; Daniela Eser; Caroline Nothdurfter; Yvonne Steng; Ines Noack; Katrin Pietschmann; Hans-Jürgen Möller; Rainer Rupprecht
The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(2):82-90.
2006: Hans-Jürgen Möller
Ethical aspects of publishing.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(2):66-9.
2006: Wolfgang Wölwer; Anja Baumann; Andreas Bechdolf; Gerhard Buchkremer; Heinz Häfner; Birgit Janssen; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Stephan Ruhrmann; Wolfgang Gaebel
The German Research Network on Schizophrenia--impact on the management of schizophrenia.
Dialogues in clinical neuroscience 2006;8(1):115-21.
2006: Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2006;7(1):5-40.
2006: Jürgen Fritz; J Aldenhoff; F Bermann; W Maier; Hans-Jürgen Möller
[Antipsychotic agents in dementia].
Der Nervenarzt 2006;77(1):110-3.
2006: Thomas C Baghai; Hans-Jürgen Möller; Rainer Rupprecht
Recent progress in pharmacological and non-pharmacological treatment options of major depression.
Current pharmaceutical design 2006;12(4):503-15.
2006: Hans-Jürgen Möller; Ronald Bottlender
Severe mental illness in depression.
Acta psychiatrica Scandinavica. Supplementum 2006;(429):64-8.
2006: Tetsuya Sato; Ronald Bottlender; Marcus Sievers; Hans-Jürgen Möller
Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states.
Journal of affective disorders 2006;90(1):1-5.
2006: Katharina Buerger; Markus Otto; Stefan J Teipel; Raymond Zinkowski; Kaj Blennow; John DeBernardis; Daniel Kerkman; Johannes Schröder; Peter Schönknecht; Lukas Cepek; Cheryl McCulloch; Hans-Jürgen Möller; Jens Wiltfang; Hans A Kretzschmar; Harald Hampel
Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
Neurobiology of aging 2006;27(1):10-5.
2005: Hans-Jürgen Möller
Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study.
European archives of psychiatry and clinical neuroscience 2005;255(6):371-2.
2005: Wolfgang Maier; Hans-Jürgen Möller
Metaanalyses - highest level of empirical evidence?
European archives of psychiatry and clinical neuroscience 2005;255(6):369-70.
2005: Michael Riedel; Norbert Müller; Martin Thomas Strassnig; Ilja Spellmann; Rolf R Engel; Richard Musil; Sandra Dehning; Anette Douhet; Markus Schwarz; Hans-Jürgen Möller
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms.
European archives of psychiatry and clinical neuroscience 2005;255(6):432-7.
2005: Oliver Pogarell; Sigrid Ehrentraut; T Rüther; Christoph Mulert; Victor Perez; Hans-Jürgen Möller; Verena Henkel
Prolonged confusional state following electroconvulsive therapy--diagnostic clues from serial electroencephalography.
Pharmacopsychiatry 2005;38(6):316-20.
2005: Stefan J Teipel; Wilhelm H Flatz; Helmut Heinsen; Arun Bokde; Stefan O Schoenberg; Stephanie Stöckel; Olaf Dietrich; Maximilian F Reiser; Hans-Jürgen Möller; Harald Hampel
Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Brain : a journal of neurology 2005;128(Pt 11):2626-44.
2005: Christoph Mulert; Lorenz Jäger; Sebastian Propp; Susanne Karch; Sylvère Störmann; Oliver Pogarell; Hans-Jürgen Möller; Georg Juckel; Victor Perez
Sound level dependence of the primary auditory cortex: Simultaneous measurement with 61-channel EEG and fMRI.
NeuroImage 2005;28(1):49-58.
2005: Michael Soyka; W Koch; Hans-Jürgen Möller; T Rüther; Klaus Tatsch
Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study.
European archives of psychiatry and clinical neuroscience 2005;255(5):308-12.
2005: Cornelius Schüle; Thomas C Baghai; Lejla Alajbegovic; Markus Schwarz; Peter Zwanzger; Daniela Eser; Ludwig Schaaf; Hans-Jürgen Möller; Rainer Rupprecht
The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients.
European archives of psychiatry and clinical neuroscience 2005;255(5):334-40.
2005: Gisela Schmitt; Eva M Meisenzahl; Thomas Frodl; Christian la Fougère; Klaus Hahn; Hans-Jürgen Möller; Stefan Dresel
The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1.
Journal of psychopharmacology (Oxford, England) 2005;19(5):488-93.
2005: Markus Jäger; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Fifteen-year follow-up of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorders: the prognostic significance of psychotic features.
Comprehensive psychiatry 2005;46(5):322-7.
2005: Hans-Jürgen Möller
Antipsychotic agents. Gradually improving treatment from the traditional oral neuroleptics to the first atypical depot.
European psychiatry : the journal of the Association of European Psychiatrists 2005;20(5-6):379-85.
2005: Dieter Adam; S Kasper; Hans-Jürgen Möller; E A Singer
Placebo-controlled trials in major depression are necessary and ethically justifiable: how to improve the communication between researchers and ethical committees.
European archives of psychiatry and clinical neuroscience 2005;255(4):258-60.
2005: Michael Riedel; Markus Schwarz; Martin Thomas Strassnig; Ilja Spellmann; A Müller-Arends; K Weber; Johanna Zach; Norbert Müller; Hans-Jürgen Möller
Risperidone plasma levels, clinical response and side-effects.
European archives of psychiatry and clinical neuroscience 2005;255(4):261-8.
2005: Harald Hampel; Andreas Haslinger; Michael Scheloske; Frank Padberg; Petra Fischer; Josef Unger; Stefan J Teipel; Michaela Neumann; Carlyn Rosenberg; Rusti Oshida; Christine M Hulette; Dieter Pongratz; Michael Ewers; Hans A Kretzschmar; Hans-Jürgen Möller
Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.
European archives of psychiatry and clinical neuroscience 2005;255(4):269-78.
2005: Hans-Jürgen Möller
Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms?
European archives of psychiatry and clinical neuroscience 2005;255(3):190-201.
2005: Christian la Fougère; Eva M Meisenzahl; Gisela Schmitt; Jan Stauss; Thomas Frodl; Klaus Tatsch; Klaus Hahn; Hans-Jürgen Möller; Stefan Dresel
D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(6):1028-33.
2005: F Padberg; Hans-Jürgen Möller; R Bottlender; Harald Hampel
[Modern therapy for dementia].
MMW Fortschritte der Medizin 2005;147 Spec No 2():71-4, 76-7.
2005: Ronald Bottlender; Harald Hampel; Marcus Sievers; Hans-Jürgen Möller
[Diagnostics and therapy of depressive symptoms in schizophrenic patients].
MMW Fortschritte der Medizin 2005;147 Spec No 2():59-62.
2005: Hans-Jürgen Möller
Risperidone: a review.
Expert opinion on pharmacotherapy 2005;6(5):803-18.
2005: Harald Hampel; Katharina Bürger; Jens C Pruessner; Raymond Zinkowski; John DeBernardis; Daniel Kerkman; Gerda Leinsinger; Alan C Evans; Peter Davies; Hans-Jürgen Möller; Stefan J Teipel
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease.
Archives of neurology 2005;62(5):770-3.
2005: Hans-Jürgen Möller; Pierre-Michel Llorca; Emilio Sacchetti; Stephen D Martin; Rossella Medori; Eduard Parellada
Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.
International clinical psychopharmacology 2005;20(3):121-30.
2005: Thomas C Baghai; Alain Marcuse; Hans-Jürgen Möller; Rainer Rupprecht
[Electroconvulsive therapy at the Department of Psychiatry and Psychotherapy, University of Munich. Development during the years 1995-2002].
Der Nervenarzt 2005;76(5):597-612.
2005: Sylvia Brettschneider; Nils G. Morgenthaler; Stefan J Teipel; Christina Fischer-Schulz; Katharina Bürger; Richard Dodel; Yansheng Du; Hans-Jürgen Möller; Andreas Bergmann; Harald Hampel
Decreased serum amyloid beta(1-42) autoantibody levels in Alzheimer's disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta(1-42) peptide.
Biological psychiatry 2005;57(7):813-6.
2005: Hans-Jürgen Möller
Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data.
European archives of psychiatry and clinical neuroscience 2005;255(2):83-93.
2005: Arun Bokde; Stefan J Teipel; Robert Schwarz; Gerda Leinsinger; Katharina Buerger; Tobias Moeller; Hans-Jürgen Möller; Harald Hampel
Reliable manual segmentation of the frontal, parietal, temporal, and occipital lobes on magnetic resonance images of healthy subjects.
Brain research. Brain research protocols 2005;14(3):135-45.
2005: Edna Grünblatt; R Schlösser; Peter Fischer; M O Fischer; J Li; Eleni Koutsilieri; Ildiko Wichart; N Sterba; D Rujescu; Hans-Jürgen Möller; W Adamcyk; B Dittrich; F Müller; K Oberegger; Gerald Gatterer; Kurt A Jellinger; Nazanin Mostafaie; Susanne Jungwirth; K Huber; Karl-Heinz Tragl; Walter Danielczyk; Peter Riederer
Oxidative stress related markers in the "VITA" and the centenarian projects.
Neurobiology of aging 2005;26(4):429-38.
2005: Michael Riedel; Martin Thomas Strassnig; Norbert Müller; P Zwack; Hans-Jürgen Möller
How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?
European archives of psychiatry and clinical neuroscience 2005;255(2):143-8.
2005: Marcus Sievers; T Sato; Hans-Jürgen Möller; Ronald Bottlender
Obsessive-compulsive disorder (OCD) with psychotic symptoms and response to treatment with SSRI.
Pharmacopsychiatry 2005;38(2):104-5.
2005: Dan Rujescu; Michael Soyka; Norbert Dahmen; Ulrich W Preuss; Annette M Hartmann; Ina Giegling; Gabriele Koller; Brigitta Bondy; Hans-Jürgen Möller; Armin Szegedi
GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;133B(1):85-7.
2005: Nikolaus Kleindienst; W. Emanuel Severus; Hans-Jürgen Möller; Waldemar Greil
Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?
European archives of psychiatry and clinical neuroscience 2005;255(1):72-4.
2005: Tetsuya Sato; Ronald Bottlender; Nikolaus Kleindienst; Hans-Jürgen Möller
Irritable psychomotor elation in depressed inpatients: a factor validation of mixed depression.
Journal of affective disorders 2005;84(2-3):187-96.
2005: Verena Henkel; Roland Mergl; Hans-Jürgen Möller
Major depression is common in people over the age of 50, particularly in those at socioeconomic disadvantage, or with poor physical health and previous depressive symptoms.
Evidence-based mental health 2005;8(1):25.
2005: Ulrich W Preuss; Thomas Zetzsche; Markus Jäger; Constanze Groll; Thomas Frodl; Ronald Bottlender; Gerda Leinsinger; Victor Perez; Klaus Hahn; Hans-Jürgen Möller; Eva M Meisenzahl
Thalamic volume in first-episode and chronic schizophrenic subjects: a volumetric MRI study.
Schizophrenia research 2005;73(1):91-101.
2005: Hans-Jürgen Möller; M Bauer; J Fritze; Ekkehard Haen; G Laux; W E Müller; Eckart Rüther
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
MMW Fortschritte der Medizin 2005;147(3):43-5.
2005: Hans-Jürgen Möller
Occurrence and treatment of depressive comorbidity/cosyndromality in schizophrenic psychoses: conceptual and treatment issues.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(4):247-63.
2005: Peter Falkai; Thomas Wobrock; Jeffrey Lieberman; Birte Glenthoj; Wagner F Gattaz; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(3):132-91.
2005: Hans-Jürgen Möller
Are placebo-controlled studies required in order to prove efficacy of antidepressants?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(3):130-1.
2005: Hans-Jürgen Möller
Problems associated with the classification and diagnosis of psychiatric disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(1):45-56.
2005: Carlos Hojaij; Hans-Jürgen Möller
A continuing success story.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2005;6(1):4-5.
2005: Tetsuya Sato; Ronald Bottlender; Marcus Sievers; Hans-Jürgen Möller
Evidence of depressive mixed states.
The American journal of psychiatry 2005;162(1):193-4; author reply 194.
2005: Oliver Pogarell; Stefan J Teipel; Georg Juckel; L Gootjes; T Möller; Katharina Bürger; Gerda Leinsinger; Hans-Jürgen Möller; Victor Perez; Harald Hampel
EEG coherence reflects regional corpus callosum area in Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2005;76(1):109-11.
2005: Michael Soyka; Catja Winter; Sabine Kagerer; Manfred Brunnauer; Gerd Laux; Hans-Jürgen Möller
Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
Journal of psychiatric research 2005;39(1):101-8.
2004: Verena Henkel; Roland Mergl; James C Coyne; Ralf Kohnen; Antje-Kathrin Allgaier; Elke Rühl; Hans-Jürgen Möller; Victor Perez
Depression with atypical features in a sample of primary care outpatients: prevalence, specific characteristics and consequences.
Journal of affective disorders 2004;83(2-3):237-42.
2004: Hans-Jürgen Möller; Vivienne A Curtis
The bipolar spectrum: diagnostic and pharmacologic considerations.
Expert review of neurotherapeutics 2004;4(6 Suppl 2):S3-8.
2004: Oliver Pogarell; Georg Juckel; Christoph Mulert; Benedikt Amann; Hans-Jürgen Möller; Ulrich Hegerl
EEG abnormalities under treatment with atypical antipsychotics: effects of olanzapine and amisulpride as compared to haloperidol.
Pharmacopsychiatry 2004;37(6):304-5.
2004: Hans-Jürgen Möller; M Riedel; N Müller; W Fischer; R Kohnen
Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Pharmacopsychiatry 2004;37(6):270-8.
2004: Hans-Jürgen Möller
Course and long-term treatment of schizophrenic psychoses.
Pharmacopsychiatry 2004;37 Suppl 2():126-35.
2004: Peter Zill; Thomas C Baghai; Peter Zwanzger; Cornelius Schüle; Daniela Eser; Rainer Rupprecht; Hans-Jürgen Möller; Brigitta Bondy; Manfred Ackenheil
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression.
Molecular psychiatry 2004;9(11):1030-6.
2004: Peter Zill; Andreas Büttner; Wolfgang Eisenmenger; Hans-Jürgen Möller; Brigitta Bondy; Manfred Ackenheil
Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims.
Biological psychiatry 2004;56(8):581-6.
2004: Rainer Rupprecht; Hans-Jürgen Möller
[Diagnosis and treatment of panic disorder].
MMW Fortschritte der Medizin 2004;146(42):45-6, 48.
2004: Hans-Jürgen Möller
SSRIs: are the accusations justified?
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(4):174-5.
2004: Richard Dodel; Yansheng Du; Candan Depboylu; Harald Hampel; Lutz Froelich; A Haag; U Hemmeter; S Paulsen; Stefan J Teipel; Sylvia Brettschneider; Annika Spottke; C Nölker; Hans-Jürgen Möller; X Wei; Martin R Farlow; Norbert Sommer; Wolfgang H Oertel
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 2004;75(10):1472-4.
2004: Christine M Born; Eva M Meisenzahl; Thomas Frodl; Thomas Pfluger; Maximilian Reiser; Hans-Jürgen Möller; Gerda Leinsinger
The septum pellucidum and its variants. An MRI study.
European archives of psychiatry and clinical neuroscience 2004;254(5):295-302.
2004: Oliver Pogarell; Klaus Tatsch; Georg Juckel; Christine Hamann; Christoph Mulert; Gabriele Pöpperl; Malte Folkerts; Martina Choukèr; Michael Riedel; Michael Zaudig; Hans-Jürgen Möller; Victor Perez
Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(10):1910-7.
2004: Rainer Rupprecht; Michael Soyka; Renate Grohmann; Eckart Rüther; Hans-Jürgen Möller
[Considerations in the combination of clozapine and benzodiazepines].
Der Nervenarzt 2004;75(9):857-60.
2004: Peter Zill; Thomas C Baghai; Rolf Engel; Peter Zwanzger; Cornelius Schüle; Daniela Eser; Stefanie Behrens; Rainer Rupprecht; Hans-Jürgen Möller; Manfred Ackenheil; Brigitta Bondy
The dysbindin gene in major depression: an association study.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;129B(1):55-8.
2004: Verena Henkel; Roland Mergl; James C Coyne; Ralf Kohnen; Hans-Jürgen Möller; Victor Perez
Screening for depression in primary care: will one or two items suffice?
European archives of psychiatry and clinical neuroscience 2004;254(4):215-23.
2004: Tetsuya Sato; Ronald Bottlender; Marcus Sievers; Andreas Schröter; Nikolaus Kleindienst; Hans-Jürgen Möller
Evaluating the inter-episode stability of depressive mixed states.
Journal of affective disorders 2004;81(2):103-13.
2004: Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles L Bowden; Hans-Jürgen Möller
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(3):120-35.
2004: Hans-Jürgen Möller
Access to the world journal of biological psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(3):118-9.
2004: Harald Hampel; Stefan J Teipel; T Fuchsberger; Niels Andreasen; J Wiltfang; M Otto; Yong Shen; Richard Dodel; Yansheng Du; Martin R Farlow; Hans-Jürgen Möller; Kaj Blennow; Katharina Buerger
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Molecular psychiatry 2004;9(7):705-10.
2004: Christoph Mulert; Oliver Pogarell; Georg Juckel; Dan Rujescu; Ina Giegling; D Rupp; Paraskevi Mavrogiorgou; Patrick Bussfeld; Jürgen Gallinat; Hans-Jürgen Möller; Victor Perez
The neural basis of the P300 potential. Focus on the time-course of the underlying cortical generators.
European archives of psychiatry and clinical neuroscience 2004;254(3):190-8.
2004: R Bottlender; Hans-Jürgen Möller
[Schizophrenics in the doctor's office. Diagnostic and therapeutic aspects].
MMW Fortschritte der Medizin 2004;146 Spec No 2():19-23.
2004: Frank Padberg; Peter Zwanzger; Robin Ella; Rainer Rupprecht; Hans-Jürgen Möller
[Repetitive transcranial magnetic stimulation of the prefrontal cortex--the last resort in the treatment of depression?].
MMW Fortschritte der Medizin 2004;146 Spec No 2():16-7.
2004: Markus Jäger; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Classification of functional psychoses and its implication for prognosis: comparison between ICD-10 and DSM-IV.
Psychopathology 2004;37(3):110-7.
2004: Verena Henkel; Roland Mergl; Martin Schäfer; Dan Rujescu; Hans-Jürgen Möller; Victor Perez
Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics?
Pharmacopsychiatry 2004;37(3):110-8.
2004: Hans-Jürgen Möller
[Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].
Der Nervenarzt 2004;75(5):499-515; quiz 516-7.
2004: Verena Henkel; Roland Mergl; Ralf Kohnen; Antje-Kathrin Allgaier; Hans-Jürgen Möller; Victor Perez
Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups.
General hospital psychiatry 2004;26(3):190-8.
2004: Christoph Mulert; Lorenz Jäger; Robert Schmitt; Patrick Bussfeld; Oliver Pogarell; Hans-Jürgen Möller; Georg Juckel; Victor Perez
Integration of fMRI and simultaneous EEG: towards a comprehensive understanding of localization and time-course of brain activity in target detection.
NeuroImage 2004;22(1):83-94.
2004: Hans-Jürgen Möller
[Are placebo controlled studies on the proof of effectiveness of antidepressants necessary?].
Der Nervenarzt 2004;75(5):421-4.
2004: Alexander Brunnauer; Gerd Laux; Elisabeth Geiger; Hans-Jürgen Möller
The impact of antipsychotics on psychomotor performance with regards to car driving skills.
Journal of clinical psychopharmacology 2004;24(2):155-60.
2004: Wolfgang Gaebel; Hans-Jürgen Möller; Gerhard Buchkremer; Christian Ohmann; Mathias Riesbeck; Wolfgang Wölwer; Martina Von Wilmsdorff; Ronald Bottlender; Stefan Klingberg
Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
European archives of psychiatry and clinical neuroscience 2004;254(2):129-40.
2004: Heinz Häfner; Kurt Maurer; Stephan Ruhrmann; Andreas Bechdolf; Joachim Klosterkötter; Michael Wagner; Wolfgang Maier; Ronald Bottlender; Hans-Jürgen Möller; Wolfgang Gaebel; Wolfgang Wölwer
Early detection and secondary prevention of psychosis: facts and visions.
European archives of psychiatry and clinical neuroscience 2004;254(2):117-28.
2004: Hans-Jürgen Möller
Non-neuroleptic approaches to treating negative symptoms in schizophrenia.
European archives of psychiatry and clinical neuroscience 2004;254(2):108-16.
2004: Victor Perez; Anita Plattner; Hans-Jürgen Möller
Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s.
European archives of psychiatry and clinical neuroscience 2004;254(2):99-107.
2004: Thomas Frodl; Eva M Meisenzahl; Thomas Zetzsche; Tom Höhne; Sandra Banac; Constanze Schorr; Markus Jäger; Gerda Leinsinger; Ronald Bottlender; Maximilian Reiser; Hans-Jürgen Möller
Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.
The Journal of clinical psychiatry 2004;65(4):492-9.
2004: Verena Henkel; Thomas C Baghai; Daniela Eser; Peter Zill; Roland Mergl; Peter Zwanzger; Cornelius Schüle; Ronald Bottlender; Markus Jäger; Rainer Rupprecht; Victor Perez; Hans-Jürgen Möller; Brigitta Bondy
The gamma amino butyric acid (GABA) receptor alpha-3 subunit gene polymorphism in unipolar depressive disorder: a genetic association study.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;126B(1):82-7.
2004: Stefan J Teipel; Gene Alexander; Mark B Schapiro; Hans-Jürgen Möller; Stanley I Rapoport; Harald Hampel
Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
Brain : a journal of neurology 2004;127(Pt 4):811-24.
2004: Tetsuya Sato; Ronald Bottlender; Andreas Schröter; Hans-Jürgen Möller
Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments.
Schizophrenia research 2004;67(2-3):175-83.
2004: Susanne Stübner; Renate Grohmann; Rolf Engel; B Bandelow; W-D Ludwig; G Wagner; Bruno Müller-Oerlinghausen; Hans-Jürgen Möller; H Hippius; Eckart Rüther
Blood dyscrasias induced by psychotropic drugs.
Pharmacopsychiatry 2004;37 Suppl 1():S70-8.
2004: Susanne Stübner; E Rustenbeck; Renate Grohmann; G Wagner; Rolf Engel; G Neundörfer; Hans-Jürgen Möller; H Hippius; Eckart Rüther
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
Pharmacopsychiatry 2004;37 Suppl 1():S54-64.
2004: Georg Juckel; Paraskevi Mavrogiorgou; S Bredemeier; Jürgen Gallinat; Thomas Frodl; Carl Schulz; Hans-Jürgen Möller; Victor Perez
Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
Pharmacopsychiatry 2004;37(2):46-51.
2004: Rainer Rupprecht; Thomas C Baghai; Hans-Jürgen Möller
[New developments in pharmacotherapy of depression].
Der Nervenarzt 2004;75(3):273-80.
2004: Thomas Frodl; Eva M Meisenzahl; Hans-Jürgen Möller
[Value of diagnostic imaging in evaluation of electroconvulsive therapy].
Der Nervenarzt 2004;75(3):227-33.
2004: Harald Hampel; A Mitchell; Kaj Blennow; R A Frank; Sylvia Brettschneider; Lars Weller; Hans-Jürgen Möller
Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity.
Journal of neural transmission (Vienna, Austria : 1996) 2004;111(3):247-72.
2004: Eva M Meisenzahl; Thomas Frodl; D Müller; Gisela Schmitt; J Gallinat; Thomas Zetzsche; A Marcuse; Georg Juckel; Gerda Leinsinger; Klaus Hahn; Hans-Jürgen Möller; Victor Perez
Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation.
Journal of psychiatric research 2004;38(2):153-62.
2004: Norbert Müller; Markus Ulmschneider; Constanze Scheppach; Markus Schwarz; Manfred Ackenheil; Hans-Jürgen Möller; Rudolf Gruber; Michael Riedel
COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy.
European archives of psychiatry and clinical neuroscience 2004;254(1):14-22.
2004: M Jäger; Ronald Bottlender; A Strauss; Hans-Jürgen Möller
[The classification of functional psychoses: the impact of ICD-10 diagnoses (research diagnostic criteria) for the prediction of the long-term course].
Fortschritte der Neurologie-Psychiatrie 2004;72(2):70-8.
2004: Thomas Frodl; Eva M Meisenzahl; Peter Zill; Thomas C Baghai; Dan Rujescu; Gerda Leinsinger; Ronald Bottlender; Cornelius Schüle; Peter Zwanzger; Rolf R Engel; Rainer Rupprecht; Brigitta Bondy; Maximilian Reiser; Hans-Jürgen Möller
Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression.
Archives of general psychiatry 2004;61(2):177-83.
2004: Ronald Bottlender; Tetsuya Sato; Nikolaus Kleindienst; Anton Strauss; Hans-Jürgen Möller
Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder.
Journal of affective disorders 2004;78(2):149-52.
2004: L Gootjes; Stefan J Teipel; York Zebuhr; Robert Schwarz; Gerda Leinsinger; Philip scheltens; Hans-Jürgen Möller; Harald Hampel
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Dementia and geriatric cognitive disorders 2004;18(2):180-8.
2004: Hans-Jürgen Möller
Novel antipsychotics in the long-term treatment of schizophrenia.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2004;5(1):9-19.
2004: Lutz Frölich; Johannes Fox; Frank Padberg; Konrad Maurer; Hans-Jürgen Möller; Harald Hampel
Targets of antidementive therapy: drugs with a specific pharmacological mechanism of action.
Current pharmaceutical design 2004;10(3):223-9.
2004: Markus Jäger; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders.
Acta psychiatrica Scandinavica 2004;109(1):30-7.
2004: Tetsuya Sato; Ronald Bottlender; Akira Tanabe; Hans-Jürgen Möller
Cincinnati criteria for mixed mania and suicidality in patients with acute mania.
Comprehensive psychiatry 2004;45(1):62-9.
2003: Oliver Pogarell; Christine Hamann; Gabriele Pöpperl; Georg Juckel; Martina Choukèr; Michael Zaudig; Michael Riedel; Hans-Jürgen Möller; Victor Perez; Klaus Tatsch
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
Biological psychiatry 2003;54(12):1406-13.
2003: Wolfgang Wölwer; Gerhard Buchkremer; Heinz Häfner; Joachim Klosterkötter; Wolfgang Maier; Hans-Jürgen Möller; Wolfgang Gaebel
German research network on schizophrenia-bridging the gap between research and care.
European archives of psychiatry and clinical neuroscience 2003;253(6):321-9.
2003: Hans-Jürgen Möller
[49. Phobic disorder, panic or generalized anxiety? Basic principles in diagnosis and therapy].
MMW Fortschritte der Medizin 2003;145(47):I-VIII; quiz IX-X.
2003: Georg Juckel; Jürgen Gallinat; Michael Riedel; Safet Sokullu; Carl Schulz; Hans-Jürgen Möller; Norbert Müller; Victor Perez
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity.
Schizophrenia research 2003;64(2-3):115-24.
2003: Mazda Adli; john rush; Hans-Jürgen Möller; Michael Bauer
Algorithms for optimizing the treatment of depression: making the right decision at the right time.
Pharmacopsychiatry 2003;36 Suppl 3():S222-9.
2003: Dan Rujescu; A M Hartmann; C Gonnermann; Hans-Jürgen Möller; Ina Giegling
M129V variation in the prion protein may influence cognitive performance.
Molecular psychiatry 2003;8(11):937-41.
2003: T C Baghai; Hans-Jürgen Möller
[How does it function? Electroconvulsive therapy].
MMW Fortschritte der Medizin 2003;145(40):59-60.
2003: Hans-Jürgen Möller
Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
Progress in neuro-psychopharmacology & biological psychiatry 2003;27(7):1101-11.
2003: Ulrich W Preuss; Dan Rujescu; Ina Giegling; Gabriele Koller; Miriam Bottlender; Rolf R Engel; Hans-Jürgen Möller; Michael Soyka
[Factor structure and validity of a german version of the barratt impulsiveness scale].
Fortschritte der Neurologie-Psychiatrie 2003;71(10):527-34.
2003: Stefan J Teipel; Mark B Schapiro; Gene Alexander; Jack S Krasuski; Barry Horwitz; Christian Hoehne; Hans-Jürgen Möller; Stanley I Rapoport; Harald Hampel
Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome.
The American journal of psychiatry 2003;160(10):1870-8.
2003: Tetsuya Sato; Ronald Bottlender; M Sievas; Andreas Schröter; S Hecht; Hans-Jürgen Möller
Long-term inter-episode stability of syndromes underlying mania.
Acta psychiatrica Scandinavica 2003;108(4):310-3.
2003: Ronald Bottlender; Markus Jäger; Ines Kunze; Constanze Groll; I Borski; Hans-Jürgen Möller
[Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].
Der Nervenarzt 2003;74(9):762-6.
2003: Annika Olsson; Kina Höglund; Magnus Sjögren; Niels Andreasen; Lennart Minthon; Lars Lannfelt; Katharina Buerger; Hans-Jürgen Möller; Harald Hampel; Pia Davidsson; Kaj Blennow
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
Experimental neurology 2003;183(1):74-80.
2003: Dan Rujescu; Ina Giegling; Tetsuya Sato; Annette M Hartmann; Hans-Jürgen Möller
Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis.
Biological psychiatry 2003;54(4):465-73.
2003: Ronald Bottlender; Tetsuya Sato; Constanze Groll; Markus Jäger; Ines Kunze; Hans-Jürgen Möller
Negative symptoms in depressed and schizophrenic patients: how do they differ?
The Journal of clinical psychiatry 2003;64(8):954-8.
2003: M Jäger M D; M Hintermayr; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Course and outcome of first-admitted patients with acute and transient psychotic disorders (ICD-10:F23). Focus on relapses and social adjustment.
European archives of psychiatry and clinical neuroscience 2003;253(4):209-15.
2003: Dan Rujescu; Ina Giegling; Anton Gietl; Claudia Gonnermann; Andre Kirner; Hans-Jürgen Möller; Norbert Dahmen
Association study of a SNP coding for a M129V substitution in the prion protein in schizophrenia.
Schizophrenia research 2003;62(3):289-91.
2003: Ralf Pukrop; Volker Schlaak; Anne Maria Möller-Leimkühler; Margot Albus; Adelheid Czernik; Joachim Klosterkötter; Hans-Jürgen Möller
Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression.
Psychiatry research 2003;119(1-2):63-79.
2003: Dan Rujescu; Ina Giegling; Anton Gietl; Annette M Hartmann; Hans-Jürgen Möller
A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits.
Biological psychiatry 2003;54(1):34-9.
2003: Hans-Jürgen Möller; Koen Demyttenaere; Emilio Sacchetti; john rush; Stuart A Montgomery
Improving the chance of recovery from the short- and long-term consequences of depression.
International clinical psychopharmacology 2003;18(4):219-25.
2003: Peter Zill; Thomas C Baghai; Rolf Engel; Peter Zwanzger; Cornelius Schüle; Christo Minov; Stefanie Behrens; Ronald Bottlender; Markus Jäger; Rainer Rupprecht; Hans-Jürgen Möller; Manfred Ackenheil; Brigitta Bondy
Beta-1-adrenergic receptor gene in major depression: influence on antidepressant treatment response.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;120B(1):85-9.
2003: Ronald Bottlender; Tesuya Sato; Markus Jäger; Ulrike Wegener; Johannes Wittmann; Anton Strauss; Hans-Jürgen Möller
The impact of the duration of untreated psychosis prior to first psychiatric admission on the 15-year outcome in schizophrenia.
Schizophrenia research 2003;62(1-2):37-44.
2003: R K Gupta; Hans-Jürgen Möller
St. John's Wort. An option for the primary care treatment of depressive patients?
European archives of psychiatry and clinical neuroscience 2003;253(3):140-8.
2003: T Fuchsberger; Hans-Jürgen Möller; Harald Hampel
[Current therapy of patients with dementia].
MMW Fortschritte der Medizin 2003;145 Suppl 2():49-52, 54.
2003: Markus Jäger; Ronald Bottlender; Ulrike Wegner; Anton Strauss; Hans-Jürgen Möller
[Diagnostic shifts of functional psychoses in the transition from ICD-9 to ICD-10].
Der Nervenarzt 2003;74(5):420-7.
2003: Markus Jäger; Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
On the descriptive validity of ICD-10 schizophrenia: empirical analyses in the spectrum of non-affective functional psychoses.
Psychopathology 2003;36(3):152-9.
2003: Peter Zwanzger; Daniela Eser; Sue A Aicher; Cornelius Schüle; Thomas C Baghai; Frank Padberg; Robin Ella; Hans-Jürgen Möller; Rainer Rupprecht
Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(5):979-84.
2003: Tetsuya Sato; Ronald Bottlender; Andreas Schröter; Hans-Jürgen Möller
Frequency of manic symptoms during a depressive episode and unipolar 'depressive mixed state' as bipolar spectrum.
Acta psychiatrica Scandinavica 2003;107(4):268-74.
2003: Frank Faltraco; Katharina Bürger; Peter Zill; Stefan J Teipel; Hans-Jürgen Möller; Harald Hampel; Brigitta Bondy; Manfred Ackenheil
Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk.
Journal of the American Geriatrics Society 2003;51(4):578-9.
2003: Victor Perez; Roland Mergl; Verena Henkel; Jürgen Gallinat; Gerhard Kotter; Florian Müller-Siecheneder; Oliver Pogarell; Georg Juckel; Andreas Schröter; Ranbir Bahra; Birol Emir; Gerd Laux; Hans-Jürgen Möller
Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia.
Journal of clinical psychopharmacology 2003;23(2):214-6.
2003: Ronald Bottlender; Tetsuya Sato; Markus Jäger; Ines Kunze; Constanze Groll; Ingrid Borski; Hans-Jürgen Möller
Does considering duration of negative symptoms increase their specificity for schizophrenia?
Schizophrenia research 2003;60(2-3):321-2.
2003: Brigitta Bondy; Thomas C Baghai; Christo Minov; Cornelius Schüle; Markus Schwarz; Peter Zwanzger; Rainer Rupprecht; Hans-Jürgen Möller
Substance P serum levels are increased in major depression: preliminary results.
Biological psychiatry 2003;53(6):538-42.
2003: Hans-Jürgen Möller
[Antistigma and awareness program: saying no to the discrimination of the mentally ill].
MMW Fortschritte der Medizin 2003;145(12):33.
2003: Cornelius Schüle; Peter Zwanzger; Thomas C Baghai; Patrick Mikhaiel; Heike Thoma; Hans-Jürgen Möller; Rainer Rupprecht; Frank Padberg
Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study.
Journal of psychiatric research 2003;37(2):145-53.
2003: Michael Riedel; Holger Krönig; Markus Schwarz; Rolf R Engel; Christopher Sikorski; K-U Kühn; S Behrens; Hans-Jürgen Möller; Manfred Ackenheil; Norbert Müller
Investigation of the ICAM-1 G241A and A469G gene polymorphisms in schizophrenia.
Molecular psychiatry 2003;8(3):257-8.
2003: Peter Zwanzger; H Jarry; Daniela Eser; Frank Padberg; Thomas C Baghai; Cornelius Schule; Robin Ella; Hans-Jürgen Möller; Rainer Rupprecht
Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(3):313-6.
2003: Ronald Bottlender; Tetsuya Sato; Hans-Jürgen Möller
Summer birth and deficit schizophrenia.
The American journal of psychiatry 2003;160(3):594-5; author reply 595-6.
2003: Cornelius Schüle; Thomas C Baghai; Peter Zwanzger; Robin Ella; Daniela Eser; Frank Padberg; Hans-Jürgen Möller; Rainer Rupprecht
Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
Psychopharmacology 2003;166(3):271-5.
2003: Thomas Frodl; Eva M Meisenzahl; Thomas Zetzsche; Christine Born; Markus Jäger; Constanze Groll; Ronald Bottlender; Gerda Leinsinger; Hans-Jürgen Möller
Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects.
Biological psychiatry 2003;53(4):338-44.
2003: Metin Bagli; Andreas Papassotiropoulos; Harald Hampel; Karin Becker; Frank Jessen; Katharina Bürger; Ursula Ptok; Marie Luise Rao; Hans-Jürgen Möller; Wolfgang Maier; Reinhard Heun
Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study.
European archives of psychiatry and clinical neuroscience 2003;253(1):44-8.
2003: David Baldwin; Karl Broich; Jürgen Fritze; Siegfried Kasper; Herman Westenberg; Hans-Jürgen Möller
Placebo-controlled studies in depression: necessary, ethical and feasible.
European archives of psychiatry and clinical neuroscience 2003;253(1):22-8.
2003: Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Hiroyuki Arai; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Frank Padberg; Frank Faltraco; Alexander Goernitz; Tero Tapiola; Stanley I Rapoport; Tuula Pirttilä; Hans-Jürgen Möller; Harald Hampel
Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.
The American journal of psychiatry 2003;160(2):376-9.
2003: André Tadic; Dan Rujescu; Armin Szegedi; Ina Giegling; Peter Singer; Hans-Jürgen Möller; Norbert Dahmen
Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;117B(1):1-6.
2003: Verena Henkel; Roland Mergl; Ralf Kohnen; Wolfgang Maier; Hans-Jürgen Möller; Victor Perez
Identifying depression in primary care: a comparison of different methods in a prospective cohort study.
BMJ (Clinical research ed.) 2003;326(7382):200-1.
2003: Frank Padberg; Barbara Goldstein-Müller; Peter Zwanzger; Hans-Jürgen Möller
Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS.
Supplements to Clinical neurophysiology 2003;56():406-32.
2003: Peter Zwanzger; Daniela Eser; Frank Padberg; Thomas C Baghai; Cornelius Schule; Florian Rötzer; Robin Ella; Hans-Jürgen Möller; Rainer Rupprecht
Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers.
Depression and anxiety 2003;18(3):140-3.
2003: Hans-Jürgen Möller
Suicide, suicidality and suicide prevention in affective disorders.
Acta psychiatrica Scandinavica. Supplementum 2003;(418):73-80.
2003: Hans-Jürgen Möller
Management of the negative symptoms of schizophrenia: new treatment options.
CNS drugs 2003;17(11):793-823.
2003: Sabine Kagerer; Catja Winter; Hans-Jürgen Möller; Michael Soyka
Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study.
Neuropsychobiology 2003;47(4):212-8.
2003: Hans-Jürgen Möller
Bipolar disorder and schizophrenia: distinct illnesses or a continuum?
The Journal of clinical psychiatry 2003;64 Suppl 6():23-7; discussion 28.
2003: Hans-Jürgen Möller; Henry A Nasrallah
Treatment of bipolar disorder.
The Journal of clinical psychiatry 2003;64 Suppl 6():9-17; discussion 28.
2003: Frank Padberg; Hans-Jürgen Möller
Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?
CNS drugs 2003;17(6):383-403.
2003: Andreas Schröter; Roland Mergl; Katharina Bürger; Harald Hampel; Hans-Jürgen Möller; Victor Perez
Kinematic analysis of handwriting movements in patients with Alzheimer's disease, mild cognitive impairment, depression and healthy subjects.
Dementia and geriatric cognitive disorders 2003;15(3):132-42.
2003: Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles L Bowden; David Baldwin; Rasmus W Licht; Eduard Vieta; Hans-Jürgen Möller
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(1):5-13.
2003: Dan Rujescu; Ina Giegling; Tetsuya Sato; Hans-Jürgen Möller
Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2003;116B(1):69-71.
2003: Stefan J Teipel; Wolfram Bayer; Gene Alexander; Arun Bokde; York Zebuhr; Diane Teichberg; F Müller-Spahn; Mark B Schapiro; Hans-Jürgen Möller; Stanley I Rapoport; Harald Hampel
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration.
Neurobiology of aging 2003;24(1):85-94.
2002: Eckhard M Steinmeyer; Joachim Klosterkötter; Hans-Jürgen Möller; Henning Sass; Stephan Herpertz; Adelheid Czernik; J T Marcea; F Matakas; J Mehne; H Bottländer; W Hesse; I Steinbring; Ralf Pukrop
[Personality and personality disorders II. The Specificity of the DAPP-model as a diagnostic system for personality disorders].
Fortschritte der Neurologie-Psychiatrie 2002;70(12):641-6.
2002: Eckhard M Steinmeyer; Joachim Klosterkötter; Hans-Jürgen Möller; Henning Sass; Stephan Herpertz; Adelheid Czernik; J T Marcea; F Matakas; J Mehne; H Bottländer; W Hesse; I Steinbring; Ralf Pukrop
[Personality and personality disorders I. Universality and sensitivity of dimensional personality models as diagnostic systems for personality disorders].
Fortschritte der Neurologie-Psychiatrie 2002;70(12):630-40.
2002: Ulrich W Preuss; Eva M Meisenzahl; Thomas Frodl; Thomas Zetzsche; Jan Holder; Gerda Leinsinger; Victor Perez; Klaus Hahn; Hans-Jürgen Möller
Handedness and corpus callosum morphology.
Psychiatry research 2002;116(1-2):33-42.
2002: Hans-Peter Volz; Harald Murck; Siegfried Kasper; Hans-Jürgen Möller
St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
Psychopharmacology 2002;164(3):294-300.
2002: Paraskevi Mavrogiorgou; Georg Juckel; Thomas Frodl; Jürgen Gallinat; Walter Hauke; Michael Zaudig; Gerhard Dammann; Hans-Jürgen Möller; Victor Perez
P300 subcomponents in obsessive-compulsive disorder.
Journal of psychiatric research 2002;36(6):399-406.
2002: Hans-Jürgen Möller
[Detecting and treating suicidal risk patients: a challenge for the general practitioner].
MMW Fortschritte der Medizin 2002;144(40):I-IX; quiz X-XII.
2002: Borwin Bandelow; Josef Zohar; Eric Hollander; Siegfried Kasper; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(4):171-99.
2002: Verena Henkel; Patrick Bussfeld; Hans-Jürgen Möller; Victor Perez
Cognitive-behavioural theories of helplessness/hopelessness: valid models of depression?
European archives of psychiatry and clinical neuroscience 2002;252(5):240-9.
2002: Michael Riedel; Holger Krönig; Markus Schwarz; Rolf R Engel; Kai-Uwe Kühn; Christopher Sikorski; Safet Sokullu; Manfred Ackenheil; Hans-Jürgen Möller; Norbert Müller
No association between the G308A polymorphism of the tumor necrosis factor-alpha gene and schizophrenia.
European archives of psychiatry and clinical neuroscience 2002;252(5):232-4.
2002: Ronald Bottlender; Tetsuya Sato; Markus Jäger; Constanze Groll; Anton Strauss; Hans-Jürgen Möller
The impact of duration of untreated psychosis and premorbid functioning on outcome of first inpatient treatment in schizophrenic and schizoaffective patients.
European archives of psychiatry and clinical neuroscience 2002;252(5):226-31.
2002: Frank Padberg; Peter Zwanzger; Martin E Keck; Norbert Kathmann; Patrick Mikhaiel; Robin Ella; Philipp Rupprecht; Heike Thoma; Harald Hampel; Nicola Toschi; Hans-Jürgen Möller
Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;27(4):638-45.
2002: Eva M Meisenzahl; Thomas Frodl; Thomas Zetzsche; Gerda Leinsinger; Klaus Peter Maag; Victor Perez; Klaus Hahn; Hans-Jürgen Möller
Investigation of a possible diencephalic pathology in schizophrenia.
Psychiatry research 2002;115(3):127-35.
2002: Robert M A Hirschfeld; Stuart A Montgomery; Eugenio Aguglia; Mario Amore; Pedro Delgado; Markus Gastpar; Christopher Hawley; Siegfried Kasper; Michael Linden; Juan Massana; Julien Mendlewicz; Hans-Jürgen Möller; Charles Nemeroff; Jerónimo Saiz; Pedro Such; Riccardo Torta; Marcio Versiani
Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.
The Journal of clinical psychiatry 2002;63(9):826-37.
2002: Gisela Schmitt; Eva M Meisenzahl; Stefan Dresel; Klaus Tatsch; B Rossmüller; Thomas Frodl; Ulrich W Preuss; Klaus Hahn; Hans-Jürgen Möller
Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.
Journal of psychopharmacology (Oxford, England) 2002;16(3):200-6.
2002: Richard Dodel; Harald Hampel; Candan Depboylu; Suizhen Lin; Feng Gao; Sabine Schock; Steffi Jäckel; Xing Wei; Katharina Buerger; Christine Höft; Bernhard Hemmer; Hans-Jürgen Möller; Martin R Farlow; Wolfgang H Oertel; Norbert Sommer; Yansheng Du
Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer's disease.
Annals of neurology 2002;52(2):253-6.
2002: Stuart A Montgomery; Per Bech; Pierre Blier; Hans-Jürgen Möller; Andrew A Nierenberg; Roger M Pinder; Frederic M Quitkin; Paul-Egbert Reimitz; Jerrold F Rosenbaum; john rush; H H Stassen; Michael E Thase
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
The Journal of clinical psychiatry 2002;63(8):694-9.
2002: Katharina Buerger; Raymond Zinkowski; Stefan J Teipel; Tero Tapiola; Hiroyuki Arai; Kaj Blennow; Niels Andreasen; Klaus Hofmann-Kiefer; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Russell Kohnken; Frank Padberg; Tuula Pirttilä; Mark B Schapiro; Stanley I Rapoport; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.
Archives of neurology 2002;59(8):1267-72.
2002: J Peuskens; Hans-Jürgen Möller; A Puech
Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2002;12(4):305-10.
2002: Tetsuya Sato; Ronald Bottlender; Nikolaus Kleindienst; A Tanabe; Hans-Jürgen Möller
The boundary between mixed and manic episodes in the ICD-10 classification.
Acta psychiatrica Scandinavica 2002;106(2):109-16.
2002: Peter Zill; Thomas C Baghai; Peter Zwanzger; Cornelius Schüle; Christo Minov; Stefanie Behrens; Rainer Rupprecht; Hans-Jürgen Möller; Rolf Engel; Brigitta Bondy
Association analysis of a polymorphism in the G-protein stimulatory alpha subunit in patients with major depression.
American journal of medical genetics 2002;114(5):530-2.
2002: Heinz Grunze; Siegfried Kasper; Guy Goodwin; Charles L Bowden; David Baldwin; Rasmus W Licht; Eduard Vieta; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(3):115-24.
2002: Ronald Bottlender; D Rudolf; M Jäger; Anton Strauss; Hans-Jürgen Möller
Are bipolar I depressive patients less responsive to treatment with antidepressants than unipolar depressive patients? Results from a case control study.
European psychiatry : the journal of the Association of European Psychiatrists 2002;17(4):200-5.
2002: Dietmar Winkler; Nicole Praschak-Rieder; Matthäus Willeit; M J Lucht; Eva Hilger; Anastasios Konstantinidis; Jürgen Stastny; Nikolaus Thierry; Edda Pjrek; Alexander Neumeister; Hans-Jürgen Möller; Siegfried Kasper
[Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics].
Der Nervenarzt 2002;73(7):637-43.
2002: Eva M Meisenzahl; Thomas Zetzsche; Ulrich W Preuss; Thomas Frodl; Gerda Leinsinger; Hans-Jürgen Möller
Does the definition of borders of the planum temporale influence the results in schizophrenia?
The American journal of psychiatry 2002;159(7):1198-200.
2002: Thomas Frodl; Eva M Meisenzahl; Thomas Zetzsche; Christine Born; Constanze Groll; Markus Jäger; Gerda Leinsinger; Ronald Bottlender; Klaus Hahn; Hans-Jürgen Möller
Hippocampal changes in patients with a first episode of major depression.
The American journal of psychiatry 2002;159(7):1112-8.
2002: Hans-Jürgen Möller; Ronald Bottlender; Anke Gross; Paul Hoff; Johannes Wittmann; Ulrike Wegner; Anton Strauss
The Kraepelinian dichotomy: preliminary results of a 15-year follow-up study on functional psychoses: focus on negative symptoms.
Schizophrenia research 2002;56(1-2):87-94.
2002: Norbert Müller; Michael Riedel; Constanze Scheppach; Bernd Brandstätter; Safet Sokullu; Karin Krampe; Markus Ulmschneider; Rolf R Engel; Hans-Jürgen Möller; Markus Schwarz
Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.
The American journal of psychiatry 2002;159(6):1029-34.
2002: Tetsuya Sato; Ronald Bottlender; Nikolaus Kleindienst; Hans-Jürgen Möller
Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients.
The American journal of psychiatry 2002;159(6):968-74.
2002: Th Fuchsberger; Frank Padberg; Frank Faltraco; Hans-Jürgen Möller; Harald Hampel
[Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer].
MMW Fortschritte der Medizin 2002;144(20):36-9.
2002: Harald Hampel; Stefan J Teipel; Gene Alexander; Oliver Pogarell; Stanley I Rapoport; Hans-Jürgen Möller
In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):837-55.
2002: Ronald Bottlender; M Jäger; E Hofschuster; P Dobmeier; Hans-Jürgen Möller
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Pharmacopsychiatry 2002;35(3):119-21.
2002: Thomas Frodl; Eva M Meisenzahl; Thomas Zetzsche; Ronald Bottlender; Christine Born; Constanze Groll; Markus Jäger; Gerda Leinsinger; Klaus Hahn; Hans-Jürgen Möller
Enlargement of the amygdala in patients with a first episode of major depression.
Biological psychiatry 2002;51(9):708-14.
2002: Frank Padberg; Cornelius Schüle; Peter Zwanzger; Thomas C Baghai; Robin Ella; Patrick Mikhaiel; Harald Hampel; Hans-Jürgen Möller; Rainer Rupprecht
Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression.
Journal of psychiatric research 2002;36(3):131-5.
2002: Michael Bauer; Peter C Whybrow; Jules Angst; Marcio Versiani; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(2):69-86.
2002: Hans-Peter Volz; Hans-Jürgen Möller; Alexandre Gerebtzoff; Serge Bischoff
Savoxepine versus haloperidol. Reasons for a failed controlled clinical trial in patients with an acute episode of schizophrenia.
European archives of psychiatry and clinical neuroscience 2002;252(2):76-80.
2002: Dietmar Winkler; Matthäus Willeit; Nicole Praschak-Rieder; M J Lucht; Eva Hilger; Anastasios Konstantinidis; Jürgen Stastny; Nikolaus Thierry; Edda Pjrek; Alexander Neumeister; Hans-Jürgen Möller; Siegfried Kasper
Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample.
European archives of psychiatry and clinical neuroscience 2002;252(2):54-62.
2002: Peter Zill; Rolf Engel; Thomas C Baghai; Georg Juckel; Thomas Frodl; Florian Müller-Siecheneder; Peter Zwanzger; Cornelius Schüle; Christo Minov; Stefanie Behrens; Rainer Rupprecht; Victor Perez; Hans-Jürgen Möller; Brigitta Bondy
Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(4):489-93.
2002: Thomas Frodl; Harald Hampel; Georg Juckel; Katharina Bürger; Frank Padberg; Rolf R Engel; Hans-Jürgen Möller; Victor Perez
Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's Disease.
Psychophysiology 2002;39(2):175-81.
2002: Robin Ella; Peter Zwanzger; Robert Stampfer; Ulrich W Preuss; Florian Müller-Siecheneder; Hans-Jürgen Möller; Frank Padberg
Switch to mania after slow rTMS of the right prefrontal cortex.
The Journal of clinical psychiatry 2002;63(3):249.
2002: Peter Zill; Rolf Engel; Thomas C Baghai; Peter Zwanzger; Cornelius Schüle; Christo Minov; Stefanie Behrens; Rainer Rupprecht; Hans-Jürgen Möller; Brigitta Bondy
Analysis of polymorphisms in the olfactory G-protein Golf in major depression.
Psychiatric genetics 2002;12(1):17-22.
2002: Thomas Frodl; Eva M Meisenzahl; Dirk Müller; Jan Holder; Georg Juckel; Hans-Jürgen Möller; Victor Perez
P300 subcomponents and clinical symptoms in schizophrenia.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2002;43(3):237-46.
2002: Harald Hampel; Stefan J Teipel; Wolfram Bayer; Gene Alexander; Robert Schwarz; Mark B Schapiro; Stanley I Rapoport; Hans-Jürgen Möller
Age transformation of combined hippocampus and amygdala volume improves diagnostic accuracy in Alzheimer's disease.
Journal of the neurological sciences 2002;194(1):15-9.
2002: Stefan J Teipel; Wolfram Bayer; Gene Alexander; York Zebuhr; Diane Teichberg; Luka Kulic; Mark B Schapiro; Hans-Jürgen Möller; Stanley I Rapoport; Harald Hampel
Progression of corpus callosum atrophy in Alzheimer disease.
Archives of neurology 2002;59(2):243-8.
2002: Peter Zwanzger; Christo Minov; Robin Ella; Cornelius Schüle; Thomas C Baghai; Hans-Jürgen Möller; Rainer Rupprecht; Frank Padberg
Transcranial magnetic stimulation for panic.
The American journal of psychiatry 2002;159(2):315-6.
2002: Hans-Jürgen Möller
Anxiety associated with comorbid depression.
The Journal of clinical psychiatry 2002;63 Suppl 14():22-6.
2002: Michael Bauer; Peter C Whybrow; Jules Angst; Marcio Versiani; Hans-Jürgen Möller
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2002;3(1):5-43.
2002: Dan Rujescu; Ina Giegling; Brigitta Bondy; Anton Gietl; Peter Zill; Hans-Jürgen Möller
Association of anger-related traits with SNPs in the TPH gene.
Molecular psychiatry 2002;7(9):1023-9.
2002: Heinz Grunze; Jörg Walden; Sandra Dittmann; M Berger; A Bergmann; Peter Bräunig; M Dose; H M Emrich; M Gastpar; W Greil; S Krüger; Hans-Jürgen Möller; R Uebelhack
[Psychopharmacotherapy of bipolar affective diseases].
Der Nervenarzt 2002;73(1):4-17; quiz 18-9.
2002: Henning Tiemeier; Eva Pelzer; Lothar Jönck; Hans-Jürgen Möller; Marie Luise Rao
Plasma catecholamines and selective slow wave sleep deprivation.
Neuropsychobiology 2002;45(2):81-6.
2002: Dan Rujescu; Eva M Meisenzahl; Ina Giegling; Andre Kirner; Gerda Leinsinger; Victor Perez; Klaus Hahn; Hans-Jürgen Möller
Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments in healthy volunteers and schizophrenic patients.
NeuroImage 2002;15(1):200-6.
2001: F Padberg; Harald Hampel; Hans-Jürgen Möller
[Alzheimer patients. To treat with anti-dementia drugs in spite of unanswered questions].
MMW Fortschritte der Medizin 2001;143(51-52):43-5.
2001: Ronald Bottlender; Markus Jäger; Constanze Groll; Anton Strauss; Hans-Jürgen Möller
Deficit states in schizophrenia and their association with the length of illness and gender.
European archives of psychiatry and clinical neuroscience 2001;251(6):272-8.
2001: Hans-Jürgen Möller; A Hartmann; C Kessler; M Rainer; T Brown; S Gamand; P Lehert
Naftidrofuryl in the treatment of vascular dementia.
European archives of psychiatry and clinical neuroscience 2001;251(6):247-54.
2001: Hans-Jürgen Möller; Ronald Bottlender; H Grunze; Anton Strauss; Johannes Wittmann
Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression?
Journal of affective disorders 2001;67(1-3):141-6.
2001: F Padberg; Harald Hampel; Hans-Jürgen Möller
[Alzheimer patients treated with anti-dementia drugs despite unanswered questions].
Fortschritte der Medizin. Originalien 2001;119(3-4):141-3.
2001: Hans-Jürgen Möller
[Depression. A challenge for the general practitioner].
MMW Fortschritte der Medizin 2001;143 Suppl():34-46; quiz 47-8.
2001: Peter Zwanzger; Thomas C Baghai; C Schuele; Andreas Ströhle; Frank Padberg; Norbert Kathmann; Markus Schwarz; Hans-Jürgen Möller; Rainer Rupprecht
Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;25(5):699-703.
2001: Hans-Jürgen Möller
Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia.
European archives of psychiatry and clinical neuroscience 2001;251(5):217-24.
2001: Peter Zwanzger; T Baghai; R J Boerner; Hans-Jürgen Möller; R Rupprecht
Anxiolytic effects of vigabatrin in panic disorder.
Journal of clinical psychopharmacology 2001;21(5):539-40.
2001: Thomas Frodl; Eva M Meisenzahl; D Müller; Gerda Leinsinger; Georg Juckel; Klaus Hahn; Hans-Jürgen Möller; Victor Perez
The effect of the skull on event-related P300.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2001;112(9):1773-6.
2001: Thomas Zetzsche; Eva M Meisenzahl; Ulrich W Preuss; J J Holder; Norbert Kathmann; Gerda Leinsinger; Klaus Hahn; Victor Perez; Hans-Jürgen Möller
In-vivo analysis of the human planum temporale (PT): does the definition of PT borders influence the results with regard to cerebral asymmetry and correlation with handedness?
Psychiatry research 2001;107(2):99-115.
2001: Peter Zwanzger; Thomas C Baghai; Cornelius Schüle; Christo Minov; Frank Padberg; Hans-Jürgen Möller; Rainer Rupprecht
Tiagabine improves panic and agoraphobia in panic disorder patients.
The Journal of clinical psychiatry 2001;62(8):656-7.
2001: Eva M Meisenzahl; Dan Rujescu; Andre Kirner; Ina Giegling; Norbert Kathmann; Gerda Leinsinger; Klaus Peter Maag; Victor Perez; Klaus Hahn; Hans-Jürgen Möller
Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia.
The American journal of psychiatry 2001;158(8):1316-9.
2001: Hans-Jürgen Möller
Past, present and future of biological psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(3):156-8.
2001: M Soyka; M Horak; V Morhart; Hans-Jürgen Möller
[The "qualified outpatient detoxification" model project].
Der Nervenarzt 2001;72(7):565-9.
2001: Verena Henkel; V Wambach; Hans-Jürgen Möller; Victor Perez
[Diagnosis and therapy of depression. Key role for the family physician].
MMW Fortschritte der Medizin 2001;143 Suppl 2():19-25.
2001: Hans-Jürgen Möller
[18. Depression: A challenge for the general practitioner].
MMW Fortschritte der Medizin 2001;143(18):I-XII; quiz XIII-XIV.
2001: Martin Schäfer; Dan Rujescu; Ina Giegling; A Guntermann; A Erfurth; Brigitta Bondy; Hans-Jürgen Möller
Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene.
The American journal of psychiatry 2001;158(5):802-4.
2001: Thomas Frodl; Eva M Meisenzahl; D Müller; J Greiner; Georg Juckel; Gerda Leinsinger; H Hahn; Hans-Jürgen Möller; Victor Perez
Corpus callosum and P300 in schizophrenia.
Schizophrenia research 2001;49(1-2):107-19.
2001: Iris Maurer; S Zierz; Hans-Jürgen Möller
Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia.
Schizophrenia research 2001;48(1):125-36.
2001: Ronald Bottlender; D Rudolf; Anton Strauss; Hans-Jürgen Möller
Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients.
Journal of affective disorders 2001;63(1-3):79-83.
2001: Hans-Jürgen Möller; Hans-Peter Volz; I W Reimann; KD Stoll
Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group.
Journal of clinical psychopharmacology 2001;21(1):59-65.
2001: Hans-Jürgen Möller
Methodological issues in psychiatry: psychiatry as an empirical science.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(1):38-47.
2001: Hans-Jürgen Möller
Empirical methodology as the main criterion of biological psychiatry.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(1):2p.
2001: Hans-Jürgen Möller
Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale.
European archives of psychiatry and clinical neuroscience 2001;251 Suppl 2():II13-20.
2001: J Fritze; Hans-Jürgen Möller
Design of clinical trials of antidepressants: should a placebo control arm be included?
CNS drugs 2001;15(10):755-64.
2001: Verena Henkel; Roland Mergl; Georg Juckel; Dan Rujescu; Paraskevi Mavrogiorgou; Ina Giegling; Hans-Jürgen Möller; Victor Perez
Assessment of handedness using a digitizing tablet: a new method.
Neuropsychologia 2001;39(11):1158-66.
2001: Frank Padberg; Georg Juckel; A Prässl; Peter Zwanzger; Paraskevi Mavrogiorgou; Victor Perez; Harald Hampel; Hans-Jürgen Möller
Prefrontal cortex modulation of mood and emotionally induced facial expressions: a transcranial magnetic stimulation study.
The Journal of neuropsychiatry and clinical neurosciences 2001;13(2):206-12.
2001: Peter Zill; Rolf Engel; Harald Hampel; Stefanie Behrens; Katharina Bürger; Frank Padberg; Susanne Stübner; Hans-Jürgen Möller; Manfred Ackenheil; Brigitta Bondy
Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients.
European archives of psychiatry and clinical neuroscience 2001;251(1):24-8.
2001: Hans-Jürgen Möller; N Müller; H Hippius
Molecular and clinical aspects of affective disorders--a hundred years after the Kraepelinian concept of manic-depressive psychosis.
Journal of affective disorders 2001;62(1-2):3-5.
2000: Peter Zill; Katharina Bürger; Stefanie Behrens; Harald Hampel; Frank Padberg; T Boetsch; Hans-Jürgen Möller; Manfred Ackenheil; Brigitta Bondy
Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients.
Neuroscience letters 2000;294(2):69-72.
2000: Hans-Jürgen Möller; K Glaser; F Leverkus; C Göbel
Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression.
Pharmacopsychiatry 2000;33(6):206-12.
2000: M Krupinski; A Fischer; Renate Grohmann; Rolf R Engel; M Hollweg; Hans-Jürgen Möller
[Schizophrenic psychoses and suicide in the clinic. Risk factors, psychopharmacologic treatment].
Der Nervenarzt 2000;71(11):906-11.
2000: Hans-Jürgen Möller
State of the art of drug treatment of schizophrenia and the future position of the novel/atypical antipsychotics.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2000;1(4):204-14.
2000: Peter Tigges; Roland Mergl; Thomas Frodl; Eva M Meisenzahl; Jürgen Gallinat; Andreas Schröter; Michael Riedel; Norbert Müller; Hans-Jürgen Möller; Victor Perez
Digitized analysis of abnormal hand-motor performance in schizophrenic patients.
Schizophrenia research 2000;45(1-2):133-43.
2000: K Bürger; Harald Hampel; M Neumann; Hans-Jürgen Möller; Hans A Kretzschmar
[Your help is needed! Autopsy brings new knowledge regarding Alzheimer dementia].
MMW Fortschritte der Medizin 2000;142(39):40-1.
2000: Hagop S Akiskal; Marc L Bourgeois; J Angst; R Post; Hans-Jürgen Möller; R Hirschfeld
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.
Journal of affective disorders 2000;59 Suppl 1():S5-S30.
2000: Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Impact of duration of symptoms prior to first hospitalization on acute outcome in 998 schizophrenic patients.
Schizophrenia research 2000;44(2):145-50.
2000: Georg Juckel; Victor Perez; Paraskevi Mavrogiorgou; Jürgen Gallinat; T Mager; Peter Tigges; Stefan Dresel; Andreas Schröter; G Stotz; I Meller; Waldemar Greil; Hans-Jürgen Möller
Clinical and biological findings in a case with 48-hour bipolar ultrarapid cycling before and during valproate treatment.
The Journal of clinical psychiatry 2000;61(8):585-93.
2000: Susanne Stübner; Frank Padberg; Renate Grohmann; Harald Hampel; M Hollweg; H Hippius; Hans-Jürgen Möller; Eckart Rüther
Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project.
The Journal of clinical psychiatry 2000;61(8):569-74.
2000: Ulrich W Preuss; Brigitta Bondy; Peter Zill; Thomas Frodl; Michael Soyka; Hans-Jürgen Möller; Victor Perez
Possible association between loudness dependence of auditory evoked potentials and tryptophan hydroxylase-alleles in alcoholics.
Addiction biology 2000;5(3):297-305.
2000: Michael Soyka; Ronald Bottlender; Hans-Jürgen Möller
Epidemiological evidence for a low abuse potential of zolpidem.
Pharmacopsychiatry 2000;33(4):138-41.
2000: Russell Kohnken; Katharina Buerger; Raymond Zinkowski; C Miller; Daniel Kerkman; John DeBernardis; J Shen; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.
Neuroscience letters 2000;287(3):187-90.
2000: Lutz Frölich; Frank Padberg; Tilman Kratzsch; Konrad Maurer; Hans-Jürgen Möller; Harald Hampel
[Therapy of Alzheimer dementia. Current status and prospects].
MMW Fortschritte der Medizin 2000;142(25):30-4.
2000: M Djemai Zoghlache; K Bürger; Stéphane Schück; Hans-Jürgen Möller; Stanley I Rapoport; Hervé Allain; Harald Hampel
[Multiconceptual therapy in Alzheimer's disease].
Presse médicale (Paris, France : 1983) 2000;29(21):1197-201.
2000: M Soyka; B Bondy; E Benda; U Preuss; Ulrich Hegerl; Hans-Jürgen Möller
Platelet monoamine oxidase activity in alcoholics with and without a family history of alcoholism.
European addiction research 2000;6(2):57-63.
2000: R Bottlender; Hans-Jürgen Möller
Monthly birth rates in residual and paranoid schizophrenic patients.
European psychiatry : the journal of the Association of European Psychiatrists 2000;15(3):227.
2000: Hans-Jürgen Möller
Rating depressed patients: observer- vs self-assessment.
European psychiatry : the journal of the Association of European Psychiatrists 2000;15(3):160-72.
2000: Iris Maurer; S Zierz; Hans-Jürgen Möller
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.
Neurobiology of aging 2000;21(3):455-62.
2000: Hans-Jürgen Möller
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Der Nervenarzt 2000;71(5):345-53.
2000: Hans-Jürgen Möller
[Current assessment of new/atypical neuroleptic agents].
Der Nervenarzt 2000;71(5):329-44.
2000: Hans-Peter Volz; Hans-Jürgen Möller; Ilselore R Reimann; KD Stoll
Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(3):211-7.
2000: Eva M Meisenzahl; Thomas Frodl; Thomas Zetzsche; Gerda Leinsinger; DT Heiss; Klaus Peter Maag; Victor Perez; Klaus Hahn; Hans-Jürgen Möller
Adhesio interthalamica in male patients with schizophrenia.
The American journal of psychiatry 2000;157(5):823-5.
2000: PJ Kahle; Michael W Jakowec; Stefan J Teipel; Harald Hampel; Giselle M Petzinger; Donato A Di Monte; Gerald D Silverberg; Hans-Jürgen Möller; Jerome A Yesavage; Jared R Tinklenberg; Eric M Shooter; Greer M Murphy
Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.
Neurology 2000;54(7):1498-504.
2000: Hans-Jürgen Möller
Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2000;1(2):75-91.
2000: Robert M A Hirschfeld; S A Montgomery; Martin B Keller; Siegfried Kasper; Alan F Schatzberg; Hans-Jürgen Möller; D Healy; D Baldwin; Mats Humble; Marcio Versiani; R Montenegro; M Bourgeois
Social functioning in depression: a review.
The Journal of clinical psychiatry 2000;61(4):268-75.
2000: Harald Hampel; Stefan J Teipel; Gene Alexander; Barry Horwitz; Pietro Pietrini; H Hippius; Hans-Jürgen Möller; Mark B Schapiro; Stanley I Rapoport
Corpus callosum measurement as an in vivo indicator for neocortical neuronal integrity, but not white matter pathology, in Alzheimer's disease.
Annals of the New York Academy of Sciences 2000;903():470-6.
2000: Ronald Bottlender; D Rudolf; Anton Strauss; Hans-Jürgen Möller
Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches into states of expansive syndromes (known in Germany as "maniform syndromes" in bipolar I depression?
Pharmacopsychiatry 2000;33(2):75-7.
2000: Ronald Bottlender; Anton Strauss; Hans-Jürgen Möller
Prevalence and background factors of depression in first admitted schizophrenic patients.
Acta psychiatrica Scandinavica 2000;101(2):153-60.
2000: Hans-Jürgen Möller; Ronald Bottlender; Ulrike Wegner; Johannes Wittmann; Anton Strauss
Long-term course of schizophrenic, affective and schizoaffective psychosis: focus on negative symptoms and their impact on global indicators of outcome.
Acta psychiatrica Scandinavica. Supplementum 2000;(407):54-7.
2000: Eva M Meisenzahl; Stefan Dresel; Thomas Frodl; Gisela Schmitt; Ulrich W Preuss; B Rossmüller; Klaus Tatsch; T Mager; Klaus Hahn; Hans-Jürgen Möller
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.
Journal of psychopharmacology (Oxford, England) 2000;14(4):364-70.
2000: Ronald Bottlender; Markus Jäger; Anton Strauss; Hans-Jürgen Möller
Suicidality in bipolar compared to unipolar depressed inpatients.
European archives of psychiatry and clinical neuroscience 2000;250(5):257-61.
2000: Peter Tigges; Georg Juckel; Andreas Schröter; Hans-Jürgen Möller; Victor Perez
Periodic motor impairments in a case of 48-hour bipolar ultrarapid cycling before and under treatment with valproate.
Neuropsychobiology 2000;42 Suppl 1():38-42.
2000: Dan Rujescu; Ina Giegling; Norbert Dahmen; Armin Szegedi; Ion Anghelescu; Anton Gietl; M Schäfer; Florian Müller-Siecheneder; Brigitta Bondy; Hans-Jürgen Möller
Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3.
Neuropsychobiology 2000;42 Suppl 1():22-5.
2000: Thomas Frodl; Georg Juckel; Jürgen Gallinat; Ronald Bottlender; Michael Riedel; U Preuss; Hans-Jürgen Möller; Victor Perez
Dipole localization of P300 and normal aging.
Brain topography 2000;13(1):3-9.
2000: Ralf Pukrop; Hans-Jürgen Möller; Eckhard M Steinmeyer
Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life".
European archives of psychiatry and clinical neuroscience 2000;250(3):120-32.
2000: Hans-Jürgen Möller; H Grunze
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?
European archives of psychiatry and clinical neuroscience 2000;250(2):57-68.
2000: Hans-Jürgen Möller
Amisulpride: a review of its efficacy in schizophrenia.
Acta psychiatrica Scandinavica. Supplementum 2000;400():17-22.
2000: Hans-Jürgen Möller
Are all antidepressants the same?
The Journal of clinical psychiatry 2000;61 Suppl 6():24-8.
2000: Ulrich Hegerl; Hans-Jürgen Möller
[Pharmacotherapy of depression in the elderly].
Der Nervenarzt 2000;71(1):1-8.
2000: Hans-Jürgen Möller
[Current pharmacologic therapy of depression].
Der Internist 2000;41(1):70-9.
1999: K Bürger née Buch; Frank Padberg; T Nolde; Stefan J Teipel; Susanne Stübner; Andreas Haslinger; Markus Schwarz; Trey Sunderland; Hiroyuki Arai; Stanley I Rapoport; Hans-Jürgen Möller; Harald Hampel
Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.
Neuroscience letters 1999;277(1):21-4.
1999: Hans-Jürgen Möller
Effectiveness and safety of benzodiazepines.
Journal of clinical psychopharmacology 1999;19(6 Suppl 2):2S-11S.
1999: Frank Padberg; Peter Zwanzger; Heike Thoma; Norbert Kathmann; C Haag; Benjamin D Greenberg; Harald Hampel; Hans-Jürgen Möller
Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.
Psychiatry research 1999;88(3):163-71.
1999: Joseph Peuskens; P Bech; Hans-Jürgen Möller; R Bale; Odile Fleurot; Werner Rein
Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Amisulpride study group.
Psychiatry research 1999;88(2):107-17.
1999: R Bottlender; A Buchberger; P Hoff; Hans-Jürgen Möller
[Decision-making and delusion. A study on decision-making in delusional, depressive and healthy subjects].
Der Nervenarzt 1999;70(11):987-92.
1999: S Dittert; Michael Soyka; C Winter; Hans-Jürgen Möller
[Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
Fortschritte der Neurologie-Psychiatrie 1999;Suppl 2():S70-3.
1999: Hans-Jürgen Möller
[Cognition in psychopathology].
Fortschritte der Neurologie-Psychiatrie 1999;Suppl 2():S43.
1999: Frank Padberg; Wolfgang Feneberg; S Schmidt; Markus Schwarz; DA Körschenhausen; Benjamin D Greenberg; T Nolde; Norbert Müller; H Trapmann; N König; Hans-Jürgen Möller; Harald Hampel
CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.
Journal of neuroimmunology 1999;99(2):218-23.
1999: R Bottlender; Hans-Jürgen Möller
Negative symptoms due to sleep apnea syndrome in a patient with a delusional disorder.
European psychiatry : the journal of the Association of European Psychiatrists 1999;14(6):352.
1999: Roland Mergl; Peter Tigges; Andreas Schröter; Hans-Jürgen Möller; Victor Perez
Digitized analysis of handwriting and drawing movements in healthy subjects: methods, results and perspectives.
Journal of neuroscience methods 1999;90(2):157-69.
1999: Stefan Dresel; T Mager; B Rossmüller; Eva M Meisenzahl; Klaus Hahn; Hans-Jürgen Möller; Klaus Tatsch
In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
European journal of nuclear medicine 1999;26(8):862-8.
1999: Reinhard J Boerner; Hans-Jürgen Möller
The importance of new antidepressants in the treatment of anxiety/depressive disorders.
Pharmacopsychiatry 1999;32(4):119-26.
1999: Alistair Burns; Martin N Rossor; J Hecker; S Gauthier; H Petit; Hans-Jürgen Möller; SL Rogers; Lawrence Friedhofff
The effects of donepezil in Alzheimer's disease - results from a multinational trial.
Dementia and geriatric cognitive disorders 1999;10(3):237-44.
1999: Hans-Jürgen Möller
Reappraising neurotransmitter-based strategies.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9 Suppl 2():S53-9.
1999: Stefan J Teipel; Harald Hampel; Pietro Pietrini; Gene Alexander; Barry Horwitz; E Daley; Hans-Jürgen Möller; Mark B Schapiro; Stanley I Rapoport
Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease.
Archives of neurology 1999;56(4):467-73.
1999: Harald Hampel; Stefan J Teipel; Frank Padberg; Andreas Haslinger; Matthias Riemenschneider; Markus Schwarz; HU Kötter; Michael Scheloske; K Buch; Susanne Stübner; RA Dukoff; RA Lasser; Norbert Müller; Trey Sunderland; Stanley I Rapoport; Hans-Jürgen Möller
Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.
Brain research 1999;823(1-2):104-12.
1999: Ulrike Wegner; Eva M Meisenzahl; Hans-Jürgen Möller; Hans-Peter Kapfhammer
[Dysmorphophobia--symptom or diagnosis?].
Der Nervenarzt 1999;70(3):233-9.
1999: Joan Massana; Hans-Jürgen Möller; G D Burrows; R M Montenegro
Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder.
International clinical psychopharmacology 1999;14(2):73-80.
1999: Harald Hampel; Frank Padberg; K Buch; J Unger; Susanne Stübner; Hans-Jürgen Möller
[Diagnosis and treatment of Alzheimer-type dementia].
Deutsche medizinische Wochenschrift (1946) 1999;124(5):124-9.
1999: Susanne Stübner; T Schön; Frank Padberg; Stefan J Teipel; Markus Schwarz; Andreas Haslinger; K Buch; RA Dukoff; RA Lasser; Norbert Müller; Trey Sunderland; Stanley I Rapoport; Hans-Jürgen Möller; Harald Hampel
Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130.
Neuroscience letters 1999;259(3):145-8.
1999: Hans-Jürgen Möller
Atypical neuroleptics: a new approach in the treatment of negative symptoms.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():99-107.
1999: Ronald Bottlender; Ulrike Wegner; Johannes Wittmann; Anton Strauss; Hans-Jürgen Möller
Deficit syndromes in schizophrenic patients 15 years after their first hospitalisation: preliminary results of a follow-up study.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():27-36.
1999: Eva M Meisenzahl; Thomas Frodl; J Greiner; Gerda Leinsinger; Klaus Peter Maag; DT Heiss; Klaus Hahn; Victor Perez; Hans-Jürgen Möller
Corpus callosum size in schizophrenia--a magnetic resonance imaging analysis.
European archives of psychiatry and clinical neuroscience 1999;249(6):305-12.
1999: Siegfried Kasper; A Hale; J M Azorin; Hans-Jürgen Möller
Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
European archives of psychiatry and clinical neuroscience 1999;249 Suppl 2():II1-II14.
1999: H Müller; Hans-Jürgen Möller; A Stippel; Mirijam Fric; Frank Grünwald; G Laux; Edzard Klemm; Hans-Jürgen Biersack
SPECT patterns in probable Alzheimer's disease.
European archives of psychiatry and clinical neuroscience 1999;249(4):190-6.
1999: Nikolaus Kleindienst; Waldemar Greil; B Rüger; Hans-Jürgen Möller
The prophylactic efficacy of lithium--transient or persistent?
European archives of psychiatry and clinical neuroscience 1999;249(3):144-9.
1999: Harald Hampel; HU Kötter; Frank Padberg; DA Körschenhausen; Hans-Jürgen Möller
Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis.
Alzheimer disease and associated disorders 1999;13(1):9-19.
1999: Ralf Pukrop; Hans-Jürgen Möller; Henning Sass; Heinrich Sauer; Joachim Klosterkötter; Adelheid Czernik; Michael Krausz; R D Stieglitz; M Lambert; H Matthies; A Schaub; M Woschnik; F Wulfinghoff; Eckhard M Steinmeyer
[Quality of life. Construct validation and the development of a modular system].
Der Nervenarzt 1999;70(1):41-53.
1999: T Frodl-Bauch; Jürgen Gallinat; Eva M Meisenzahl; Hans-Jürgen Möller; Victor Perez
P300 subcomponents reflect different aspects of psychopathology in schizophrenia.
Biological psychiatry 1999;45(1):116-26.
1998: Hans-Peter Volz; Hans-Jürgen Möller
[Opipramol in anxiety and somatoform disorders. Results of a controlled study].
Fortschritte der Neurologie-Psychiatrie 1998;66 Suppl 1():S21-4.
1998: Michael Soyka; C Aichmüller; Ulrich W Preuss; Hans-Jürgen Möller
Effects of acamprosate on psychomotor performance and driving ability in abstinent alcoholics.
Pharmacopsychiatry 1998;31(6):232-5.
1998: T Held; B Hawellek; K Dickopf-Kaschenbach; T Schneider-Axmann; A Schmidtke; Hans-Jürgen Möller
[Violent and non-violent methods of parasuicide: what determines the choice?].
Fortschritte der Neurologie-Psychiatrie 1998;66(11):505-11.
1998: Stefan J Teipel; Harald Hampel; Gene Alexander; Mark B Schapiro; Barry Horwitz; Diane Teichberg; E Daley; H Hippius; Hans-Jürgen Möller; Stanley I Rapoport
Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease.
Neurology 1998;51(5):1381-5.
1998: Hans-Jürgen Möller; Jürgen Gallinat; Victor Perez; M Arató; Z Janka; B Pflug; H Bauer
Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression.
Pharmacopsychiatry 1998;31(5):170-7.
1998: K Broich; F Grünwald; S Kasper; E Klemm; Hans-Jürgen Biersack; Hans-Jürgen Möller
D2-dopamine receptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects.
Pharmacopsychiatry 1998;31(5):159-62.
1998: Stephan Ruhrmann; S Kasper; B Hawellek; B Martinez; G Höflich; T Nickelsen; Hans-Jürgen Möller
Effects of fluoxetine versus bright light in the treatment of seasonal affective disorder.
Psychological medicine 1998;28(4):923-33.
1998: Hans-Jürgen Möller
[How are depressions treated today?].
Krankenpflege Journal 1998;36(6):224-6.
1998: I Maurer; S Zierz; Hans-Jürgen Möller
Carnitine acyltransferases are not changed in Alzheimer disease.
Alzheimer disease and associated disorders 1998;12(2):71-6.
1998: H Müller; Hans-Jürgen Möller
A regression analytical approach to estimate the onset of activity of antidepressants.
European psychiatry : the journal of the Association of European Psychiatrists 1998;13(3):134-7.
1998: Hans-Jürgen Möller; C A Gagiano; D E Addington; L Von Knorring; J F Torres-Plank; C Gaussares
Long-term treatment of chronic schizophrenia with risperidone: an open-label, multicenter study of 386 patients.
International clinical psychopharmacology 1998;13(3):99-106.
1998: Heinz Grunze; R W Greene; Hans-Jürgen Möller; T Meyer; Jörg Walden
Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current.
Brain research 1998;791(1-2):330-4.
1998: Pietro Pietrini; Stefan J Teipel; P Bartenstein; Stanley I Rapoport; Hans-Jürgen Möller; Harald Hampel
PET and the effects of aging and neurodegeneration on brain function: basic principles.
Drug news & perspectives 1998;11(3):161-5.
1998: T Ehrhardt; Harald Hampel; Ulrich Hegerl; Hans-Jürgen Möller
[Behavior therapy competence training--a specific intervention with beginning Alzheimer dementia].
Zeitschrift für Gerontologie und Geriatrie 1998;31(2):112-9.
1998: Manuel B Graeber; Siegfried Kösel; Eva Grasbon-Frodl; Hans-Jürgen Möller; Parviz Mehraein
Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.
Neurogenetics 1998;1(3):223-8.
1998: Hans-Jürgen Möller
Novel antipsychotics and negative symptoms.
International clinical psychopharmacology 1998;13 Suppl 3():S43-7.
1998: H Müller; Hans-Jürgen Möller
Methodological problems in the estimation of the onset of the antidepressant effect.
Journal of affective disorders 1998;48(1):15-23.
1998: Harald Hampel; Trey Sunderland; HU Kötter; C Schneider; Stefan J Teipel; Frank Padberg; RA Dukoff; J Levy; Hans-Jürgen Möller
Decreased soluble interleukin-6 receptor in cerebrospinal fluid of patients with Alzheimer's disease.
Brain research 1998;780(2):356-9.
1998: Thomas Frodl; Eva M Meisenzahl; Jürgen Gallinat; Victor Perez; Hans-Jürgen Möller
Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia.
European archives of psychiatry and clinical neuroscience 1998;248(6):307-13.
1998: Ronald Bottlender; D Rudolf; Anton Strauss; Hans-Jürgen Möller
Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression.
European archives of psychiatry and clinical neuroscience 1998;248(6):296-300.
1998: Hans-Jürgen Möller
Therapeutic strategies based on immunological hypotheses of Alzheimer's disease.
Journal of neural transmission. Supplementum 1998;54():175-86.
1998: Rüdiger Mielke; Hans-Jürgen Möller; Timo Erkinjuntti; B Rosenkranz; M Rother; B Kittner
Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials.
Alzheimer disease and associated disorders 1998;12 Suppl 2():S29-35.
1998: Peter Danos; D Van Roos; S Kasper; T Brömel; K Broich; C Krappel; L Solymosi; Hans-Jürgen Möller
Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: a stereological CT study.
Neuropsychobiology 1998;38(2):80-3.
1998: M Krupinski; A Fischer; Renate Grohmann; Rolf Engel; M Hollweg; Hans-Jürgen Möller
Risk factors for suicides of inpatients with depressive psychoses.
European archives of psychiatry and clinical neuroscience 1998;248(3):141-7.
1998: Hans-Jürgen Möller; M B Graeber
The case described by Alois Alzheimer in 1911. Historical and conceptual perspectives based on the clinical record and neurohistological sections.
European archives of psychiatry and clinical neuroscience 1998;248(3):111-22.
1998: Victor Perez; Ronald Bottlender; Jürgen Gallinat; HJ Kuss; Manfred Ackenheil; Hans-Jürgen Möller
The serotonin syndrome scale: first results on validity.
European archives of psychiatry and clinical neuroscience 1998;248(2):96-103.
1998: Ronald Bottlender; P Dobmeier; Hans-Jürgen Möller
[The effect of selective serotonin-reuptake inhibitors in blood coagulation].
Fortschritte der Neurologie-Psychiatrie 1998;66(1):32-5.
1997: Norbert Müller; Michael Riedel; A Erfurth; Hans-Jürgen Möller
[Immunoglobulin therapy in Gilles de la Tourette syndrome].
Der Nervenarzt 1997;68(11):914-6.
1997: T Sobanski; J P Sieb; G Laux; Hans-Jürgen Möller
[Acoustic hallucinations as a symptom of a REM sleep-associated parasomnia].
Psychiatrische Praxis 1997;24(6):302-3.
1997: M Soyka; C Kirchmayer; G Kotter; C John; E Löhnert; Hans-Jürgen Möller
[New possibilities in therapy and rehabilitation of alcohol dependent patients. Catamnestic study of the efficacy of ambulatory withdrawal therapy exemplified by a model facility].
Fortschritte der Neurologie-Psychiatrie 1997;65(9):407-12.
1997: I Maurer; Hans-Jürgen Möller
Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics.
Molecular and cellular biochemistry 1997;174(1-2):255-9.
1997: Jan Marcusson; M Rother; B Kittner; M Rössner; R J Smith; T Babic; V Folnegovic-Smalc; Hans-Jürgen Möller; K H Labs
A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.
Dementia and geriatric cognitive disorders 1997;8(5):320-8.
1997: Hans-Jürgen Möller; P Boyer; Odile Fleurot; Werner Rein
Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.
Psychopharmacology 1997;132(4):396-401.
1997: R Bottlender; Andreas Erfurth; P Hoff; Hans-Jürgen Möller
[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].
Der Nervenarzt 1997;68(7):591-2.
1997: H P Volz; C H Gleiter; Hans-Jürgen Möller
Brofaromine versus imipramine in in-patients with major depression--a controlled trial.
Journal of affective disorders 1997;44(2-3):91-9.
1997: Harald Hampel; D Schoen; Markus Schwarz; HU Kötter; C Schneider; Trey Sunderland; RA Dukoff; J Levy; Frank Padberg; Susanne Stübner; K Buch; Norbert Müller; Hans-Jürgen Möller
Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease.
Neuroscience letters 1997;228(3):143-6.
1997: Harald Hampel; HU Kötter; Hans-Jürgen Möller
Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.
Alzheimer disease and associated disorders 1997;11(2):78-87.
1997: M Rietschel; D Naber; R Fimmers; Hans-Jürgen Möller; Peter Propping; M M Nöthen
Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.
Neuroreport 1997;8(8):1999-2003.
1997: Manuel B Graeber; Siegfried Kösel; Rupert Egensperger; Richard B Banati; U Müller; Karl Bise; P Hoff; Hans-Jürgen Möller; K Fujisawa; Parviz Mehraein
Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis.
Neurogenetics 1997;1(1):73-80.
1997: Harald Hampel; Stefan J Teipel; HU Kötter; B Horwitz; Thomas Pfluger; T Mager; Hans-Jürgen Möller; F Müller-Spahn
[Structural magnetic resonance tomography in diagnosis and research of Alzheimer type dementia].
Der Nervenarzt 1997;68(5):365-78.
1997: Ronald Bottlender; CG Schütz; Hans-Jürgen Möller; Michael Soyka
Zolpidem dependence in a patient with former polysubstance abuse.
Pharmacopsychiatry 1997;30(3):108.
1997: Hans-Jürgen Möller
[Pharmacotherapy of depressed patients. Increasing the therapeutic arsenal with a new generation of antidepressive drugs].
Fortschritte der Medizin 1997;115(11):30-4, 36.
1997: C Haag; Frank Padberg; Hans-Jürgen Möller
[Transcranial magnetic stimulation. A diagnostic means from neurology as therapy in psychiatry?].
Der Nervenarzt 1997;68(3):274-8.
1997: H Müller; Hans-Jürgen Möller
Methodological considerations and empirical data to the onset of efficacy of antidepressants and to the prediction of therapy outcome.
European psychiatry : the journal of the Association of European Psychiatrists 1997;12(4):177-82.
1997: Hans-Jürgen Möller; Josef Bäuml; F Ferrero; J Fuger; C Geretsegger; S Kasper; Werner Kissling; H Schubert
Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland.
European archives of psychiatry and clinical neuroscience 1997;247(6):291-6.
1997: Victor Perez; Hans-Jürgen Möller
Electroencephalography as a diagnostic instrument in Alzheimer's disease: reviews and perspectives.
International psychogeriatrics / IPA 1997;9 Suppl 1():237-46; discussion 247-52.
1997: T Frodl-Bauch; Norbert Kathmann; Hans-Jürgen Möller; Victor Perez
Dipole localization and test-retest reliability of frequency and duration mismatch negativity generator processes.
Brain topography 1997;10(1):3-8.
1997: M Hollweg; Hans-Peter Kapfhammer; M Krupinski; Hans-Jürgen Möller
[Psychopathological syndromes in treatment with gyrase inhibitors].
Der Nervenarzt 1997;68(1):38-47.
1997: Hans-Jürgen Möller; H Müller
Statistical differentiation between direct and indirect effects of neuroleptics on negative symptoms.
European archives of psychiatry and clinical neuroscience 1997;247(1):1-5.
1996: Edzard Klemm; Peter Danos; F Grünwald; Siegfried Kasper; Hans-Jürgen Möller; Hans-Jürgen Biersack
Temporal lobe dysfunction and correlation of regional cerebral blood flow abnormalities with psychopathology in schizophrenia and major depression--a study with single photon emission computed tomography.
Psychiatry research 1996;68(1):1-10.
1996: Hans-Jürgen Möller; H P Volz
Drug treatment of depression in the 1990s. An overview of achievements and future possibilities.
Drugs 1996;52(5):625-38.
1996: Marcella Rietschel; D Naber; H Oberländer; R Holzbach; R Fimmers; K Eggermann; Hans-Jürgen Möller; Peter Propping; Markus M Nöthen
Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(5):491-6.
1996: Marie Luise Rao; E Pelzer; Andreas Papassotiropoulos; H Tiemeier; L Jönck; Hans-Jürgen Möller
Selective slow-wave sleep deprivation influences blood serotonin profiles and serum melatonin concentrations in healthy subjects.
Biological psychiatry 1996;40(7):664-7.
1996: Marie Luise Rao; S Ruhrmann; B Retey; N Liappis; J Fuger; M Kraemer; Siegfried Kasper; Hans-Jürgen Möller
Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome.
Pharmacopsychiatry 1996;29(5):180-6.
1996: R Horn; Burkhard Ostertun; M Fric; Laszlo Solymosi; A Steudel; Hans-Jürgen Möller
Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment.
Dementia (Basel, Switzerland) 1996;7(4):182-6.
1996: Victor Perez; Georg Juckel; Hans-Jürgen Möller
[Event related brain potentials as indicators of neurochemical dysfunctions in psychiatric patients].
Der Nervenarzt 1996;67(5):360-8.
1996: Hans-Peter Volz; C H Gleiter; Hans-Jürgen Möller
[Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Der Nervenarzt 1996;67(5):339-47.
1996: Marcella Rietschel; Markus M Nöthen; Margot Albus; W Maier; J Minges; Brigitta Bondy; J Körner; S Hemmer; Rolf Fimmers; Hans-Jürgen Möller; Dieter B Wildenauer; Peter Propping
Dopamine D3 receptor Gly9/Ser9 polymorphism and schizophrenia: no increased frequency of homozygosity in German familial cases.
Schizophrenia research 1996;20(1-2):181-6.
1996: Marie Luise Rao; A Deister; G Laux; U Staberock; G Höflich; Hans-Jürgen Möller
Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse.
Pharmacopsychiatry 1996;29(3):97-102.
1996: Klaus Adelhard; A Strauss; Hans-Jürgen Möller
[Correlation between symptoms and diagnosis in pharmacotherapeutic decision process].
Fortschritte der Neurologie-Psychiatrie 1996;64(4):123-31.
1996: S Kraemer; L Hartl; M Böhmer; Hans-Jürgen Möller
[Psychophysiologic and psychologic correlates of the emotional family climate in schizophrenic patients and their family].
Der Nervenarzt 1996;67(3):219-28.
1996: Metin Bagli; Marie Luise Rao; G Höflich; Siegfried Kasper; M Langer; U Barlage; M Beneke; Richard Süverkrüp; Hans-Jürgen Möller
Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
Arzneimittel-Forschung 1996;46(3):247-50.
1996: Hans-Jürgen Möller; H Müller; H P Volz
How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales.
Pharmacopsychiatry 1996;29(2):57-62.
1996: Edzard Klemm; F Grünwald; Siegfried Kasper; Christian Menzel; K Broich; Peter Danos; Karl Reichmann; C Krappel; O Rieker; B Briele; A L Hotze; Hans-Jürgen Möller; Hans-Jürgen Biersack
[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
The American journal of psychiatry 1996;153(2):183-90.
1996: Hans-Peter Volz; C H Gleiter; P C Waldmeier; M Struck; Hans-Jürgen Möller
Brofaromine--a review of its pharmacological properties and therapeutic use.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(1-2):217-45.
1996: Hans-Jürgen Möller
Review: treatment of schizophrenia. State of the art.
European archives of psychiatry and clinical neuroscience 1996;246(5):229-34.
1995: Metin Bagli; G Höflich; Marie Luise Rao; M Langer; P Baumann; M Kolbinger; U Barlage; Siegfried Kasper; Hans-Jürgen Möller
Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.
International journal of clinical pharmacology and therapeutics 1995;33(12):646-52.
1995: Hans-Jürgen Möller; Siegfried Kasper; H Müller; Werner Kissling; J Fuger; S Ruhrmann
A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients.
Pharmacopsychiatry 1995;28(6):249-52.
1995: I Maurer; S Zierz; Hans-Jürgen Möller; F Jerusalem
Neuroleptic associated extrapyramidal symptoms.
The British journal of psychiatry : the journal of mental science 1995;167(4):551-2.
1995: M M Nöthen; Marcella Rietschel; Jeanette Erdmann; H Oberländer; Hans-Jürgen Möller; D Nober; P Propping
Genetic variation of the 5-HT2A receptor and response to clozapine.
Lancet 1995;346(8979):908-9.
1995: Hans-Peter Volz; H Müller; Y Sturm; B Preussler; Hans-Jürgen Möller
Effect of initial treatment with antidepressants as a predictor of outcome after 8 weeks.
Psychiatry research 1995;58(2):107-15.
1995: Hans-Jürgen Möller
The psychopathology of schizophrenia: an integrated view on positive symptoms and negative symptoms.
International clinical psychopharmacology 1995;10 Suppl 3():57-64.
1995: Wolfgang Block; Frank Träber; Christiane Kuhl; M Fric; E Keller; Rolf Lamerichs; H Rink; Hans-Jürgen Möller; Hans H Schild
[1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1995;163(3):230-7.
1995: I Maurer; S Zierz; Hans-Jürgen Möller; F Jerusalem
Cytochrome c oxidase in Alzheimer's disease.
Neurology 1995;45(7):1423.
1995: G Höflich; Siegfried Kasper; K W Burghof; H P Scholl; Hans-Jürgen Möller
Maintenance ECT for treatment of therapy-resistant paranoid schizophrenia and Parkinson's disease.
Biological psychiatry 1995;37(12):892-4.
1995: Bernd Ahrens; Paul Grof; Hans-Jürgen Möller; Bruno Müller-Oerlinghausen; T Wolf
Extended survival of patients on long-term lithium treatment.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 1995;40(5):241-6.
1995: Hans-Jürgen Möller; D von Zerssen
Self-rating procedures in the evaluation of antidepressants.
Psychopathology 1995;28(6):291-306.
1995: Hans-Jürgen Möller
Dementia treatment: a German perspective on psychosocial aspects and therapeutic approaches.
International psychogeriatrics / IPA 1995;7(3):459-70.
1995: Hans-Jürgen Möller
[Recent developments in antipsychotic medication].
Schweizer Archiv für Neurologie und Psychiatrie (Zurich, Switzerland : 1985) 1995;146(5):230-9.
1995: Siegfried Kasper; Hans-Jürgen Möller; S A Montgomery; E Zondag
Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
International clinical psychopharmacology 1995;9 Suppl 4():3-12.
1995: H P Volz; H Müller; Hans-Jürgen Möller
Are there any differences in the safety and efficacy of brofaromine and imipramine between non-elderly and elderly patients with major depression?
Neuropsychobiology 1995;32(1):23-30.
1995: Hans-Jürgen Möller
The negative component in schizophrenia.
Acta psychiatrica Scandinavica. Supplementum 1995;388():11-4.
1995: Hans-Jürgen Möller; H Müller; R L Borison; N R Schooler; G Chouinard
A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.
European archives of psychiatry and clinical neuroscience 1995;245(1):45-9.
1994: Hans-Peter Volz; R D Stieglitz; K Menges; Hans-Jürgen Möller
Somatoform disorders--diagnostic concept, controlled clinical trials, and methodological issues.
Pharmacopsychiatry 1994;27(6):231-7.
1994: Hans-Jürgen Möller; J Fuger; Siegfried Kasper
Efficacy of new generation antidepressants: meta-analysis of imipramine-controlled studies.
Pharmacopsychiatry 1994;27(6):215-23.
1994: B Martinez; Siegfried Kasper; S Ruhrmann; Hans-Jürgen Möller
Hypericum in the treatment of seasonal affective disorders.
Journal of geriatric psychiatry and neurology 1994;7 Suppl 1():S29-33.
1994: Hans-Jürgen Möller
[Suicidal behavior. Clinical picture, diagnosis and therapy].
Der Internist 1994;35(9):849-56.
1994: Hans-Jürgen Möller
[The effect of antidepressive agents on suicide in depressive patients].
Fortschritte der Neurologie-Psychiatrie 1994;62 Suppl 1():19-23.
1994: Hans-Jürgen Möller; I Maurer; B Saletu
Placebo-controlled trial of the xanthine derivative propentofylline in dementia.
Pharmacopsychiatry 1994;27(4):159-65.
1994: H P Volz; H Heimann; J Bellaire; G Laux; Hans-Jürgen Möller
Brofaromine in non-endogenous major depressed inpatients--results of a preliminary dose-finding trial versus tranylcypromine.
Pharmacopsychiatry 1994;27(4):152-8.
1994: H P Scholl; Siegfried Kasper; Peter Danos; G Höflich; Hans-Jürgen Möller
[Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
Der Nervenarzt 1994;65(7):478-81.
1994: Hans-Jürgen Möller
Non-response to antidepressants: risk factors and therapeutic possibilities.
International clinical psychopharmacology 1994;9 Suppl 2():17-23.
1994: Hans-Jürgen Möller; H M van Praag; B Aufdembrinke; P Bailey; Thomas R E Barnes; J Beck; H Bentsen; F X Eich; L Farrow; W W Fleischhacker
Negative symptoms in schizophrenia: considerations for clinical trials. Working group on negative symptoms in schizophrenia.
Psychopharmacology 1994;115(1-2):221-8.
1994: H P Volz; Hans-Jürgen Möller
Antidepressant drug therapy in the elderly--a critical review of the controlled clinical trials conducted since 1980.
Pharmacopsychiatry 1994;27(3):93-100.
1994: Hans-Jürgen Möller; Eckhard M Steinmeyer
Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(1):55-9.
1994: Peter Danos; Siegfried Kasper; H P Scholl; J Kaiser; S Ruhrmann; G Höflich; Hans-Jürgen Möller
Clinical response to sleep deprivation and auditory-evoked potentials--preliminary results.
Pharmacopsychiatry 1994;27(2):70-1.
1994: H P Volz; F Faltus; I Magyar; Hans-Jürgen Möller
Brofaromine in treatment-resistant depressed patients--a comparative trial versus tranylcypromine.
Journal of affective disorders 1994;30(3):209-17.
1994: G Höflich; K W Burghof; Siegfried Kasper; Hans-Jürgen Möller
[Electroconvulsive therapy in comorbidity of treatment refractory paranoid hallucinatory psychoses with Parkinson disease].
Der Nervenarzt 1994;65(3):202-5.
1994: Siegfried Kasper; S Ruhrmann; T Haase; Hans-Jürgen Möller
Evidence for a seasonal form of recurrent brief depression (RBD-seasonal).
European archives of psychiatry and clinical neuroscience 1994;244(4):205-10.
1994: Marie Luise Rao; Hans-Jürgen Möller
Biochemical findings of negative symptoms in schizophrenia and their putative relevance to pharmacologic treatment. A review.
Neuropsychobiology 1994;30(4):160-72.
1994: H P Volz; A Mackert; A Diefenbacher; A Friedrich; W Gaebel; H Müller; G Stock; Hans-Jürgen Möller
Orthostatic challenge during neuroleptic test dose: a possible predictor of short-term outcome.
Neuropsychobiology 1994;30(2-3):94-100.
1993: Hans-Jürgen Möller; H P Volz
Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(4):501-10.
1993: E Klemm; Hans-Jürgen Möller
[Aggressive episodes without amnesia. Differential diagnostic problems based on a case report].
Der Nervenarzt 1993;64(7):474-7.
1993: F Grünwald; R Horn; O Rieker; Edzard Klemm; Christian Menzel; Hans-Jürgen Möller; Hans-Jürgen Biersack
[HMPAO-SPECT in Alzheimer-type dementia and major depression with memory disorders].
Nuklearmedizin. Nuclear medicine 1993;32(3):128-33.
1993: Hans-Jürgen Möller; H Berzewski; F Eckmann; N Gonzalves; Werner Kissling; W Knorr; P Ressler; G A Rudolf; Eckhard M Steinmeyer; I Magyar
Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients.
Pharmacopsychiatry 1993;26(3):75-8.
1993: Siegfried Kasper; M Dötsch; H Kick; A Vieira; Hans-Jürgen Möller
Plasma concentrations of fluvoxamine and maprotiline in major depression: implications on therapeutic efficacy and side effects.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):13-21.
1993: Hans-Jürgen Möller
Neuroleptic treatment of negative symptoms in schizophrenic patients. Efficacy problems and methodological difficulties.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1993;3(1):1-11.
1993: Hans-Jürgen Möller; M Krokenberger; D von Zerssen
Prediction of short-term outcome of neurotic-depressive inpatients. Results of an empirical study of 134 inpatients.
European archives of psychiatry and clinical neuroscience 1993;242(5):301-9.
1992: Hans-Jürgen Möller
Antidepressants--do they decrease or increase suicidality?
Pharmacopsychiatry 1992;25(6):249-53.
1992: Hans-Jürgen Möller; H P Volz
Brofaromine in major depressed patients: a controlled clinical trial versus imipramine and open follow-up of up to one year.
Journal of affective disorders 1992;26(3):163-72.
1992: Hans-Jürgen Möller
Attempted suicide: efficacy of different aftercare strategies.
International clinical psychopharmacology 1992;6 Suppl 6():58-69.
1992: E M Steinmeyer; Hans-Jürgen Möller
Facet theoretic analysis of the Hamilton-D scale.
Journal of affective disorders 1992;25(1):53-61.
1992: Siegfried Kasper; J Fuger; H J Zinner; J Bäuml; Hans-Jürgen Möller
Early clinical results with the neuroleptic roxindole (EMD 49,980) in the treatment of schizophrenia--an open study.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1992;2(1):91-5.
1992: Siegfried Kasper; S Ruhrmann; T Haase; Hans-Jürgen Möller
Recurrent brief depression and its relationship to seasonal affective disorder.
European archives of psychiatry and clinical neuroscience 1992;242(1):20-6.
1992: Siegfried Kasper; J Fuger; Hans-Jürgen Möller
Comparative efficacy of antidepressants.
Drugs 1992;43 Suppl 2():11-22; discussion 22-3.
1991: Hans-Jürgen Möller
[Therapy resistance to antidepressive drugs: risk factors and treatment possibilities].
Der Nervenarzt 1991;62(11):658-69.
1991: Hans-Jürgen Möller; E Pelzer; Werner Kissling; T Riehl; T Wernicke
Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Pharmacopsychiatry 1991;24(6):185-9.
1991: Hans-Jürgen Möller
[Drug treatment strategies in antidepressive drug therapy-resistant depression].
Klinische Wochenschrift 1991;69(9):413-5.
1991: Hans-Jürgen Möller
Outcome criteria in antidepressant drug trials: self-rating versus observer-rating scales.
Pharmacopsychiatry 1991;24(3):71-5.
1991: Hans-Jürgen Möller; G Wendt; P Waldmeier
Brofaromine--a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findings.
Pharmacopsychiatry 1991;24(2):50-4.
1991: Hans-Jürgen Möller; T Riehl; T Dietzfelbinger; T Wernicke
A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression.
International clinical psychopharmacology 1991;6(3):179-92.
1990: Hans-Jürgen Möller; Eckhard M Steinmeyer
Mood curves of neurotic-depressive patients undergoing treatment with antidepressants: time-series analyses of experience with HTAKA model.
Pharmacopsychiatry 1990;23(5):215-21.
1990: Detlev von Zerssen; C A León; Hans-Jürgen Möller; Hans-Ulrich Wittchen; H Pfister; N Sartorius
Care strategies for schizophrenic patients in a transcultural comparison.
Comprehensive psychiatry 1990;31(5):398-408.
1990: Hans-Jürgen Möller
[A real advance in therapy for clinical practice].
Fortschritte der Medizin. Supplement : die Kongressinformation für die Praxis 1990;103():17-9.
1990: Bernd Saletu; Hans-Jürgen Möller; Josef Grünberger; H Deutsch; M Rössner
Propentofylline in adult-onset cognitive disorders: double-blind, placebo-controlled, clinical, psychometric and brain mapping studies.
Neuropsychobiology 1990;24(4):173-84.
1989: Hans-Jürgen Möller
Efficacy of different strategies of aftercare for patients who have attempted suicide.
Journal of the Royal Society of Medicine 1989;82(11):643-7.
1989: Hans-Jürgen Möller; G Wendt
[Brofaromine--a selective, reversible and short-acting MAO-A inhibitor].
Psychiatrische Praxis 1989;16 Suppl 1():32-6.
1989: Hans-Jürgen Möller; M Hohe-Schramm; C Cording-Tömmel; W Schmid-Bode; Hans-Ulrich Wittchen; M Zaudig; Detlev von Zerssen
The classification of functional psychoses and its implications for prognosis.
The British journal of psychiatry : the journal of mental science 1989;154():467-72.
1989: Hans-Jürgen Möller; R Blank; E M Steinmeyer
Single-case evaluation of sleep-deprivation effects by means of nonparametric time-series analysis (according to the HTAKA model)
European archives of psychiatry and neurological sciences 1989;239(2):133-9.
1989: Hans-Jürgen Möller; Werner Kissling; T Riehl; J Bäuml; U Binz; G Wendt
Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol.
Progress in neuro-psychopharmacology & biological psychiatry 1989;13(1-2):127-36.
1989: Hans-Jürgen Möller; Werner Kissling; T Dietzfelbinger; K D Stoll; G Wendt
Efficacy and tolerability of a new antipsychotic compound (savoxepine): results of a pilot-study.
Pharmacopsychiatry 1989;22(1):38-41.
1988: Hans-Jürgen Möller; G Haug
Secondary and meta-analysis of the efficacy of non-tricyclic antidepressants.
Pharmacopsychiatry 1988;21(6):363-4.
1988: Hans-Jürgen Möller; K Meier; T Wernicke
Empirical investigation on the risk of agranulocytosis/leucopenia under medication with antidepressants.
Pharmacopsychiatry 1988;21(6):304-5.
1988: Hans-Jürgen Möller; W Kissling; P Baumann; U Breyer-Pfaff; A Delini-Stula; F Holsboer; G Jungkunz; H Kuhs; G Laux; W E Müller; W Baumann
Non-response to antidepressants: risk factors and therapeutic possibilities.
Pharmacopsychiatry 1988;21(6):285-7.
1988: Peter Riederer; G Laux; Helmut Beckmann; B Saletu; P Waldmeier; J Fritze; M DaPrada; Hans-Jürgen Möller; M Schmauss; Horst Przuntek
The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives.
Pharmacopsychiatry 1988;21(6):283-4.
1988: Hans-Jürgen Möller; M Leitner
Typology of mood assessment curves by means of cluster analysis of computerized mathematical descriptions of time-series mood data collected from depressive inpatients treated with antidepressants.
Pharmacopsychiatry 1988;21(4):192-6.
1988: Hans-Jürgen Möller; M Leitner
A non-linear mathematical model for computerized analysis of mood curves: construction of the model and its application to the mood curves of depressive and schizophrenic inpatients.
Journal of affective disorders 1988;14(3):203-11.
1988: Hans-Jürgen Möller; W Schmid-Bode; C Cording-Tömmel; Hans-Ulrich Wittchen; M Zaudig; Detlev von Zerssen
Psychopathological and social outcome in schizophrenia versus affective/schizoaffective psychoses and prediction of poor outcome in schizophrenia. Results from a 5-8 year follow-up.
Acta psychiatrica Scandinavica 1988;77(4):379-89.
1988: Hans-Jürgen Möller; H Hacker
Study concerning the sample dependency and temporal variance of the factor structure in the Inpatient Multidimensional Psychiatric Scale.
Psychopathology 1988;21(6):281-90.
1987: Hans-Jürgen Möller; G Fischer; Detlev von Zerssen
Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients.
European archives of psychiatry and neurological sciences 1987;236(6):349-57.
1987: Hans-Jürgen Möller; M Leitner; T Dietzfelbinger
A linear mathematical model for computerized analyses of mood curves. An empirical investigation on mood courses in depressive and schizophrenic inpatients.
European archives of psychiatry and neurological sciences 1987;236(5):260-8.
1987: Hans-Jürgen Möller; M Leitner
Optimizing a nonlinear mathematical approach for the computerized analysis of mood curves.
Psychopathology 1987;20(5-6):255-67.
1986: Hans-Jürgen Möller; Werner Kissling; B Herberger; U Binz; G Wendt; H Spahn
Controlled trial on the possible advantages of a combined therapy with maprotiline and haloperidol in endogenous depression.
Pharmacopsychiatry 1986;19(5):362-4.
1986: Hans-Jürgen Möller
[Neuroleptics and tranquilizers: indications and dangers].
Medizinische Klinik (Munich, Germany : 1983) 1986;81(11):385-8.
1986: Hans-Jürgen Möller; W Kissling; P Bottermann
The dexamethasone suppression test in depressive and schizophrenic patients under controlled treatment conditions.
European archives of psychiatry and neurological sciences 1986;235(5):263-8.
1986: Hans-Jürgen Möller; W Schmid-Bode; D von Zerssen
Prediction of long-term outcome in schizophrenia by prognostic scales.
Schizophrenia bulletin 1986;12(2):225-34.
1986: Hans-Jürgen Möller; W Kissling
Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
Clinical neuropharmacology 1986;9 Suppl 4():259-62.
1985: Hans-Jürgen Möller; W Scharl; D von Zerssen
[Prediction of therapeutic success in acute neuroleptic treatment: results of an empirical study of 243 inpatient-treated schizophrenic patients].
Fortschritte der Neurologie-Psychiatrie 1985;53(10):370-83.
1985: Hans-Jürgen Möller; D von Zerssen
[Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
Der Nervenarzt 1985;56(9):498-505.
1985: W Kissling; Hans-Jürgen Möller; K Walter; B Wittmann; R Krueger; D Trenk
Double-blind comparison of haloperidol decanoate and fluphenazine decanoate effectiveness, side-effects, dosage and serum levels during a six months' treatment for relapse prevention.
Pharmacopsychiatry 1985;18(3):240-5.
1985: F Bürk; Alexander Kurz; Hans-Jürgen Möller
Suicide risk scales: do they help to predict suicidal behaviour?
European archives of psychiatry and neurological sciences 1985;235(3):153-7.
1984: Hans-Jürgen Möller; W Schmid-Bode; Detlev von Zerssen
[Development of new prognosis indices for patients with schizophrenic diseases and evaluation of their predictive validity].
Fortschritte der Neurologie-Psychiatrie 1984;52(12):421-7.
1984: Hans-Jürgen Möller; W Kissling; P Bottermann
Serial application of clonidine tests during antidepressive treatment with chlorimipramine.
Pharmacopsychiatry 1984;17(6):184-7.
1984: Hans-Jürgen Möller; W Scharl; D von Zerssen
[Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses].
Der Nervenarzt 1984;55(7):358-64.
1984: Hans-Jürgen Möller; C Griesshammer; H Hacker
[Life change events preceding acute psychiatric diseases].
European archives of psychiatry and neurological sciences 1984;234(2):118-24.
1984: Hans-Jürgen Möller; W Scharl; D von Zerssen
[The Strauss-Carpenter Scale: evaluation of its prognostic value for the 5-year outcome of schizophrenic patients].
European archives of psychiatry and neurological sciences 1984;234(2):112-7.
1984: Hans-Jürgen Möller; Werner Kissling; B Herberger; H J Kuss
[Controlled study on the possible benefits of combination therapy with chlorimipramine and haloperidol inpatients with endogenous depression].
Pharmacopsychiatry 1984;17(1):29-33.
1984: Hans-Jürgen Möller
[Gangrene of the extremities following intravenous injection of neuroleptics].
Der Nervenarzt 1984;55(1):43-5.
1983: Hans-Jürgen Möller; W Kissling; D von Zerssen
[Prognostic value of the early response of psychiatric patients to neuroleptics for the subsequent course of treatment].
Pharmacopsychiatria 1983;16(2):46-9.
1983: Hans-Jürgen Möller; D von Zerssen
[Psychopathometric procedures: II. Standardized assessment procedures].
Der Nervenarzt 1983;54(1):1-16.
1982: Hans-Jürgen Möller; W Kissling; C Lang; P Doerr; K M Pirke; Detlev von Zerssen
Efficacy and side effects of haloperidol in psychotic patients: oral versus intravenous administration.
The American journal of psychiatry 1982;139(12):1571-5.
1982: Hans-Jürgen Möller; D von Zerssen
[Psychopathometric methods: I. General part].
Der Nervenarzt 1982;53(9):493-503.
1982: Hans-Jürgen Möller; K Werner-Eilert; M Wüschner-Stockheim; D von Zerssen
[Relevant predictors of the 5 year outcome of patients with schizophrenic or similar paranoid psychoses (author's transl)].
Archiv für Psychiatrie und Nervenkrankheiten 1982;231(4):305-22.
1982: Hans-Jürgen Möller; D von Zerssen; K Werner-Eilert; M Wüschner-Stockheim
Outcome in schizophrenic and similar paranoid psychoses.
Schizophrenia bulletin 1982;8(1):99-108.
1982: Hans-Jürgen Möller; D von Zerssen
Depressive states occurring during the neuroleptic treatment of schizophrenia.
Schizophrenia bulletin 1982;8(1):109-17.
1981: Hans-Jürgen Möller; D von Zerssen
[Depressive states in schizophrenic in-patients on admission and at discharge (author's transl)].
Der Nervenarzt 1981;52(9):525-30.
1981: Hans-Jürgen Möller; D V von Zerssen
[Depressive states during the clinical treatment of 280 schizophrenic inpatients (author's transl)].
Pharmacopsychiatria 1981;14(5):172-9.
1981: Hans-Jürgen Möller; D von Zerssen; M Wüschner-Stockheim; K Werner-Eilert
[The prognostic value of psychopathometric data about the psychopathological state of schizophrenic patients on admission and discharge (author's transl)].
Archiv für Psychiatrie und Nervenkrankheiten 1981;231(1):13-34.
1981: H M Emrich; D von Zerssen; W Kissling; Hans-Jürgen Möller
On a possible role of GABA in mania. Therapeutic efficacy of sodium valproate.
Advances in biochemical psychopharmacology 1981;26():287-96.
1981: Hans-Jürgen Möller; D von Zerssen; K Werner-Eilert; M Wüschner-Stockheim
[Psychopathometric examinations on patients with schizophrenia and related psychoses (author's transl)].
Archiv für Psychiatrie und Nervenkrankheiten 1981;230(4):275-92.
1980: H M Emrich; D von Zerssen; W Kissling; Hans-Jürgen Möller; A Windorfer
Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.
Archiv für Psychiatrie und Nervenkrankheiten 1980;229(1):1-16.